# HSBC Holdings plc Pillar 3 Disclosures at 31 December 2024

## Contents

| Page | Item |
|---|---|
| 3 | Introduction |
| 3 | Pillar 3 Disclosures and Governance |
| 5 | Highlights |
| 6 | Key metrics |
| 7 | Regulatory developments and Key changes |
| 9 | Linkage to the Annual Report and Accounts 2024 |
| 13 | Risk management |
| 16 | Treasury risk management |
| 17 | Own funds |
| 19 | Capital buffers |
| 19 | Pillar 1 minimum capital requirements and RWA flow |
| 23 | Leverage |
| 25 | Liquidity |
| 30 | Asset encumbrance |
| 31 | Pillar 2 and ICAAP |
| 32 | Minimum requirement for own funds and eligible liabilities |
| 40 | Credit risk |
| 87 | Counterparty credit risk |
| 93 | Securitisation |
| 99 | Market risk |
| 104 | Non-financial risk |
| 105 | Other risks |
| 106 | Countercyclical capital buffer |
| 108 | Board Diversity |
| 109 | Appendix I – Summary of disclosures withheld |
| 109 | Appendix II – Mapping - Internal ratings to external ratings |
| 110 | Compliance with CRR II Pillar 3 requirements |
| 125 | Other information |
| 125 | Abbreviations |
| 126 | Cautionary statement regarding forward-looking statements |
| 128 | Contacts |

Unless the context requires otherwise, ‘HSBC Holdings’ means HSBC Holdings plc and ‘HSBC’, the ‘Group’, ‘we’, ‘us’ and ‘our’ refer to HSBC Holdings together with its subsidiaries. Within this document the Hong Kong Special Administrative Region of the People’s Republic of China is referred to as ‘Hong Kong’. When used in the terms ‘shareholders’ equity’ and ‘total shareholders’ equity’, ‘shareholders’ means holders of HSBC Holdings ordinary shares and those preference shares and capital securities issued by HSBC Holdings classified as equity. The abbreviations ‘$m’, ‘$bn’ and ‘$tn’ represent millions, billions (thousands of millions) and trillions (millions of millions) of US dollars respectively.

This document should be read in conjunction with the Annual Report and Accounts 2024, which has been published on our website at www.hsbc.com/investors.

## Tables

| Page | Table Reference | Activity |
|---|---|---|
| 6 | Table 1: Key metrics (KM1/IFRS9-FL) | |
| 9 | Table 2: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2) | |
| 10 | Table 3: Principal entities with a different regulatory and accounting scope of consolidation (LI3) | |
| 11 | Table 4: Differences between accounting and regulatory scopes of consolidation and mapping of financial statement categories with regulatory risk categories (LI1) | |
| 12 | Table 5: Main sources of differences between regulatory exposure amounts and carrying values in financial statements (LI2) | |
| 17 | Table 6: Composition of Regulatory own funds (UK CC1) | |
| 20 | Table 7: Overview of risk-weighted exposure amounts (OV1) | |
| 21 | Table 8: RWA flow statements of credit risk exposures under the IRB approach (CR8) | |
| 21 | Table 9: RWA flow statements of CCR exposures under IMM (CCR7) | |
| 22 | Table 10: RWA flow statements of market risk exposures under IMA (MR2-B) | |
| 23 | Table 11: Leverage ratio common disclosure (UK LR2-LRCom) | |
| 24 | Table 12: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1- LRSum) | |
| 24 | Table 13: Leverage ratio – split of on-balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3-LRSpl) | |
| 26 | Table 14: Quantitative information of LCR (LIQ1) | |
| 27 | Table 15: Net stable funding ratio (LIQ2) | |
| 30 | Table 16: Quantitative information on IRRBB (UK IRRBB1) | |
| 30 | Table 17: Encumbered and unencumbered assets (UK AE1) | |
| 31 | Table 18: Collateral received and own debt securities issued (UK AE2) | |
| 31 | Table 19: Sources of encumbrance (UK AE3) | |
| 34 | Table 20.i: Key metrics of the European resolution group (KM2) | |
| 34 | Table 20.ii: Key metrics of the Asian resolution group | |
| 35 | Table 20.iii: Key metrics of the US resolution group | |
| 36 | Table 21: TLAC composition (TLAC1) | |
| 37 | Table 22: HSBC Holdings plc creditor ranking (TLAC3) | |
| 37 | Table 23: HSBC UK Bank plc creditor ranking (TLAC2) | |
| 38 | Table 24: HSBC Bank plc creditor ranking (TLAC2) | |
| 38 | Table 25: HSBC Asia Holdings Ltd creditor ranking¹ (TLAC3) | |
| 39 | Table 26: The Hongkong and Shanghai Banking Corporation Limited creditor ranking (TLAC2) | |
| 39 | Table 27: Hang Seng Bank Ltd creditor ranking (TLAC2) | |
| 40 | Table 28: HSBC North America Holdings Inc. creditor ranking¹ (TLAC3) | |
| 41 | Table 29: Performing and non-performing exposures and related provisions (CR1) | |
| 43 | Table 30: Maturity of exposures (CR1-A) | |
| 43 | Table 31: Changes in the stock of non-performing loans and advances (CR2) | |
| 44 | Table 32: Credit quality of forborne exposures (CQ1) | |
| 45 | Table 33: Credit quality of performing and non-performing exposures by past due days (CQ3) | |
| 46 | Table 34: Collateral obtained by taking possession and execution processes (CQ7) | |
| 47 | Table 35: Quality of non-performing exposures by geography (CQ4) | |
| 48 | Table 36: Credit quality of loans and advances to non-financial corporations by industry (CQ5) | |
| 49 | Table 37: Credit risk mitigation techniques – overview (CR3) | |
| 50 | Table 38: Standardised approach – credit conversion factor ('CCF') and credit risk mitigation ('CRM') effects (CR4) | |
| 51 | Table 39: IRB – Effect on the RWA of credit derivatives used as CRM techniques (CR7) | |
| 52 | Table 40: IRB approach – Disclosure of the extent of the use of CRM techniques (CR7-A) | |
| 54 | Table 41: Specialised lending and equity exposures under the simple risk-weight approach (CR10) | |
| 55 | Table 41.i: Equity exposures under simple risk-weighted approach (CR10) | |
| 56 | Table 42: Scope of the use of IRB and SA approaches (UK CR6-A) | |
| 58 | Table 43: CQS reference table | |
| 59 | Table 44: Standardised approach – exposures by asset classes and risk weights (CR5) | |
| 60 | Table 45: IRB – Credit risk exposures by portfolio and PD range (CR6) | |
| 65 | Table 45: IRB – Credit risk exposures by portfolio and PD range (CR6) (continued) | |
| 75 | Table 46: Wholesale IRB credit risk models | |
| 76 | Table 48: Wholesale IRB exposure – back-testing of probability of default (PD) per portfolio¹ (CR9) | |
| 83 | Table 50: Retail IRB models – estimated and actual values | |
| 84 | Table 51: Retail IRB exposure – back-testing of probability of default (PD) per portfolio (CR9) | |
| 86 | Table 51: Retail IRB exposure – back-testing of probability of default (PD) per portfolio (CR9) (continued) | |
| 88 | Table 52: Analysis of counterparty credit risk exposure by approach (excluding centrally cleared exposures) (CCR1) | |
| 89 | Table 53: Credit valuation adjustment capital charge (CCR2) | |
| 89 | Table 54: Standardised approach – CCR exposures by regulatory exposure class and risk weights (CCR3) | |
| 90 | Table 55: Composition of collateral for CCR exposure (CCR5) | |
| 90 | Table 56: Credit derivatives exposures (CCR6) | |
| 91 | Table 57: Exposures to central counterparties (CCR8) | |
| 92 | Table 58: IRB – CCR exposures by portfolio and PD scale (CCR4) | |
| 95 | Table 59: Securitisation exposures in the non-trading book (SEC1) | |
| 96 | Table 60: Securitisation exposures in the trading book (SEC2) | |
| 97 | Table 61: Securitisation exposures in the non-trading book and associated regulatory capital requirements – bank acting as originator or as sponsor (SEC3) | |
| 98 | Table 62.i: Securitisation exposures in the non-trading book and associated capital requirements – bank acting as investor (SEC4) | |
| 98 | Table 62.ii: Securitisation exposures in the trading book and associated capital requirements – bank acting as investor (SEC4) | |
| 99 | Table 63: Exposures securitised by the institution – Institution acts as originator or as sponsor (SEC5) | |
| 100 | Table 64: Market risk under standardised approach (MR1) | |
| 100 | Table 65: Market risk under IMA (MR2-A) | |
| 102 | Table 66: Comparison of VaR estimates with gains/losses (MR4) | |
| 103 | Table 67: IMA values for trading portfolios (MR3) | |
| 104 | Table 68: Prudential valuation adjustments (PV1) | |
| 105 | Table 69: Operational risk own funds requirements and risk-weighted exposure amounts¹ (OR1) | |
| 107 | Table 70: Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer (UK CCyB1) | |
| 108 | Table 71: Amount of institution-specific countercyclical capital buffer (UK CCyB2) | |

# Introduction

## Pillar 3 Disclosures and Governance

### Regulatory framework for disclosure

Our Pillar 3 Disclosures at 31 December 2024 comprise both quantitative and qualitative information required under Pillar 3. These disclosures are made in accordance with the Prudential Regulation Authority (‘PRA’) Rulebook Disclosure (Capital Requirements Regulation). They are supplemented by specific additional requirements of the PRA and discretionary disclosures on our part.

We are supervised on a consolidated basis in the United Kingdom (‘UK’) by the PRA, which receives information on the capital and liquidity adequacy of, and sets capital and liquidity requirements for the Group as a whole. Individual banking subsidiaries are directly regulated by their local banking supervisors, who set and monitor their local capital and liquidity adequacy requirements. In most jurisdictions, non-banking financial subsidiaries are also subject to the supervision and capital and liquidity requirements of local regulatory authorities.

The Basel Committee on Banking Supervision (‘Basel’) III framework is structured around three ‘pillars’, with Pillar 1 minimum capital requirements and Pillar 2 supervisory review process complemented by the Pillar 3 market discipline. The aim of Pillar 3 is to produce disclosures that allow market participants to assess the scope of application by banks of the Basel framework and the rules in their jurisdiction, their capital resources, risk exposures and risk management processes, and hence their capital adequacy.

At the consolidated Group level, capital is calculated for prudential regulatory purposes using the Basel III framework as implemented in the UK. Any references to European Union (‘EU’) regulations and directives (including technical standards) should, as applicable, be read as references to the UK’s version of such regulation and/or directive, as onshored into UK law under the European Union (Withdrawal) Act 2018, and may be subsequently amended under UK law. We refer to the regulatory requirements of the Capital Requirements Regulation and Directive, the CRR II regulation and the PRA Rulebook as ‘CRR II’.

The regulators of the Group’s banking entities outside the UK are at varying stages of implementation of Basel’s framework, so local regulation may have been on the basis of Basel I, II, III or Basel 3.1. Further details on our implementations from 1 January 2025 can be found on page 7 within the Regulatory developments section.

While the frameworks may vary for some of our banking subsidiaries they do not impact the Group’s disclosures. However, the changes to local regulatory frameworks may impact distributions from our subsidiaries.

Information relating to the rationale for withholding certain disclosures is provided in Appendix I.

We publish our Pillar 3 disclosures quarterly on our website www.hsbc.com/investors.

### Regulatory reporting processes and controls

We are advancing a comprehensive initiative aimed at strengthening our global regulatory reporting processes and making them more sustainable. This multifaceted programme includes enhancing data, consistency and controls. This remains a key priority for both HSBC management and regulatory authorities.

While this programme continues, there may be further impacts on some of our regulatory ratios, such as the common equity tier 1 (‘CET1’) ratio, liquidity coverage ratio (‘LCR’) and net stable funding ratio (‘NSFR’), as we implement recommended changes and continue to enhance our controls across the process.

### Comparatives and references

To give insight into movements during 2024, we provide comparative figures, commentary on variances and flow tables for capital requirements. In all tables where the term ‘capital requirements’ is used, this represents the minimum total capital charge set at 8% of risk-weighted assets (‘RWAs’) by Article 92(1) of CRR II. Narratives are included to explain quantitative disclosures where necessary.

Where disclosures have been enhanced, or are new, we do not generally restate or provide comparatives. Wherever specific rows and columns in the tables prescribed are not applicable or are immaterial to our activities, we omit them and follow the same approach for comparatives.

In alignment with the PRA Rulebook table requirements, we have shaded cells where no information is required to be disclosed.

Pillar 3 requirements may be met by inclusion in other disclosure media. Where we adopt this approach, references are provided to the relevant pages of the Annual Report and Accounts 2024 of HSBC Holdings plc or to other documents.

The table below references where comparatives have been restated.

| Page ref | Table Reference | Activity |
|---|---|---|
| 6 and 27 | Table 1: Key metrics (KM1/IFRS9-FL) | Updated net stable funding ratio (‘NSFR’) based on enhanced calculation. |
| 30 | Table 16: Net stable funding ratio (LIQ2) | Introduction of banking net interest income (‘BNII’) sensitivity to align with the Annual Reports and Accounts. |

The table below references where disclosures have been enhanced.

| Page ref | Table Reference | Activity |
|---|---|---|
| 6, 26 and 27 | Table 1 – KM1/IFRS9-FL | Enhanced liquidity consolidation process during 2024 by revising provisions that addressed historical limitations. |
| Table 15 – UK LIQ1 | | |
| Table 16 – UK LIQ2 | | |
| 17 | Table 6 – UK CC1 | Updated the classification between components of shareholders’ equity. |
| 22 | Table 10 – MR2-B | Enhanced to present the RWA movements on a FX spot basis. |
| 30 | Table 14 – IRRBB1 | Introduction of BNII sensitivity and application of simplified pass-on assumptions to align with the Annual Reports and Accounts. |
| 38 | Table 24 – TLAC2 (HSBC Bank plc) | Enhanced disclosures for subordinated notes and loans owned by the resolution entity. |
| 43 | Table 30 – CR1-A | Enhanced disclosures to align to CR1. |
| 46 | Table 35 – CQ4 | Disclosure of our materiality applied to the data presented in this table. |
| 60 | Table 51 – CR6 | Enhanced to include value adjustment and provision disclosure split by PD bands. |
| 89 | Table 55 – CCR5 | Enhanced disclosures to align to EBA Q&A guidelines. |
| 90 | Table 57 – CCR8 | Enhanced disclosure for pre-funded and unfunded default fund contributions. |

## Governance

The HSBC Holdings Board of Directors (‘Board’) continued to oversee the governance, operation and oversight of the Group and its principal and material subsidiaries.

The HSBC Pillar 3 disclosures at 31 December 2024 comply with the PRA Rulebook. They are approved by the Board of Directors and are governed by the Group’s disclosure policy and internal controls framework as approved by the Group Audit Committee (‘GAC’).

This Pillar 3 disclosure report was approved by the HSBC Board on 19 February 2025 and signed on its behalf by

Pam Kaur
Group Chief Financial Officer

For further details of our Corporate Governance, see page 236 of the Annual Report and Accounts 2024.

# Highlights

## CET1 Capital and ratio

Our CET1 capital was \$124.9bn and our ratio was 14.9%, up marginally as compared with the prior year as capital generation and a reduction in RWAs through strategic transactions, were offset by dividends, share buy-backs and organic balance sheet growth.

We intend to continue to manage the CET1 capital ratio within our medium-term target range of 14% to 14.5%, with a dividend payout ratio target basis of 50% for 2025, excluding material notable items and related impacts.

The Board has approved a fourth interim dividend of \$0.36 per share, resulting in a total of \$0.87 per share in respect of 2024, inclusive of a special dividend of \$0.21 per share. We also intend to initiate a share buy-back of up to \$2bn, which we expect to complete by our first quarter 2025 results announcement.

### Capital and ratio

```mermaid
bar chart
    title Capital and ratio (\$bn)
    section CET1 Capital
        31 Dec 23: 126.5
        31 Mar 24: 131.4
        30 Jun 24: 125.3
        30 Sep 24: 126.3
        31 Dec 24: 124.9
    section CET1 Ratio (%)
        31 Dec 23: 14.8%
        31 Mar 24: 15.2%
        30 Jun 24: 15.0%
        30 Sep 24: 15.2%
        31 Dec 24: 14.9%
```

### Ratio movement

```mermaid
bar chart
    title Ratio movement
    section CET1 4Q23
        CET1 4Q23: 14.8
    section Regulatory profits
        Regulatory profits: 3.4
    section Dividend
        Dividend: -1.6
    section Share buy back
        Share buy back: -1.4
    section Strategic initiatives
        Strategic initiatives: 0.9
    section Change in RWAs
        Change in RWAs: -0.9
    section FX translation differences
        FX translation differences: -0.1
    section Others
        Others: -0.2
    section CET1 4Q24
        CET1 4Q24: 14.9
```

### RWAs

Our RWAs are \$838.3bn, a decrease of \$15.8bn compared with 31 December 2023, mainly due to strategic disposals of \$47.8bn and foreign currency translation differences of \$22.2bn, which were partly offset by asset size movements of \$49.4bn and credit migrations of \$6.3bn.

#### RWAs by risk type

| Risk-weighted assets | 31 Dec 2024 \$bn | 31 Dec 2023 \$bn |
|---|---|---|
| Credit risk | 657.9 | 683.9 |
| Counterparty credit risk | 37.7 | 35.5 |
| Market risk | 36.2 | 37.5 |
| Operational risk | 106.5 | 97.2 |
| **Total RWAs** | **838.3** | **854.1** |

### Leverage

Our leverage ratio was 5.6%, unchanged during the year. This was due to the leverage exposures decrease, primarily from strategic disposals and adverse foreign currency translation differences, which exceeded the increase in the underlying balance sheet. This was offset by a fall in the tier 1 capital.

| Leverage | 31 Dec 2024 | 31 Dec 2023 |
|---|---|---|
| Leverage ratio (%) | 5.6 | 5.6 |

### Liquidity

The Group LCR was 138% or \$179bn above the regulatory requirement and the average high-quality liquid assets (‘HQLA’) were \$649bn. The Group NSFR was 143%. At 31 December 2024, all material operating entities were above regulatory minimum levels.

We enhanced our liquidity consolidation process in 2Q24 by revising provisions that addressed historical limitations. As our Group LCR and NSFR are reported on an average basis, the benefit of these changes incrementally increased our LCR and NSFR by circa 3% and 11% during the year, respectively. Compared to year ended 31 December 2023, the increase in LCR was mainly driven by these enhancements. The associated NSFR increase driven by these changes was partly offset by higher required stable funding primarily due to a rise in financial investments and derivatives activities.

| Liquidity | 31 Dec 2024 | 31 Dec 2023 |
|---|---|---|
| LCR (%) | 138 | 136 |
| NSFR (%)* | 143 | 138 |

* We enhanced our calculation process during 1Q24 and our NSFR comparative has been restated.

## Key metrics

The table below sets out the key regulatory metrics covering the Group's available capital (including buffer requirements and ratios), RWAs, Leverage ratio, LCR and NSFR. Unless stated otherwise, figures have been prepared on an IFRS 9 transitional basis, which ends from 1 January 2025. Capital figures and ratios are reported on a CRR II transitional basis for capital instruments and the leverage ratio is calculated using the CRR II end point basis for capital. The calculation for LCR is the average of the preceding 12 months for each quarter and NSFR is the average of the preceding four quarters.

Table 1: Key metrics (KM1/IFRS9-FL)

| | At | | | | |
|---|---|---|---|---|---|
| | 31 Dec 2024 | 30 Sep 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
| **Available capital (\$bn)** | | | | | |
| 1 Common equity tier 1 (‘CET1’) capital | 124.9 | 131.4 | 125.3 | 126.3 | 126.5 |
| CET1 capital as if IFRS 9 transitional arrangements had not been applied | 124.9 | 131.4 | 125.3 | 126.3 | 126.4 |
| 2 Tier 1 capital | 144.1 | 150.6 | 144.3 | 144.1 | 144.2 |
| Tier 1 capital as if IFRS 9 transitional arrangements had not been applied | 144.1 | 150.6 | 144.3 | 144.1 | 144.1 |
| 3 Total capital | 172.4 | 179.8 | 172.1 | 172.5 | 171.2 |
| Total capital as if IFRS 9 transitional arrangements had not been applied | 172.4 | 179.8 | 172.1 | 172.5 | 171.1 |
| **Risk-weighted assets (\$bn)** | | | | | |
| 4 Total RWAs | 838.3 | 863.9 | 835.1 | 832.6 | 854.1 |
| Total RWAs as if IFRS 9 transitional arrangements had not been applied | 838.2 | 863.9 | 835.1 | 832.6 | 854.0 |
| **Capital ratios (%)** | | | | | |
| 5 CET1 | 14.9 | 15.2 | 15.0 | 15.2 | 14.8 |
| CET1 as if IFRS 9 transitional arrangements had not been applied | 14.9 | 15.2 | 15.0 | 15.2 | 14.8 |
| 6 Tier 1 | 17.2 | 17.4 | 17.3 | 17.3 | 16.9 |
| Tier 1 as if IFRS 9 transitional arrangements had not been applied | 17.2 | 17.4 | 17.3 | 17.3 | 16.9 |
| 7 Total capital | 20.6 | 20.8 | 20.6 | 20.7 | 20.0 |
| Total capital as if IFRS 9 transitional arrangements had not been applied | 20.6 | 20.8 | 20.6 | 20.7 | 20.0 |
| **Additional own funds requirements based on Supervisory Review and Evaluation Process (‘SREP’) as a percentage of RWAs (%)** | | | | | |
| UK-7a Additional CET1 SREP requirements | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
| UK-7b Additional tier 1 (‘AT1’) SREP requirements | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| UK-7c Additional tier 2 (‘T2’) SREP requirements | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| UK-7d Total SREP own funds requirements | 10.6 | 10.6 | 10.6 | 10.6 | 10.6 |
| **Combined buffer requirement as a percentage of RWAs (%)** | | | | | |
| 8 Capital conservation buffer requirement | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| 9 Institution-specific countercyclical capital buffer | 0.7 | 0.8 | 0.7 | 0.7 | 0.7 |
| 10 Global systemically important institution buffer | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
| 11 Combined buffer requirement | 5.2 | 5.3 | 5.2 | 5.2 | 5.2 |
| UK-11a Overall capital requirements | 15.8 | 15.9 | 15.8 | 15.8 | 15.8 |
| 12 CET1 available after meeting the total SREP own funds requirements | 8.9 | 9.2 | 9.0 | 9.2 | 8.8 |
| **Leverage ratio** | | | | | |
| 13 Total exposure measure excluding claims on central banks (\$bn) | 2,571.1 | 2,657.8 | 2,514.5 | 2,528.0 | 2,574.8 |
| 14 Leverage ratio excluding claims on central banks (%) | 5.6 | 5.7 | 5.7 | 5.7 | 5.6 |
| **Additional leverage ratio disclosure requirements** | | | | | |
| 14a Fully loaded expected credit losses (‘ECL’) accounting model leverage ratio excluding claims on central banks (%) | 5.6 | 5.7 | 5.7 | 5.7 | 5.6 |
| 14b Leverage ratio including claims on central banks (%) | 4.9 | 5.0 | 5.0 | 5.0 | 4.8 |
| 14c Average leverage ratio excluding claims on central banks (%) | 5.5 | 5.7 | 5.7 | 5.6 | 5.7 |
| 14d Average leverage ratio including claims on central banks (%) | 4.9 | 5.0 | 5.0 | 4.9 | 4.9 |
| 14e Countercyclical leverage ratio buffer (%) | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 |
| EU-14d Leverage ratio buffer requirement (%) | 0.9 | 1.0 | 1.0 | 1.0 | 0.9 |
| EU-14e Overall leverage ratio requirements (%) | 4.2 | 4.3 | 4.3 | 4.3 | 4.2 |
| **Liquidity coverage ratio (‘LCR’) (\$bn)¹** | | | | | |
| 15 Total high-quality liquid assets | 649.2 | 649.2 | 646.1 | 645.8 | 647.5 |
| UK-16a Cash outflows – total weighted value | 656.3 | 657.9 | 660.1 | 666.6 | 672.3 |
| UK-16b Cash inflows – total weighted value | 185.6 | 184.9 | 187.8 | 192.8 | 195.2 |
| 16 Total net cash outflow | 470.7 | 473.0 | 472.3 | 473.8 | 477.1 |
| 17 LCR (%) | 138 | 137 | 137 | 136 | 136 |
| **Net stable funding ratio ('NSFR') (\$bn)¹,²** | | | | | |
| 18 Total available stable funding | 1,523.4 | 1,538.7 | 1,544.1 | 1,571.9 | 1,601.9 |
| 19 Total required stable funding | 1,064.5 | 1,092.7 | 1,115.1 | 1,151.1 | 1,162.3 |
| 20 NSFR (%) | 143 | 141 | 138 | 137 | 138 |

1 We enhanced our liquidity consolidation process in 2Q24 by revising provisions that addressed historical limitations. As our Group LCR and NSFR are reported on an average basis, the benefit of these changes incrementally increased our LCR and NSFR by circa 3% and 11% during the year, respectively. Compared to year ended 31 December 2023, the increase in LCR was mainly driven by these enhancements. The associated NSFR increase driven by these changes was partly offset by higher required stable funding primarily due to a rise in financial investments and derivatives activities.
2 We enhanced our calculation processes during 1Q24 and our NSFR comparatives have been restated.

## Regulatory developments

### Basel 3.1

Near-final rules in relation to the market risk, credit valuation adjustments, counterparty risk and operational risk elements of the Basel 3.1 package were published by the PRA in December 2023. In September 2024, the PRA published its near final rules on the credit risk, output floor and reporting and disclosure elements of the Basel 3.1 standards. The key changes include:
– an adjustment to the calculation of the output floor to reflect the different treatment of accounting provisions under the standardised approach and the Internal Ratings Based (‘IRB’) approach;
– changes to the credit conversion factors applicable to off balance sheet exposures;
– the introduction of new firm-specific adjustments in Pillar 2A for small and medium sized enterprises ('SMEs') and infrastructure lending and simplifying the definition of SMEs; and
– changes to the real estate requirements, such as in relation to valuation and the removal of commercial real estate floor.

In October 2024, the PRA published a consultation on incorporating the remaining elements of the UK’s Capital Requirements Regulation into its rulebook, which included further changes arising from Basel 3.1, such as in relation to the securitisation framework.

In September 2024, the PRA’s proposed implementation date for the package was 1 January 2026, with a transitional period of four years; however, in January 2025, this was delayed until 1 January 2027 to allow time for greater clarity in the implementation plans of the US. The transitional period has also been reduced to three years, so that the date of full implementation remains 1 January 2030.

We continue to assess the impact of Basel 3.1 standards on our capital, including the recent release of more beneficial PRA near-final rules, developments in the US and associated implementation challenges (including data provision). We expect that the impact on our CET 1 ratio at 1 January 2027 will be a modest benefit.

Across the other major jurisdictions that are key to HSBC, the progress of implementation varies:
– EU: The majority of the Basel 3.1 provisions went live on 1 January 2025; however, the market risk rules have been delayed until 1 January 2026.
– US: Final rules have yet to be published. The implementation date remains uncertain.
– Hong Kong: The final Basel 3.1 package went live on 1 January 2025.

### IFRS 9 transitional arrangements

We have adopted the regulatory transitional arrangements of the CRR II for IFRS 9, including paragraph four of article 473a. These allow banks to add back to their capital base a proportion of the impact that IFRS 9 has upon their loan loss allowances. Our capital and ratios are presented under these arrangements throughout the tables in this disclosure, including the end point figures. This transitional period ended 1 January 2025.

### Counterparty risk management

In December 2024, the Basel Committee on Banking Supervision (‘Basel’) published final guidelines for counterparty risk (‘CCR’) management. The guidelines set out key practices for CCR management, which include the need to:
– conduct comprehensive due diligence;
– develop a comprehensive credit risk mitigation strategy;
– measure, control and limit CCR using a wide variety of complementary metrics; and
– build a strong CCR governance framework.

### Large exposures

In October 2024, the PRA published proposals to implement the remaining elements of Basel’s large exposures standards. These include changes relating to the use of credit risk mitigation techniques and limits on trading book exposures.

### Environmental, social and governance (‘ESG’) risk

Globally, regulators and standard setters continue to publish multiple proposals and discussion papers on ESG topics. In recent years, this included multiple consultations on sustainability-related disclosure across jurisdictions including the UK, the EU, the US, Hong Kong and globally through the International Sustainability Standards Board (‘ISSB’) and Basel.

The work by Basel on climate-related financial risks across all three pillars of regulation, supervision and disclosure is ongoing. The initial work concluded that climate risk drivers, including physical and transition risks can be captured in traditional financial risk categories such as credit, market, operational and liquidity risks. As part of its wider efforts to improve ESG risk coverage, Basel is expected to finalise its work on the proposed Pillar 3 disclosures framework for climate-related financial risks in the first half of 2025 and has proposed an effective date of 1 January 2026.

## Key changes

In 2024, the below changes have impacted our capital and liquidity adequacy.

### Sale of our retail banking operations in France

In January 2024, we completed the sale of our retail banking operations in France and we recognised a \$2.0bn loss with no material incremental impact on CET1. Our leverage exposures decreased by \$15.4bn. In accordance with the terms of the sale, we retained a €7.1bn (\$7.4bn) portfolio of home and other loans. During the fourth quarter of 2024 we began to actively market this retained portfolio for sale. On 1 January 2025 we reclassified this portfolio as hold-to-collect-and sell and expect to recognise an estimated \$1bn fair value pre-tax loss in ‘other comprehensive income’ in equity on the remeasurement of the financial instruments in 1Q25. This had an immaterial impact on liquidity metrics.

### Sale of our banking business in Canada

On 28 March 2024, HSBC completed the sale of HSBC Bank Canada to the Royal Bank of Canada. The associated gain on sale of \$4.8bn, including the recycling of related reserves, added approximately 0.8 percentage points to our CET1 ratio in Q1 2024. The Board approved a special dividend of \$0.21 per share, paid in June 2024 alongside the first interim dividend. Leverage exposures were reduced by \$85.4bn and Group RWAs reduced by \$35.8bn, including the impact from the foreign exchange hedges for the Canada sale proceeds and the operational risk RWAs post the PRA waiver permission granted in October 2024. This had an immaterial impact on liquidity metrics.

### Sale of our banking business in Argentina

On 6 December 2024, HSBC completed the sale of HSBC Argentina to Grupo Financiero Galicia with a loss of \$1bn on disposal and recycling of FX reserves of \$5.2bn. As at 31 December 2024, this had an immaterial capital impact and leverage exposures decreased by \$6bn.This had an immaterial impact on liquidity metrics.

### Other disposals

We have completed other disposals within the Group in 2024 which had immaterial impacts on capital and liquidity adequacy.

### Hong Kong residential mortgages and countercyclical buffer

On 18 October 2024, the Hong Kong Monetary Authority (‘HKMA’) announced two changes with immediate effect. These were related to the removal of the 15% risk-weight floor for Hong Kong residential mortgages loans under the internal ratings-based approach. As directed by the PRA this floor was included for group reporting, this change resulted in a \$7.5bn decrease to our RWAs. Additionally HKMA announced a reduction to the countercyclical capital buffer (‘CCyB’) buffer from 1% to 0.5%.

For further details of assets held for sale, liabilities of disposal groups held for sale and business acquisitions, see page 3 and Note 23 on page 411 of the Annual Report and Accounts 2024.

### Our new organisational structure

Effective from 1 January 2025, we have implemented a new organisational business structure that aims to unleash our full potential by building on our strong progress in recent years and driving our success into the future.

#### Hong Kong

Being the market leader in our home market of Hong Kong is one of our clear strengths and remains a strategic priority.

#### UK

Our UK ring-fenced bank has a leading market position in our home market of the UK and will continue to be a critical pillar of our strategy.

#### Corporate and Institutional Banking

Our new Corporate and Institutional Banking business is a market leader in cross-border transaction banking and capital markets, and integrates our Commercial Banking business (outside the UK and Hong Kong) with our Global Banking and Markets business.

#### International Wealth and Premier Banking

This business brings together Premier focused banking (outside Hong Kong and the UK), our Global Private Bank, and our wealth manufacturing businesses of Asset Management and Insurance.

#### Group Operating Committee

To align with the new structure, a new Group Operating Committee comprised of 12 members will serve as the leading decision-making committee of the Group, replacing the Group Executive Committee of 18 members. The Group’s functions will also be realigned to mirror the new business structure.

* Both our Hong Kong and UK businesses will serve our personal customers and commercial clients residing in these home markets.

For further details on our senior management team, see page 242 of the Annual Report and Accounts 2024.

# Linkage to the Annual Report and Accounts 2024

This section demonstrates the links between the Group’s audited financial balance sheet and its regulatory counterpart.

### Structure of the regulatory group

The regulatory consolidation is consistent with the accounting consolidation, with the following exceptions:
– the subsidiaries engaged in insurance activities are equity accounted in the regulatory consolidation and then deducted from CET1 capital, subject to thresholds;
– the special purpose entities (‘SPEs’) are excluded where significant risk has been transferred to third parties. Exposures to these SPEs are risk weighted as securitisation positions for regulatory purposes;
– the participating interests in banking associates are proportionally consolidated for regulatory purposes by including our share of assets, liabilities, profits and losses, and RWAs in accordance with the PRA’s regulatory requirements; and
– non-participating significant investments are deducted from capital, subject to thresholds.

For further details of the differences between the accounting and regulatory scope of consolidation and their definition of exposure, see pages 9 to 12.

The table below presents the reconciliation between the Group's financial balance sheet and the regulatory scope of consolidation. The regulatory balance sheet value cannot be directly reconciled to other tables within the regulatory scope of consolidation as it is not a measure of RWAs, but rather, it is derived from an accounting measure. It discloses an analysis of the regulatory reporting balance sheet by risk type.

Table 2: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2)

| Ref † | Accounting balance sheet \$m | Deconsolidation of insurance/ other entities \$m | Consolidation of banking associates \$m | Equity accounting of Insurance subsidiaries \$m | Regulatory balance sheet \$m |
|---|---|---|---|---|---|
| **Assets** | | | | | |
| Cash and balances at central banks | 267,674 | (11) | 338 | — | 268,001 |
| Hong Kong Government certificates of indebtedness | 42,293 | — | — | — | 42,293 |
| Trading assets | 314,842 | (418) | — | — | 314,424 |
| Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | 115,769 | (103,195) | 924 | — | 13,498 |
| – of which: debt securities eligible as tier 2 issued by Group Financial Sector Entities (‘FSEs’) that are outside the regulatory scope of consolidation | q | — | 136 | — | — | 136 |
| Derivatives | 268,637 | 26 | 184 | — | 268,847 |
| Loans and advances to banks | k | 102,039 | (883) | 1,781 | — | 102,937 |
| Loans and advances to customers | k | 930,658 | 27 | 20,869 | — | 951,554 |
| – of which: lending eligible as Tier 2 to Group FSEs outside the regulatory scope of consolidation | q | — | 335 | — | — | 335 |
| – expected credit losses on IRB portfolios | h | (6,980) | — | — | — | (6,980) |
| Reverse repurchase agreements – non-trading | 252,549 | 1,230 | — | — | 253,779 |
| Financial investments | 493,166 | (7,104) | 7,972 | — | 494,034 |
| – of which: lending eligible as Tier 2 to Group FSEs outside the regulatory scope of consolidation | q | — | 524 | — | — | 524 |
| Assets held for sale | 27,234 | (24,222) | — | — | 3,012 |
| – of which: goodwill and intangible assets | e | 5 | — | — | — | 5 |
| – of which: expected credit losses on IRB portfolios | h | (3) | — | — | — | (3) |
| Capital invested in insurance and other entities | — | 3,709 | — | 3,513 | 7,222 |
| – of which: positive goodwill on acquisition | e | — | 234 | — | — | 234 |
| Prepayments, accrued income and other assets | 152,740 | (6,634) | 872 | — | 146,978 |
| – of which: retirement benefit assets | j | 7,548 | — | — | — | 7,548 |
| Current tax assets | 1,313 | (19) | — | — | 1,294 |
| Interests in associates and joint ventures | 28,909 | (474) | (6,041) | — | 22,394 |
| – of which: positive goodwill on acquisition | e | 462 | (10) | — | — | 452 |
| Goodwill and intangible assets | e | 12,384 | (468) | 914 | — | 12,830 |
| Deferred tax assets | f | 6,841 | (1,115) | 55 | — | 5,781 |
| **Total assets at 31 Dec 2024** | **3,017,048** | **(139,551)** | **27,868** | **3,513** | **2,908,878** |
| **Liabilities and equity** | | | | | |
| Hong Kong currency notes in circulation | 42,293 | — | — | — | 42,293 |
| Deposits by banks | 73,997 | 5 | 3,113 | — | 77,115 |
| Customer accounts | 1,654,955 | 4,246 | 21,503 | — | 1,680,704 |
| Repurchase agreements – non-trading | 180,880 | (426) | 840 | — | 181,294 |
| Trading liabilities | 65,982 | — | — | — | 65,982 |
| Financial liabilities designated at fair value | 138,727 | (5,436) | — | — | 133,291 |
| – of which: included in tier 2 | n,p,i | 9,241 | — | — | — | 9,241 |
| Derivatives | 264,448 | 100 | 182 | — | 264,730 |
| – of which: debit valuation adjustment | k | (24) | — | — | — | (24) |
| Debt securities in issue | 105,785 | (1,351) | — | — | 104,434 |
| Liabilities of disposals group held for sale | 29,011 | (23,419) | — | — | 5,592 |
| – of which: credit-related contingent liabilities and contractual commitments on IRB portfolios | h | — | — | — | — | — |
| Accruals, deferred income and other liabilities | 130,340 | (2,106) | 1,607 | — | 129,841 |
| Liabilities and equity | | | | | |
| Current tax liabilities | 1,729 | (282) | 152 | — | 1,599 |
| Insurance contract liabilities | 107,629 | (107,629) | — | — | — |
| Provisions | 1,724 | (20) | 87 | — | 1,791 |
| – of which: credit-related contingent liabilities and contractual commitments on IRB portfolios | h | 529 | — | — | — | 529 |
| Deferred tax liabilities | 1,317 | 9 | — | — | 1,326 |
| Subordinated liabilities | 25,958 | — | 419 | — | 26,377 |
| – of which: included in tier 2 | n,o,p | 25,003 | — | — | — | 25,003 |
| **Total liabilities at 31 Dec 2024** | **2,824,775** | **(136,309)** | **27,903** | **—** | **2,716,369** |
| **Equity** | | | | | |
| Called up share capital | a | 8,973 | — | — | — | 8,973 |
| Share premium account | a | 14,810 | — | — | — | 14,810 |
| Other equity instruments | l | 19,070 | — | — | — | 19,070 |
| Other reserves | b,c,g | (10,282) | 2,284 | (18) | 6,053 | (1,963) |
| Retained earnings | b,c,i | 152,402 | (5,332) | 18 | (2,540) | 144,548 |
| Total shareholders’ equity | 184,973 | (3,048) | — | 3,513 | 185,438 |
| Non-controlling interests | d,m,p | 7,300 | (194) | (35) | — | 7,071 |
| **Total equity at 31 Dec 2024** | **192,273** | **(3,242)** | **(35)** | **3,513** | **192,509** |
| **Total liabilities and equity at 31 Dec 2024** | **3,017,048** | **(139,551)** | **27,868** | **3,513** | **2,908,878** |

† The references (a)–(q) identify balance sheet components that are used in the calculation of regulatory capital in Table 6: Composition of Regulatory own funds (‘UK CC1’). This table shows such items at their accounting values, which may be subject to analysis or adjustment in the calculation of regulatory capital shown in Table 6.

The table below lists the principal entities to which different accounting methods are applied under the regulatory scope of consolidation and refer to the structure of the regulatory group above.

Table 3: Principal entities with a different regulatory and accounting scope of consolidation (LI3)

| | At 31 Dec 2024 | | | | | |
|---|---|---|---|---|---|---|
| Principal associates | Principal activities | Method of accounting consolidation | Method of regulatory consolidation | | | |
| | | | Proportional consolidation | Neither consolidated nor deducted | Equity method | Deducted from capital subject to thresholds |
| Saudi Awwal Bank | Banking services | Equity | u | | | |
| **Principal insurance entities** | | | | | | |
| HSBC Life (International) Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Assurances Vie (France) | Life insurance manufacturing | Fully consolidated | u | | | |
| Hang Seng Insurance Company Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Insurance (Singapore) Pte Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Life (UK) Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Life Assurance (Malta) Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Life Insurance Company Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Seguros S.A. (Mexico) | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Life (Singapore) Pte. Ltd. | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Insurance (Bermuda) Ltd | Reinsurance | Fully consolidated | u | | | |
| **Principal SPEs** | | | | | | |
| Metrix Portfolio Distribution plc | Securitisation | Fully consolidated | u | | | |
| Neon Portfolio Distribution DAC | Securitisation | Fully consolidated | u | | | |
| Regency Assets DAC | Securitisation | Fully consolidated | u | | | |

Table 2: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2) (continued)

| Ref † | Accounting balance sheet \$m | Deconsolidation of insurance/ other entities \$m | Consolidation of banking associates \$m | Equity accounting of Insurance subsidiaries \$m | Regulatory balance sheet \$m |
|---|---|---|---|---|---|
| **Liabilities and equity** | | | | | |
| Hong Kong currency notes in circulation | 42,293 | — | — | — | 42,293 |
| Deposits by banks | 73,997 | 5 | 3,113 | — | 77,115 |
| Customer accounts | 1,654,955 | 4,246 | 21,503 | — | 1,680,704 |
| Repurchase agreements – non-trading | 180,880 | (426) | 840 | — | 181,294 |
| Trading liabilities | 65,982 | — | — | — | 65,982 |
| Financial liabilities designated at fair value | 138,727 | (5,436) | — | — | 133,291 |
| – of which: included in tier 2 | n,p,i | 9,241 | — | — | — | 9,241 |
| Derivatives | 264,448 | 100 | 182 | — | 264,730 |
| – of which: debit valuation adjustment | k | (24) | — | — | — | (24) |
| Debt securities in issue | 105,785 | (1,351) | — | — | 104,434 |
| Liabilities of disposals group held for sale | 29,011 | (23,419) | — | — | 5,592 |
| – of which: credit-related contingent liabilities and contractual commitments on IRB portfolios | h | — | — | — | — | — |
| Accruals, deferred income and other liabilities | 130,340 | (2,106) | 1,607 | — | 129,841 |
| Liabilities and equity | | | | | |
| Current tax liabilities | 1,729 | (282) | 152 | — | 1,599 |
| Insurance contract liabilities | 107,629 | (107,629) | — | — | — |
| Provisions | 1,724 | (20) | 87 | — | 1,791 |
| – of which: credit-related contingent liabilities and contractual commitments on IRB portfolios | h | 529 | — | — | — | 529 |
| Deferred tax liabilities | 1,317 | 9 | — | — | 1,326 |
| Subordinated liabilities | 25,958 | — | 419 | — | 26,377 |
| – of which: included in tier 2 | n,o,p | 25,003 | — | — | — | 25,003 |
| **Total liabilities at 31 Dec 2024** | **2,824,775** | **(136,309)** | **27,903** | **—** | **2,716,369** |
| **Equity** | | | | | |
| Called up share capital | a | 8,973 | — | — | — | 8,973 |
| Share premium account | a | 14,810 | — | — | — | 14,810 |
| Other equity instruments | l | 19,070 | — | — | — | 19,070 |
| Other reserves | b,c,g | (10,282) | 2,284 | (18) | 6,053 | (1,963) |
| Retained earnings | b,c,i | 152,402 | (5,332) | 18 | (2,540) | 144,548 |
| Total shareholders’ equity | 184,973 | (3,048) | — | 3,513 | 185,438 |
| Non-controlling interests | d,m,p | 7,300 | (194) | (35) | — | 7,071 |
| **Total equity at 31 Dec 2024** | **192,273** | **(3,242)** | **(35)** | **3,513** | **192,509** |
| **Total liabilities and equity at 31 Dec 2024** | **3,017,048** | **(139,551)** | **27,868** | **3,513** | **2,908,878** |

† The references (a)–(q) identify balance sheet components that are used in the calculation of regulatory capital in Table 6: Composition of Regulatory own funds (‘UK CC1’). This table shows such items at their accounting values, which may be subject to analysis or adjustment in the calculation of regulatory capital shown in Table 6.

The table below lists the principal entities to which different accounting methods are applied under the regulatory scope of consolidation and refer to the structure of the regulatory group above.

Table 3: Principal entities with a different regulatory and accounting scope of consolidation (LI3)

| | At 31 Dec 2024 | | | | | |
|---|---|---|---|---|---|---|
| Principal associates | Principal activities | Method of accounting consolidation | Method of regulatory consolidation | | | |
| | | | Proportional consolidation | Neither consolidated nor deducted | Equity method | Deducted from capital subject to thresholds |
| Saudi Awwal Bank | Banking services | Equity | u | | | |
| **Principal insurance entities** | | | | | | |
| HSBC Life (International) Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Assurances Vie (France) | Life insurance manufacturing | Fully consolidated | u | | | |
| Hang Seng Insurance Company Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Insurance (Singapore) Pte Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Life (UK) Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Life Assurance (Malta) Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Life Insurance Company Ltd | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Seguros S.A. (Mexico) | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Life (Singapore) Pte. Ltd. | Life insurance manufacturing | Fully consolidated | u | | | |
| HSBC Insurance (Bermuda) Ltd | Reinsurance | Fully consolidated | u | | | |
| **Principal SPEs** | | | | | | |
| Metrix Portfolio Distribution plc | Securitisation | Fully consolidated | u | | | |
| Neon Portfolio Distribution DAC | Securitisation | Fully consolidated | u | | | |
| Regency Assets DAC | Securitisation | Fully consolidated | u | | | |

## Measurement of regulatory exposures

This section sets out the main reasons why the measurement of regulatory exposures is not directly comparable with the financial information presented in the Annual Report and Accounts 2024.

The Pillar 3 Disclosures at 31 December 2024 are prepared in accordance with regulatory capital and liquidity adequacy concepts and rules, while the Annual Report and Accounts 2024 is prepared in accordance with IFRSs. The regulatory exposure value includes an estimation of risk, and is expressed as the amount expected to be outstanding were the counterparty to default.

Moreover, regulatory exposure classes are based on different criteria from accounting asset types and are therefore not comparable on a line by line basis.

The table below provides a breakdown of assets and liabilities under the accounting and regulatory scope of consolidation, by risk types that form the basis for regulatory capital requirements and the link to regulatory exposure value.

Table 4: Differences between accounting and regulatory scopes of consolidation and mapping of financial statement categories with regulatory risk categories (LI1)

| | Carrying value of items | | | | | |
|---|---|---|---|---|---|---|
| | Carrying values as reported in published financial statements \$bn | Carrying values under scope of regulatory consolidation¹ \$bn | Subject to the credit risk framework \$bn | Subject to the counter party credit risk framework² \$bn | Subject to the securitisation framework³ \$bn | Subject to the market risk framework⁴ \$bn | Not subject to own funds requirements or subject to deduction from own funds \$bn |
| **Assets** | | | | | | | |
| Cash and balances at central banks | 267.7 | 268.0 | 268.0 | — | — | — | — |
| Hong Kong Government certificates of indebtedness | 42.3 | 42.3 | 42.3 | — | — | — | — |
| Trading assets | 314.8 | 314.4 | 3.5 | 25.2 | 0.1 | 312.4 | — |
| Financial assets designated and otherwise mandatorily measured at fair value | 115.8 | 13.5 | 7.6 | 5.6 | 0.1 | — | 0.2 |
| Derivatives | 268.6 | 268.8 | — | 268.4 | 0.4 | 268.8 | — |
| Loans and advances to banks | 102.0 | 102.9 | 102.5 | 0.4 | — | — | — |
| Loans and advances to customers | 930.7 | 951.6 | 919.0 | 0.2 | 31.9 | — | 0.5 |
| Reverse repurchase agreements – non-trading | 252.5 | 253.8 | — | 253.8 | — | — | — |
| Financial investments | 493.2 | 494.0 | 491.8 | — | 1.8 | — | 0.4 |
| Assets held for sale | 27.2 | 3.0 | 3.0 | — | — | — | — |
| Capital invested in insurance and other entities | — | 7.2 | 3.4 | — | — | 3.8 |
| Prepayments, accrued income and other assets | 152.8 | 147.1 | 53.0 | 65.2 | — | 13.7 | 21.8 |
| Current tax assets | 1.3 | 1.3 | 1.3 | — | — | — | — |
| Interests in associates and joint ventures⁵ | 28.9 | 22.4 | 10.6 | — | — | — | 11.8 |
| Goodwill and intangible assets | 12.4 | 12.8 | — | — | — | — | 12.3 |
| Deferred tax assets | 6.8 | 5.8 | 5.2 | — | — | — | 0.6 |
| **Total assets at 31 Dec 2024** | **3,017.0** | **2,908.9** | **1,911.2** | **618.8** | **34.3** | **594.9** | **51.4** |
| **Liabilities** | | | | | | | |
| Hong Kong currency notes in circulation | 42.3 | 42.3 | — | — | — | — | 42.3 |
| Deposits by banks | 74.0 | 77.1 | — | — | — | — | 77.1 |
| Customer accounts | 1,655.0 | 1,680.7 | — | — | — | — | 1,680.7 |
| Repurchase agreements – non-trading | 180.9 | 181.3 | — | 181.3 | — | — | — |
| Trading liabilities | 66.0 | 66.0 | — | 18.4 | — | 66.0 | — |
| Financial liabilities designated at FV | 138.7 | 133.3 | — | — | — | 63.8 | 69.5 |
| Derivatives | 264.4 | 264.7 | — | 264.7 | — | 264.7 | — |
| Debt securities in issue | 105.8 | 104.4 | — | — | — | — | 104.4 |
| Liabilities for disposal groups held for sale | 29.0 | 5.6 | — | — | — | — | 5.6 |
| Accruals, deferred income, and other liabilities | 130.4 | 129.9 | — | 58.0 | — | — | 71.9 |
| Current tax liabilities | 1.7 | 1.6 | — | — | — | — | 1.6 |
| Liabilities under insurance contract | 107.6 | — | — | — | — | — | — |
| Provisions | 1.7 | 1.8 | 0.7 | — | — | — | 1.1 |
| Deferred tax liabilities | 1.3 | 1.3 | 0.9 | — | — | — | 2.8 |
| Subordinated liabilities | 26.0 | 26.4 | — | — | — | — | 26.4 |
| **Total liabilities at 31 Dec 2024** | **2,824.8** | **2,716.4** | **1.6** | **522.4** | **—** | **394.5** | **2,083.4** |

1 The amounts shown do not equal the sum of the amounts shown in the remaining columns of this table for line items ‘Derivatives’, ’Trading assets’, ‘Assets held for sale’ and ‘Prepayments, accrued income and other assets’ as some of the assets in this column are subject to regulatory capital charges for credit risk, counterparty credit risk and market risk.
2 The amounts shown include both non-trading book and trading book.
3 The amounts shown are non-trading book positions. Trading book securitisation positions are included in the market risk column.
4 The amounts shown do not consider exposures subject to foreign exchange risk RWA calculations.
5 Our investment in BoCom is recognised as a significant investment in a financial sector entity. At 31 December 2024, \$11.4bn was deducted from CET1 and \$26.4bn RWAs were reported for this investment, with a related exposure of \$10.6bn.

Table 5: Main sources of differences between regulatory exposure amounts and carrying values in financial statements (LI2)

| of which items subject to: | Total \$bn | Credit risk framework \$bn | Securitisation framework \$bn | CCR framework \$bn | Market risk framework \$bn |
|---|---|---|---|---|---|
| 1 Assets carrying value amount under the scope of regulatory consolidation (as per template LI1) | 2,857.5 | 1,911.2 | 34.3 | 618.8 | 594.9 |
| 2 Liabilities carrying value amount under the regulatory scope of consolidation (as per template LI1) | 633.0 | 1.6 | — | 522.4 | 394.5 |
| 3 Total net amount under the regulatory scope of consolidation | 2,224.5 | 1,909.6 | 34.3 | 96.4 | 200.4 |
| 4 Off-balance-sheet amounts | 945.9 | 906.6 | 22.3 | 17.0 | |
| 6 Differences due to different netting rules, other than those already included in row 2 | 37.0 | 16.5 | — | 20.5 | |
| 7 Differences due to consideration of provisions | 7.6 | 7.6 | — | — | |
| 8 Differences due to the use of credit risk mitigation techniques (CRMs) | (70.2) | (19.6) | (1.7) | (48.9) | |
| 9 Differences due to credit conversion factors | (630.6) | (630.6) | — | — | |
| 10 Differences due to Securitisation with risk transfer | (10.8) | — | (10.8) | — | |
| 11 Other differences | 73.9 | 0.3 | (0.2) | 73.8 | — |
| 12 Exposure amounts considered for regulatory purposes at 31 Dec 2024 | 2,577.3 | 2,190.4 | 43.9 | 158.8 | — |

### Explanations of differences between carrying values in financial statements and regulatory exposure amounts

#### Differences in netting rules

The increase from carrying value due to differences in netting rules is the reversal of amounts deducted from gross loans and advances to customers in the published financial statements in accordance with the offsetting criteria of IAS 32 ‘Financial instruments: presentation’. This also includes the differences between accounting carrying values versus regulatory exposures considered for counterparty credit risk reporting purposes.

#### Differences due to consideration of provisions

The carrying value of assets is net of credit risk adjustments. The regulatory exposure value under IRB approaches is before deducting credit risk adjustments.

#### Differences due to the use of credit risk mitigation techniques

Exposure value under the standardised approach (‘SA’) is calculated after deducting credit risk mitigation whereas accounting value is before such deductions.

#### Differences due to credit conversion factors

Exposure value of off-balance sheet items are calculated after the application of the relevant conversion factors as defined in the CRR II.

#### Differences due to securitisation with risk transfer

Securitisation exposure is based on risk transfer of exposure at default (‘EAD’) of underlying loans instead of accounting value.

#### Other differences

Other differences primarily relate to exposures at default (‘EAD’) modelling impacts, potential future exposures (‘PFE’) and adjustments relating to FSR for counterparty credit risk, IFRS 9 transitional arrangements applicable to standardised credit risk exposure and dilution risk.

### Explanation of differences between accounting fair value and regulatory prudent valuation

Fair value is defined as the best estimate of the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date.

Some fair value adjustments already reflect valuation uncertainty to some degree. These are market data uncertainty and model uncertainty. However, it is recognised that a variety of valuation techniques using stressed assumptions and combined with the range of plausible market parameters at a given point in time may still generate unexpected uncertainty beyond fair value.

A series of additional valuation adjustments (‘AVAs’) are therefore required to reach a specified degree of confidence (the ‘prudent value’) set by regulators that differs both in terms of scope and measurement from HSBC’s own quantification for disclosure purposes.

AVAs should consider at the minimum: market price uncertainty, bid-offer (close-out) uncertainty, model risk, concentration, administrative costs, unearned credit spreads and investing and funding costs.

AVAs are not limited to level 3 exposures, for which a 95% uncertainty range is already computed and disclosed, but must also be calculated for any exposure for which the exit price cannot be determined with a high degree of certainty. Table 68 presents further information on the prudent valuation adjustment.

For further details of level 3 exposures, see Note 12 on page 386 of the Financial Statements of the Annual Report and Accounts 2024.

# Risk management

## Our risk management framework

We aim to use a comprehensive risk management approach across the organisation and across all risk types, underpinned by our culture and values. This is outlined in our risk management framework (‘RMF’), including the key principles and practices that we employ in managing material risks, both financial and non-financial.

The framework fosters continuous monitoring and promotes risk awareness and a positive risk culture. It encourages a sound operational and strategic decision-making and escalation process. It also supports a consistent approach to identifying, assessing, managing and reporting the risks we accept and incur in our activities, with clear accountabilities.

For further details of our risk management framework, see page 128 of the Annual Report and Accounts 2024.

For details on the management and mitigation of principal risks facing the Group, see page 131 of the Annual Report and Accounts 2024.

For details on our management of treasury risk, see page 16, and for commentary on hedging strategies, see pages 93 and 99.

### Material risks

Pillar 3 requires that all material risks be disclosed to provide a comprehensive view of a bank’s risk profile. In addition to the disclosure in this document, other information on material risks can be found on page 136 of the Annual Report and Accounts 2024. Please see the following sections for further details on:
– Credit risk (refer to page 138 of the Annual Report and Accounts 2024)
– Treasury risk (refer to page 200 of the Annual Report and Accounts 2024)
– Market risk (refer to page 216 of the Annual Report and Accounts 2024)
– Climate risk (refer to page 219 of the Annual Report and Accounts 2024)
– Resilience risk (refer to page 229 of the Annual Report and Accounts 2024)
– Regulatory compliance risk (refer to page 229 of the Annual Report and Accounts 2024)
– Financial crime risk (refer to page 230 of the Annual Report and Accounts 2024)
– Model risk (refer to page 230 of the Annual Report and Accounts 2024)
– Financial risk (refer to page 234 of the Annual Report and Accounts 2024)
– Insurance manufacturing operations risk (refer to page 231 of the Annual Report and Accounts 2024)

For further details on our risk management see page 126 of the Annual Report and Accounts 2024.

### Culture

HSBC understands the importance of a strong culture. Our culture refers to our shared attitudes, beliefs, values and standards that shape behaviours including those related to risk awareness, risk taking and risk management. It is instrumental in aligning the behaviours of individuals with our attitude to assuming and managing risk, which helps to ensure that our risk profile remains in line with our risk appetite. The fostering of a strong culture is a key responsibility of our senior executives.

Our culture is also reinforced by our approach to remuneration. Individual awards, including those for senior executives, are based on compliance with our values and the achievement of financial and non-financial objectives that are aligned to our risk appetite and global strategy.

For further details of risk and remuneration, see page 304 of the Annual Report and Accounts 2024.

### Remuneration

Our remuneration policy, including the remuneration committee membership and activities, remuneration strategy and remuneration details of HSBC’s identified staff and material risk takers, is available in the Directors’ Remuneration Report on page 279 of the Annual Report and Accounts 2024.

### Risk governance

The Board has ultimate responsibility for the effective management of risk and approves our risk appetite. It is advised on risk-related matters by the Group Risk Committee (‘GRC’).

For further details of the activities of the GRC, see pages 271 to 278 of the Annual Report and Accounts 2024.

Executive accountability for the ongoing monitoring, assessment and management of the enterprise-wide risk environment, and the effectiveness of the risk management framework resides with the Group Chief Risk and Compliance Officer (‘GCRCO’). The GCRCO is supported by the Group Risk Management Meeting (‘GRMM’) of the Group Executive Committee (‘GEC’).

For further details of risk governance, see page 128 of the Annual Report and Accounts 2024.

Day-to-day responsibility for risk management is delegated to senior managers with individual accountability for decision making. These senior managers are supported by global functions. All our people have a role to play in risk management.

These roles are defined using the three lines of defence model, which takes into account our business and functional structures.

We use a defined executive risk governance structure to ensure appropriate oversight and accountability for risk, which facilitates the reporting and escalation to the Risk Management Meetings (‘RMM’).

For further details of the Group’s three lines of defence model and executive risk governance structures, see page 129 of the Annual Report and Accounts 2024.

### Risk appetite

Risk appetite is a key component of our management of risk. It defines our desired forward-looking risk profile, and informs the strategic and financial planning process. At HSBC, risk appetite is managed through a global risk appetite framework and articulated in a risk appetite statement (‘RAS’), which is reviewed and approved by the Board on the advice of the GRC, to make sure it remains fit for purpose.

Our risk appetite provides an objective baseline to guide strategic decision making, helping to ensure that planned business activities provide an appropriate balance of return for the risk assumed, while remaining within acceptable risk levels. It is also integrated within other risk management tools, such as stress testing, to help ensure consistency in risk management.

For further details of our risk management tools and risk appetite, see page 127 of the Annual Report and Accounts 2024.

### Global Risk and Compliance

We have a dedicated Global Risk and Compliance function, headed by the GCRCO, which is responsible for the Group‘s risk management framework. This includes establishing global policy, monitoring risk profiles, and identifying and managing forward-looking risk.

Global Risk and Compliance is made up of sub-functions covering all risks to our business. It is independent from the global businesses to provide challenge, appropriate oversight and balance in risk versus return decisions. The global Risk and Compliance function operates in line with the three lines of defence model and plays an important role in reinforcing our culture and values. It focuses on creating an environment that encourages our people to speak up and do the right thing.

For further details of Global Risk and Compliance, see page 129 of the Annual Report and Accounts 2024.

### Stress testing

HSBC operates a wide-ranging stress testing programme that supports our risk management and capital and liquidity planning and assesses our capital and liquidity strength through a examination of our resilience to external shocks. As well as undertaking regulatory driven stress tests, we conduct our own internal stress tests to understand the nature and level of material risks, quantify the impact of such risks and develop plausible mitigating actions. The outcome of a stress test provides management with key insights into the impact of severely adverse events on the Group and provides an indication to regulators of the Group’s resilience to shocks and financial stability.

The Group stress testing programme is overseen by the GRC, and results are reported, where appropriate, to the GRMM and GRC.

For further details of stress testing and the Group’s regulatory stress test results, see page 129 of the Annual Report and Accounts 2024.

### Risk management and internal control systems

The Directors are responsible for maintaining and reviewing the effectiveness of the risk management and internal control systems, and for determining the aggregate level of risk and the risk types they are willing to accept in achieving the Group’s business objectives. On behalf of the Board, the GRC has responsibility for the oversight of risk management and internal controls other than for financial reporting, and the GAC has responsibility for oversight of risk management and internal controls over financial reporting.

The Directors, through the GRC and the GAC, receive regular updates and confirmation that management has taken, or is taking, the necessary actions to remediate any failings or weaknesses identified through the operation of our framework of controls.

For further details of HSBC’s key risk management and internal control procedures, see page 271 of the Annual Report and Accounts 2024, where the Report of the Directors on the effectiveness of internal controls can also be found.

### Risk measurement and reporting systems

Our risk measurement and reporting systems are designed to help ensure that risks are comprehensively captured with all the attributes necessary to support well-founded decisions, that those attributes are accurately assessed, and that information is delivered in a timely manner for those risks to be successfully managed and mitigated.

Risk measurement and reporting systems are also subject to a governance framework designed to help ensure that their build and implementation are fit for purpose and functioning appropriately. Risk information system development is a key responsibility of the Global Risk and Compliance function, while the development and operation of risk rating and management systems and processes are ultimately subject to the oversight of the Board.

We are advancing a comprehensive initiative aimed at strengthening our global regulatory reporting processes and making them more sustainable. This multifaceted programme includes enhancing data, consistency and controls.

We remain committed to investing in the reliability and resilience of our technology systems and critical services, which support all parts of our business. We assess our third parties to ensure they deliver the standard of services we require to provide resilient services to our customers. We do so to help protect our customers, affiliates and counterparties, and to help ensure that we minimise any disruption to services. In our approach to defending against these threats, we invest in business and technical controls to help us prevent, detect, manage and recover from issues in a timely manner within our risk appetite.

Risk measurement and reporting structures deployed at Group level are applied throughout global businesses and major operating subsidiaries through a common operating model for integrated risk management and control. This model sets out the respective responsibilities of Group, global business, region and country level risk and compliance functions in respect of risk governance and oversight, approval authorities and lending guidelines, global and local scorecards, management information and reporting, and relations with third parties such as regulators, rating agencies and auditors.

### Global Risk analytics and model governance

The Global Risk function manages a number of analytics disciplines supporting the development and management of models, including those for risk rating, behavioural scoring, economic capital, climate and stress testing, covering different risk types and business segments.

The analytics functions support technical responses to industry developments and regulatory policy in the field of risk analytics. They develop HSBC’s global risk models, and oversee local model development and use across the Group as we work towards our implementation targets for internal ratings based approaches (‘IRB’). The Global Model Risk Committee (‘GMRC’) is the primary committee responsible for the oversight of model risk globally. It serves an important role in providing strategic direction on the management of models and their associated risks to HSBC's businesses globally. It is also an essential element of the governance structure for model risk management. GMRC is supported by the Global Model Oversight Forum (‘GMOF’), which is responsible for model risk management within the functional areas, including wholesale credit risk, market risk, wealth and personal banking risk, and Finance. All new or materially changed IRB capital models require pre-approval from the PRA.

The GMRC meets regularly and reports to the GRMM. The GMRC is chaired by the GCRCO and its membership includes the chief executive officers (‘CEOs’) of the global businesses, and senior executives from risk and finance. Through its oversight of the GMOF, it identifies emerging risks for all aspects of the risk rating system, ensuring that model risk is managed within our RAS, and formally advises the GRMM on any material model-related issues. The governance structure is implemented consistently at regional levels, with regional model oversight forums reporting to the regional model risk committees, which in turn report to the GMRC.

Models are also subject to an independent validation process and governance oversight by the model risk management and independent model review team within Global Risk. The team helps to challenge the modelling approaches used across the Group. It also helps to ensure that the performance of those models is transparent and that any limitations are visible to key stakeholders. The model risk management function is separate from the risk analytics functions that are responsible for the development of models.

Model risk remains a key area of focus given the regulatory scrutiny in this area, with local regulatory exams taking place in many jurisdictions and the PRA’s supervisory statement 1/23 (SS1/23) coming into effect, This provided detailed principles-based guidance on how model risk should be managed, and further developments in policy are also expected from other regulators.

Global risk policy and procedures govern the development, validation, independent review, approval, implementation, performance monitoring of credit risk rating models and any model changes. The development and use of data and models to meet local requirements are the responsibility of global businesses or functions, as well as regional and/or local entities under the governance of their own management, subject to overall Group policy and oversight.

Regulatory and other expectations continue to evolve with regards to our capability and practice of model risk management.

In the ‘Risk review, Our Responsibilities’ section of the Annual Report and Accounts 2024 on page 129 we outline how roles are defined using the three lines of defence model, which takes into account our business and functional structures. The internal audit function work as part of the third line of defence and is independent to the global risk function.

Model risk management works closely with businesses to help ensure that models in development meet risk management, pricing and capital management needs. Global internal audit provides assurance over the risk management framework for models.

Additional assurance work is performed by the model risk governance teams, which act as second lines of defence. The teams test whether controls implemented by model users comply with model risk policy and if model risk standards are adequate.

Within this Pillar 3 document, relevant risk types disclose their model information and governance in further detail to meet CRR II requirements.

For further details of model risk management, see page 230 of the Annual Report and Accounts 2024.

# Treasury Risk Management

Within the risk framework, treasury risk is the risk of having insufficient capital, liquidity or funding resources to meet financial obligations and satisfy regulatory requirements. This includes the risk of an adverse impact on earnings or capital due to structural and transactional foreign exchange exposures, as well as changes in market interest rates, together with pension risk and insurance risk.

The Global Head of Traded and Treasury Risk Management and Risk Analytics is the accountable risk steward for all treasury risks. The Group Treasurer is the risk owner for all treasury risks, with the exception of pension risk and insurance risk. The Group Treasurer co-owns pension risk with the Group Head of Performance and Reward. Insurance risk is owned by the Chief Executive Officer for Global Insurance. Insurance risk is owned by the Chief Executive Officer for Global Insurance.

The Global Treasury function actively manages capital risk, liquidity risk, interest rate risk in the banking book and non-trading book foreign exchange risk on an ongoing basis, supported by the Holdings Asset and Liability Management Committee (‘ALCO’) and local ALCOs, overseen by Treasury Risk Management and the RMM. Pension risk is overseen by a network of local and regional pension financial risk management meetings.

The Group uses stress testing to inform management of the capital and liquidity needed to withstand internal and external shocks, including a global economic downturn or a systems failure.

Outside the stress testing framework, other risks may be identified that have the potential to affect our RWAs, capital and/or liquidity position. Downside and upside scenarios are assessed against our management objectives, and mitigating actions are assigned as necessary.

For further details of our approach to treasury risk management including capital risk, liquidity risk, interest rate in the banking book, non-trading foreign exchange exposure and pension risk, see page 200 of the Annual Report and Accounts 2024.

### Capital risk

Our approach to capital management is driven by our strategic and organisational requirements, taking into account the regulatory, economic and commercial environment. We aim to maintain a strong capital base to support the risks inherent in our business and invest in accordance with our strategy, meeting both consolidated and local regulatory capital requirements at all times.

As at 31 December 2024, capital securities included in the capital base of HSBC have been issued on a fully compliant or grandfathered basis in accordance with the Capital Requirements Regulation. Capital securities are regularly reviewed for compliance with guidelines. A list of the main features of our capital instruments and eligible liabilities, in accordance with Articles 437 and 437a of CRR II is also published on our website at www.hsbc.com with reference to our balance sheet on 31 December 2024. The full terms and conditions of our securities are also available at www.hsbc.com.

HSBC has no current or foreseen practical or legal impediment envisaged with regard to planned dividends or payments from material subsidiaries to the parent. However, the ability of subsidiaries to pay dividends or advance monies to HSBC Holdings depends on, among other things, their respective local regulatory capital and banking requirements, exchange controls, statutory reserves, and financial and operating performance. None of our subsidiaries that are excluded from the regulatory consolidation had capital resources below their minimum regulatory requirement as at 31 December 2024.

### Liquidity risk

We aim to ensure that management has oversight of our liquidity and funding risks at Group and entity level by maintaining comprehensive policies, metrics and controls. We maintain a strong liquidity base to support the risks inherent in our business and invest in accordance with our strategy, meeting both consolidated and local regulatory requirements at all times. We manage liquidity and funding risk at an operating entity level to help ensure that obligations can be met in the jurisdiction under which they fall, and generally without reliance on other parts of the Group.

### Interest rate risk in the banking book

Interest rate risk in the banking book (‘IRRBB’) is the risk of an adverse impact to earnings or capital due to changes in market interest rates or changes in expected interest rate repricing of client products that impact banking book positions. It is generated by our non-traded assets and liabilities, specifically loans, deposits and financial instruments that are not held for trading intent or in order to hedge positions held with trading intent.

Our global IRRBB risk management framework is designed to ensure that all material sources of IRRBB are identified, measured, managed, and monitored, with policies and frameworks in place.

Our IRRBB risks are measured and managed using a combination of economic value and earnings based measures to ensure that the balance between stabilising earnings and generating value sensitivity is managed appropriately. These metrics measure IRRBB risks across the banking book, to support the overall monitoring against risk appetite including:
– Banking net interest income sensitivity ; and
– Economic value of equity sensitivity.

For further details of IRRBB, see page 28.

### Non-trading book foreign exchange exposures

Structural foreign exchange exposures arise from capital invested or net assets in a foreign operation. A foreign operation is an entity that is a subsidiary, associate, joint venture or branch of a reporting entity the activities of which are based or conducted in a country or currency other than those of the reporting entity. An entity’s functional reporting currency is normally that of the primary economic environment in which the entity operates.

Our structural foreign exchange exposures are managed with the primary objective of ensuring, where practical, that our consolidated capital ratios and the capital ratios of individual banking subsidiaries are largely protected from the effect of changes in exchange rates. We hedge structural foreign exchange positions where it is capital efficient to do so, and subject to approved limits. This is achieved through a combination of net investment hedges and economic hedges. Hedging positions are monitored and rebalanced periodically to manage RWA or downside risks associated with HSBC’s foreign currency investments.

Transactional foreign exchange risk arises primarily from day-to-day transactions in the banking book generating profit and loss or fair value through other comprehensive income reserves in a currency other than the reporting currency of the operating entity.

Transactional foreign exchange exposure generated through profit and loss is periodically transferred to Markets and Securities Services (‘MSS’) and managed within limits, with the exception of limited residual foreign exchange exposure arising from timing differences or for other reasons. Transactional foreign exchange exposure generated through other comprehensive income reserves is managed by Global Treasury within the approved appetite.

# Own funds

The table below provides a detailed breakdown of the key components of our CET1, tier 1 (‘T1’) and tier 2 (‘T2’) capital, and the regulatory adjustments impacting our capital base on a transitional basis. Additional value adjustments are calculated on assets measured at fair value. The minimum deductions for holdings of own CET1, AT1 and T2 capital instruments are set by the PRA. The threshold deduction for significant investments relates to balances recorded on numerous lines on the balance sheet and includes: investments in insurance subsidiaries and non-consolidated associates; other CET1 equity held in financial institutions; connected funding of a capital nature; and other balance sheet lines.

Table 6: Composition of Regulatory own funds (UK CC1)

| Ref † | | At 31 Dec 2024 \$m | At 31 Dec 2023 \$m |
|---|---|---|---|
| **Common equity tier 1 (‘CET1’) capital: instruments and reserves** | | | |
| 1 | Capital instruments and the related share premium accounts | 22,378 | 22,964 |
| | – ordinary shares | a | 22,378 | 22,964 |
| 2 | Retained earnings¹ | b | 138,959 | 135,614 |
| 3 | Accumulated other comprehensive income (and other reserves)¹ | c | (8,410) | (7,195) |
| 5 | Minority interests (amount allowed in consolidated CET1) | d | 3,960 | 3,917 |
| UK-5a | Independently reviewed interim net profits net of any foreseeable charge or dividend | b | 7,184 | 10,568 |
| 6 | Common equity tier 1 capital before regulatory adjustments | 164,071 | 165,868 |
| **Common equity tier 1 capital: regulatory adjustments** | | | |
| 7 | Additional value adjustments (negative amount) | | (1,141) | (1,238) |
| 8 | Intangible assets (net of related deferred tax liability) (negative amount) | e | (12,890) | (13,378) |
| 10 | Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability where the conditions in Article 38 (3) CRR II are met) (negative amount) | f | (3,513) | (4,308) |
| 11 | Fair value reserves related to gains or losses on cash flow hedges of financial instruments that are not valued at fair value | g | 1,057 | 992 |
| 12 | Negative amounts resulting from the calculation of expected loss amounts | h | (3,125) | (2,304) |
| 14 | Gains or losses on liabilities valued at fair value resulting from changes in own credit standing | i | 1,243 | 932 |
| 15 | Defined-benefit pension fund assets (negative amount) | j | (5,651) | (5,773) |
| 16 | Direct and indirect holdings of own CET1 instruments (negative amount) | | (40) | (40) |
| 19 | Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount above 10% threshold and net of eligible short positions) | | (15,076) | (14,309) |
| 27a | Other regulatory adjustments to CET1 capital (including IFRS 9 transitional adjustments when relevant) | k | (24) | 59 |
| 28 | Total regulatory adjustments to common equity tier1 | | (39,160) | (39,367) |
| 29 | **Common equity tier 1 (‘CET1’) capital** | | **124,911** | **126,501** |
| **Additional tier 1 (‘AT1’) capital: instruments** | | | | |
| 30 | Capital instruments and the related share premium accounts | | 19,070 | 17,719 |
| 31 | – classified as equity under IFRSs | l | 19,070 | 17,719 |
| 34 | Qualifying tier 1 capital included in consolidated AT1 capital (including minority interests not included in CET1) issued by subsidiaries and held by third parties | m | 216 | 13 |
| 36 | Additional tier 1 capital before regulatory adjustments | | 19,286 | 17,732 |
| **Additional tier 1 capital: regulatory adjustments** | | | | |
| 37 | Direct and indirect holdings of own AT1 instruments (negative amount) | | (70) | (70) |
| 43 | Total regulatory adjustments to additional tier 1 capital | | (70) | (70) |
| 44 | **Additional tier 1 capital** | | **19,216** | **17,662** |
| 45 | **Tier 1 capital (T1 = CET1 + AT1)** | | **144,127** | **144,163** |
| **Tier 2 capital: instruments and provisions** | | | | |
| 46 | Capital instruments and the related share premium accounts | n | 24,292 | 22,848 |
| UK-47b | Amount of qualifying items referred to in Article 494b (2) CRR II subject to phase out from T2 | o | 3,858 | 4,112 |
| 48 | Qualifying own funds instruments included in consolidated T2 capital (including minority interests and AT1 instruments not included in CET1 or AT1) issued by subsidiaries and held by third parties | p | 1,184 | 1,188 |
| 51 | Tier 2 capital before regulatory adjustments | | 29,334 | 28,148 |
| **Tier 2 capital: regulatory adjustments** | | | | |
| 52 | Direct, indirect and synthetic holdings by an institution of own T2 instruments and subordinated loans (negative amount) | | (80) | (80) |
| 55 | Direct and indirect holdings by the institution of the T2 instruments and subordinated loans of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) | q | (995) | (1,027) |
| 57 | Total regulatory adjustments to tier 2 capital | | (1,075) | (1,107) |
| 58 | **Tier 2 capital** | | **28,259** | **27,041** |
| 59 | **Total capital (TC = T1 + T2)** | | **172,386** | **171,204** |
| 60 | **Total Risk exposure amount** | | **838,254** | **854,114** |

† The references (a)–(q) identify balance sheet components in ‘Table 2: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2)’, which are used in the calculation of regulatory capital. This table shows how they contribute to the regulatory capital calculation. Their contribution may differ from their accounting value in Table 2 as a result of adjustment or analysis to apply regulatory definitions of capital.
1 We have updated the classification between components of shareholders’ equity to present ‘Retained Earnings’ in Row 2 and ‘Accumulated other comprehensive income (and other reserves) in Row 3. The comparatives have been aligned.

The CET1 capital ratio increased marginally from 14.8% at 31 December 2023 to 14.9% at 31 December 2024, reflecting a decrease in RWAs of \$15.8bn, partly offset by a decrease in CET1 capital of \$1.6bn. The key drivers of the overall rise in our CET1 ratio during the year were:
– a 0.9 percentage point increase, excluding foreign exchange fluctuations, was primarily driven by a reduction in RWAs through strategic transactions, and the gain on disposal of our Canadian banking business adjusted for the \$0.21 per share special dividend;
– a 0.9 percentage point reduction excluding foreign exchange fluctuations, owing to higher RWAs mainly driven by organic balance sheet growth and credit migrations excluding strategic transactions;
– a 0.4 percentage point increase from capital generation, mainly through regulatory profits and other reserves less dividends and share buy-backs; and
– a 0.3 percentage point decrease from the adverse impact of regulatory deductions and foreign exchange fluctuations on our RWAs and capital.

Our Pillar 2A requirement at 31 December 2024, as per the PRA’s Individual Capital Requirement based on a point-in-time assessment, was equivalent to 2.6% of RWAs, of which 1.5% was required to be met by CET1. Throughout 2024, we complied with the PRA’s regulatory capital adequacy requirements.

Table 6: Composition of Regulatory own funds (UK CC1) (continued)

| | Ref † | At 31 Dec 2024 \$m | At 31 Dec 2023 \$m |
|---|---|---|---|
| **Capital ratios and buffers (%)** | | | |
| 61 | Common equity tier 1 (as a percentage of total risk exposure amount) | | 14.9 | 14.8 |
| 62 | Tier 1 (as a percentage of total risk exposure amount) | | 17.2 | 16.9 |
| 63 | Total capital (as a percentage of total risk exposure amount) | | 20.6 | 20.0 |
| 64 | Institution CET1 overall capital requirement (per Article 92 (1) CRR II, plus additional requirement in accordance with point (a) of Article 104(1) CRR II, and combined buffer requirement in accordance with Article 128(6) CRR II as a percentage of risk exposure amount) | | 11.1 | 11.2 |
| 65 | – capital conservation buffer requirement | | 2.5 | 2.5 |
| 66 | – countercyclical buffer requirement | | 0.7 | 0.7 |
| 67a | – Global systemically important institution (‘G-SII’) buffer | | 2.0 | 2.0 |
| 68 | Common equity tier 1 available to meet buffers | | 8.9 | 8.8 |
| **Amounts below the threshold for deduction (before risk weighting)** | | | |
| 72 | Direct and indirect holdings of own funds and eligible liabilities of financial sector entities where the institution does not have a significant investment in those entities (amount below 10% threshold and net of eligible short positions) | | 3,497 | 3,965 |
| 73 | Direct and indirect holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount below 17.65% thresholds and net of eligible short positions) | | 13,997 | 14,069 |
| 75 | Deferred tax assets arising from temporary differences (amount below 17.65% threshold, net of related tax liability where the conditions in Article 38 (3) CRR II are met) | | 4,364 | 4,694 |
| **Applicable caps on the inclusion of provisions in tier 2** | | | | |
| 77 | Cap on inclusion of credit risk adjustments in T2 under standardised approach | | 2,251 | 2,128 |
| 79 | Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach | | 3,015 | 3,226 |

† The references (a)–(q) identify balance sheet components in ‘Table 2: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2)’, which are used in the calculation of regulatory capital. This table shows how they contribute to the regulatory capital calculation. Their contribution may differ from their accounting value in Table 2 as a result of adjustment or analysis to apply regulatory definitions of capital.

## Capital buffers

Our geographical breakdown and institution-specific countercyclical capital buffer (‘CCyB’) disclosure is provided on page 107 of this document. The global systemically important bank (‘G-SIB’) indicators disclosure is published annually on our website, www.hsbc.com/investors.

## Pillar 1 minimum capital requirements and RWA flow

Pillar 1 covers the minimum capital resource requirements for credit risk, counterparty credit risk (‘CCR’), equity, securitisation, market risk and operational risk. These requirements are expressed in terms of RWAs.

### Risk category Scope of permissible approaches Our approach

Credit risk: The Basel committee’s framework applies three approaches of increasing sophistication to the calculation of Pillar 1 credit risk capital requirements. The most basic level, the standardised approach, requires banks to use external credit ratings to determine the risk weightings applied to rated counterparties. Other counterparties are grouped into broad categories, and standardised risk weightings are applied to these categories. The next level, the Foundation IRB (‘FIRB’) approach, allows banks to calculate their credit risk capital requirements on the basis of their internal assessment of a counterparty’s probability of default (‘PD’), but subjects their quantified estimates of EAD and loss given default (‘LGD’) to standard supervisory parameters. Finally, the advanced IRB (‘AIRB’) approach allows banks to use their own internal assessment in both determining PD and quantifying EAD and LGD.

For consolidated Group reporting, we have adopted the AIRB approach for the majority of our business.

Some portfolios remain on the standardised or FIRB approaches:
– pending the issuance of local regulations or model approval;
– following supervisory prescription of a non-advanced approach; or
– under exemptions from IRB treatment.

Counterparty credit risk: CCR covers the risk of counterparty default and potential mark-to-market losses in derivatives and securities financing transactions (‘SFTs’). The potential for mark-to-market losses is known as CVA risk. The exposure value, for a given netting set, is determined either by the credit risk mitigation (‘CRM’) approach, Standardised Approach for Counterparty Credit Risk (‘SA-CCR’), or by IMM. For SFTs either the simple or comprehensive approach is applied to recognition of collateral with SFTs or the Value at Risk (‘VaR’) approach. For CVA, permissible approaches are the Standardised Approach (‘SA CVA’) and Advanced Approach (‘AA-CVA’).

We primarily use the SA-CCR and internal model method (‘IMM’) approaches for CCR.

For CVA, we apply an approach consistent with our permissions.

Details of the IMM permission we have received from the PRA can be found in the Financial Services Register on the PRA’s website.

Equity: Capital requirements for non-trading book holdings of equity can be assessed under the standardised or IRB approaches. Underlying equity positions within collective investment undertakings (‘CIU’) must be treated using the IRB equity simple risk-weight approach.

We calculate capital requirements for:
– non-trading book equity holdings using the standardised approach; and
– underlying equity positions within collective investments undertakings using the IRB equity simple risk-weight approach.

Securitisation: The framework prescribes the following approaches:
– internal ratings-based approach (‘SEC-IRBA’);
– standardised approach (‘SEC-SA’);
– external ratings-based approach (‘SEC-ERBA’); and
– internal assessment approach (‘IAA’).

Under the framework:
– our originated positions are reported under SEC-IRBA;
– our positions in the sponsored Solitaire programme and our investment in third-party positions are reported under SEC-SA and SEC-ERBA; and,
– our sponsored positions in Regency are reported under IAA. Our IAA approach is audited annually by internal model review and is subject to review by the PRA.

For definitions of Solitaire and Regency securities, see page 93.

Market risk: Market risk capital requirements can be determined under either the standardised rules or the internal models approach (‘IMA’). The latter involves the use of internal value at risk (‘VaR’) models to measure market risks and determine the appropriate capital requirement. In addition to the VaR models, other internal models permitted under IMA include stressed VaR (‘SVaR’), incremental risk charge (‘IRC’) and comprehensive risk measure.

The market risk capital requirement is measured using internal market risk models, where approved by the PRA, or under the standardised rules. Our internal market risk models comprise VaR, SVaR and IRC. Non-proprietary details of the scope of our IMA permissions are available in the Financial Services Register on the PRA’s website.

Operational risk: The Basel Committee allows firms to calculate their operational risk capital requirement under the basic indicator approach, the standardised approach or the advanced measurement approach.

We currently use the standardised approach in determining our operational risk capital requirement. We have in place an operational risk model that is used for economic capital calculation purposes.

Table 7: Overview of risk-weighted exposure amounts (OV1)

| | RWAs \$m | RWAs \$bn | Total own funds requirements \$m |
|---|---|---|---|
| **1 Credit risk (excluding counterparty credit risk)** | **648,230** | **680,610** | **51,859** |
| 2 – standardised approach | 177,202 | 183,862 | 14,176 |
| 3 – foundation IRB approach | 84,195 | 84,794 | 6,736 |
| 4 – slotting approach | 22,269 | 24,027 | 1,782 |
| UK 4a – equities under the simple risk weighted approach | 4,700 | 5,703 | 376 |
| 5 – advanced IRB approach | 359,864 | 382,224 | 28,789 |
| **6 Counterparty credit risk** | **37,642** | **37,495** | **3,012** |
| 7 – standardised approach | 9,225 | 9,259 | 738 |
| 8 – internal model method | 13,771 | 13,021 | 1,102 |
| UK-8a – exposures to a central counterparty | 1,808 | 1,999 | 145 |
| UK-8b – credit valuation adjustment | 2,235 | 1,925 | 179 |
| 9 – other counterparty credit risk | 10,603 | 11,292 | 848 |
| **15 Settlement risk** | **40** | **62** | **3** |
| **16 Securitisation exposures in the non-trading book (after the cap)** | **9,665** | **9,412** | **774** |
| 17 – internal ratings-based approach (‘SEC-IRBA’) | 2,832 | 2,894 | 227 |
| 18 – external ratings-based approach (‘SEC-ERBA’) (including internal assessment approach (‘IAA’)) | 2,063 | 2,296 | 165 |
| 19 – standardised approach (‘SEC-SA’) | 4,488 | 4,047 | 359 |
| UK-19a – 1250%/deduction | 282 | 175 | 23 |
| **20 Position, foreign exchange and commodities risks (market risk)** | **36,205** | **37,432** | **2,897** |
| 21 – standardised approach | 9,334 | 10,093 | 747 |
| 22 – internal models approach | 26,871 | 27,339 | 2,150 |
| **23 Operational risk** | **106,472** | **98,913** | **8,518** |
| UK-23b – standardised approach | 106,472 | 98,913 | 8,518 |
| **29 Total** | **838,254** | **863,923** | **67,062** |
| **24 – of which: Amounts below the thresholds for deduction (subject to 250% risk weight)¹** | **45,784** | **47,156** | **3,663** |

1 These balances are included in rows 2 and 5 of the table and include thresholds for the recognition of significant investments and deferred tax assets.

The quarter-on-quarter RWA movements in the table above are explained by risk type in the following comments.

### Credit risk, including amounts below the thresholds for deduction

Credit risk RWAs reduced by \$32.4bn. Excluding a decrease of \$20.0bn from foreign currency translation differences, RWAs fell by \$12.4bn, reflecting the following movements:
– a \$10.2bn decrease due to methodology and policy changes, mainly driven by a \$7.5bn fall due to regulatory changes related to the risk-weighting of residential mortgages in Hong Kong. Credit risk parameter refinements further contributed to the fall in RWAs; and
– a \$7.7bn decrease from strategic disposals, mainly from the sale of our business in Argentina \$7.3bn.

These decreases were partly offset by:
– a \$2.3bn increase largely from unfavourable credit risk migrations in Asia and HSBC UK Bank plc, partly offset by our portfolio mix in the US, and a \$1.3bn rise from the post-model adjustments for the Hong Kong unsecured portfolio; and
– a \$2.0bn increase from asset size movements, mainly from increased corporate lending in HSBC UK Bank plc and SAB, partly offset by a fall in corporate exposures in the US and higher sovereign exposures in Asia.

### Counterparty credit risk, including settlement risk

Counterparty credit risk RWAs increased by \$0.1bn, primarily due to mark-to-market movements in Asia, partly offset by a \$0.2bn reduction from the sale of our business in Argentina.

### Market risk

Market risk RWAs fell by \$1.2bn primarily due to a decrease in the incremental risk charge from reduced positions in Asia and HSBC Bank plc, and lower interest rate risk driven by a reduction in exposures in Mexico. A further decrease of \$0.4bn relates to the sale of our business in Argentina.

### Securitisation

An increase of \$0.3bn RWAs was mainly due to new positions across regions, partly offset by foreign currency translation differences.

### Operational risk

Operational risk RWAs increased by \$7.6bn, predominantly due to book size movements of \$14.6bn driven by an increase in average income. This was partly offset by the exclusion of \$3.1bn in operational risk RWAs for HSBC Bank Canada post the PRA waiver permission granted in October 2024, and a fall from foreign currency translation differences of \$3.9bn.

Table 8: RWA flow statements of credit risk exposures under the IRB approach (CR8)

| | Quarter ended | | | |
|---|---|---|---|---|
| | 31 Dec 2024 \$m | 30 Sep 2024 \$m | 30 Jun 2024 \$m | 31 Mar 2024 \$m |
| 1 | RWAs at the opening period | 478,334 | 460,941 | 466,154 | 489,736 |
| 2 | Asset size | 810 | 4,437 | 4,030 | 4,772 |
| 3 | Asset quality | 2,915 | 3,709 | (6,052) | 7,623 |
| 4 | Model updates | 1,305 | (549) | (1,773) | — |
| 5 | Methodology and policy | (9,283) | (834) | (472) | (750) |
| 6 | Acquisitions and disposals¹ | (4,753) | — | 62 | (28,933) |
| 7 | Foreign exchange movements¹ | (15,079) | 10,630 | (1,008) | (6,294) |
| 9 | RWAs at the closing period | 454,249 | 478,334 | 460,941 | 466,154 |

1 Foreign exchange movements in this disclosure are computed by retranslating the RWAs into US dollars based on the underlying transactional currencies, and other movements in the table are presented on a constant currency basis.

Excluding foreign currency translation differences, RWAs under the IRB approach decreased by \$9.0bn during the fourth quarter of 2024 primarily from:
– a \$9.3bn decrease in methodology and policy was mainly a \$7.5bn fall due to regulatory changes related to the risk-weighting of residential mortgages in Hong Kong;
– a \$4.8bn decrease mainly from the sale of our business in Argentina;
– a \$2.9bn increase in asset quality movements was primarily due to credit risk migrations in Asia;
– a \$1.3bn rise from the post-model adjustments for the Hong Kong unsecured portfolio; and
– a \$0.8bn increase in asset size movements primarily due to higher sovereign exposures, partly offset by a decrease in corporate lending.

Table 9: RWA flow statements of CCR exposures under IMM (CCR7)

| | Quarter ended | | | |
|---|---|---|---|---|
| | 31 Dec 2024 \$m | 30 Sep 2024 \$m | 30 Jun 2024 \$m | 31 Mar 2024 \$m |
| 1 | RWAs at the opening period | 13,021 | 12,682 | 11,312 | 11,208 |
| 2 | Asset size | 725 | 748 | 27 | 163 |
| 3 | Credit quality of counterparties | (36) | (409) | 1,343 | (59) |
| 4 | Model updates (IMM only) | 61 | — | — | — |
| 9 | RWAs at the closing period | 13,771 | 13,021 | 12,682 | 11,312 |

RWAs under the internal model method increased by \$0.8bn in the fourth quarter of 2024, largely driven by an increased derivatives portfolio, mainly in HSBC Bank plc and Asia.

Table 10: RWA flow statements of market risk exposures under IMA (MR2-B)

| | VaR \$m | SVaR \$m | Incremental risk charge (‘IRC’) \$m | Other \$m | Total RWAs \$m | Total capital requirements \$m |
|---|---|---|---|---|---|---|
| 1 | RWAs at 1 Oct 2024 | 6,485 | 12,272 | 6,941 | 1,641 | 27,339 | 2,187 |
| 2 | Movement in risk levels | (400) | 687 | (635) | (124) | (472) | (37) |
| 3 | Model updates/changes | (1) | 1 | — | 14 | 14 | 1 |
| 5 | Acquisitions and disposals | (1) | (8) | (1) | — | (10) | (1) |
| 8 | RWAs at 31 Dec 2024 | 6,083 | 12,952 | 6,305 | 1,531 | 26,871 | 2,150 |
| 1 | RWAs at 1 Jul 2024 | 8,173 | 11,186 | 6,418 | 1,750 | 27,527 | 2,202 |
| 2 | Movement in risk levels | (1,675) | 1,435 | 496 | (109) | 147 | 12 |
| 3 | Model updates/changes | (13) | (349) | 27 | — | (335) | (27) |
| 5 | Acquisitions and disposals | — | — | — | — | — | — |
| 8 | RWAs at 30 Sep 2024 | 6,485 | 12,272 | 6,941 | 1,641 | 27,339 | 2,187 |
| 1 | RWAs at 1 Apr 2024 | 8,395 | 11,596 | 4,926 | 1,741 | 26,658 | 2,132 |
| 2 | Movement in risk levels | (222) | (410) | 1,492 | 9 | 869 | 70 |
| 3 | Model updates/changes | — | — | — | — | — | — |
| 5 | Acquisitions and disposals | — | — | — | — | — | — |
| 8 | RWAs at 30 Jun 2024 | 8,173 | 11,186 | 6,418 | 1,750 | 27,527 | 2,202 |
| 1 | RWAs at 1 Jan 2024 | 7,164 | 8,297 | 5,163 | 1,694 | 22,318 | 1,785 |
| 2 | Movement in risk levels | 1,231 | 3,299 | (237) | 47 | 4,340 | 347 |
| 3 | Model updates/changes | — | — | — | — | — | — |
| 5 | Acquisitions and disposals | — | — | — | — | — | — |
| 8 | RWAs at 31 Mar 2024 | 8,395 | 11,596 | 4,926 | 1,741 | 26,658 | 2,132 |

RWAs under the internal model approach decreased by \$0.5bn during 4Q24, due to a lower incremental risk charge from reduced positions and VaR driven by the averaging effect, partly offset by an increase in SVaR driven by sensitivity to interest rate shocks captured in the stressed period.

The table below shows the drivers of the quarterly movements of market risk RWAs under the internal model approach, split by VaR, SVaR, IRC and other models. Rows 1a/1b and 8a/8b represent differences between RWAs reported for the period and RWAs includes components that are calculated on a spot basis at the end of the reporting period, except RWAs in ‘Other’ which includes components that are calculated on an average basis.

Table 10a:RWA flow statements of market risk exposures under IMA (MR2-B)

| | VaR \$m | SVaR \$m | IRC \$m | Other \$m | Total RWAs \$m | Total own funds requirements \$m |
|---|---|---|---|---|---|---|
| 1 | RWAs at 1 Oct 2024 | 6,485 | 12,272 | 6,941 | 1,641 | 27,339 | 2,187 |
| 1a | Regulatory adjustment | (4,915) | (8,996) | (923) | — | (14,834) | (1,187) |
| 1b | RWAs at the previous quarter end (end of day) | 1,570 | 3,276 | 6,018 | 1,641 | 12,505 | 1,000 |
| 2 | Movement in risk levels | 56 | 999 | (754) | (124) | 177 | 15 |
| 3 | Model updates/changes | (1) | 1 | — | 14 | 14 | 1 |
| 8a | RWAs at the end of the reporting period (end of day) | 1,624 | 4,268 | 5,263 | 1,531 | 12,686 | 1,015 |
| 8b | Regulatory adjustment | 4,459 | 8,684 | 1,042 | — | 14,185 | 1,135 |
| 8 | RWAs at 31 Dec 2024 | 6,083 | 12,952 | 6,305 | 1,531 | 26,871 | 2,150 |
| 1 | RWAs at 1 Jul 2024 | 8,173 | 11,186 | 6,418 | 1,750 | 27,527 | 2,202 |
| 1a | Regulatory adjustment | (6,052) | (7,653) | — | — | (13,705) | (1,096) |
| 1b | RWAs at the previous quarter end (end of day) | 2,121 | 3,533 | 6,418 | 1,750 | 13,822 | 1,106 |
| 2 | Movement in risk levels | (538) | 92 | (427) | (109) | (982) | (83) |
| 3 | Model updates/changes | (13) | (349) | 27 | — | (335) | (27) |
| 8a | RWAs at the end of the reporting period (end of day) | 1,570 | 3,276 | 6,018 | 1,641 | 12,505 | 996 |
| 8b | Regulatory adjustment | 4,915 | 8,996 | 923 | — | 14,834 | 1,191 |
| 8 | RWAs at 30 Sep 2024 | 6,485 | 12,272 | 6,941 | 1,641 | 27,339 | 2,187 |

# Leverage

The risk of excessive leverage is managed as part of HSBC’s global risk appetite framework and monitored using the leverage ratio metric within the RAS.

For further details of our risk management tools and the management of our risk appetite through our global risk appetite framework, see page 127 of the Annual Report and Accounts 2024.

The table below provides a detailed breakdown of the components of our leverage exposure, including the split of the on- and off-balance sheet exposures, leverage ratios, minimum requirements and buffers on an IFRS 9 transitional basis. The components of the leverage ratio on an average basis are included below in accordance with the UK’s leverage ratio framework.

Table 11: Leverage ratio common disclosure (UK LR2-LRCom)

| | At | |
|---|---|---|
| | 31 Dec 2024 \$bn | 31 Dec 2023 \$bn |
| **On-balance sheet exposures (excluding derivatives and securities financing transactions (‘SFTs’))** | | |
| 1 On-balance sheet items (excluding derivatives, SFTs, but including collateral) | 2,342.9 | 2,383.2 |
| 2 Gross-up for derivatives collateral provided, where deducted from the balance sheet assets pursuant to the applicable accounting framework | 5.6 | 7.1 |
| 3 (Deductions of receivables assets for cash variation margin provided in derivatives transactions) | (54.3) | (51.8) |
| 6 (Asset amounts deducted in determining tier 1 capital (leverage)) | (40.4) | (40.1) |
| 7 Total on-balance sheet exposures (excluding derivatives and SFTs) | 2,253.8 | 2,298.5 |
| **Derivative exposures** | | |
| 8 Replacement cost associated with SA-CCR derivatives transactions (i.e. net of eligible cash variation margin) | 60.3 | 44.4 |
| 9 Add-on amounts for potential future exposure associated with SA-CCR derivatives transactions | 114.9 | 119.1 |
| 10 (Exempted CCP leg of client-cleared trade exposures) (SA-CCR) | (33.9) | (42.1) |
| 11 Adjusted effective notional amount of written credit derivatives | 56.6 | 61.5 |
| 12 (Adjusted effective notional offsets and add-on deductions for written credit derivatives) | (54.7) | (58.1) |
| 13 Total derivative exposures | 143.2 | 124.8 |
| **SFT exposures** | | |
| 14 Gross SFT assets (with no recognition of netting), after adjusting for sales accounting transactions | 486.8 | 495.3 |
| 15 (Netted amounts of cash payables and cash receivables of gross SFT assets) | (190.7) | (182.2) |
| 16 Counterparty credit risk exposure for SFT assets | 13.5 | 12.1 |
| 18 Total securities financing transaction exposures | 309.6 | 325.2 |
| **Other off-balance sheet exposures** | | |
| 19 Off-balance sheet exposures at gross notional amount | 938.4 | 952.1 |
| 20 (Adjustments for conversion to credit equivalent amounts) | (707.2) | (716.7) |
| 22 Total off-balance sheet exposures | 231.2 | 235.4 |
| **Capital and total exposures measure** | | |
| 23 Tier 1 capital (leverage) | 144.1 | 144.2 |
| 24 Total exposure measure including claims on central banks | 2,937.8 | 2,983.9 |
| UK-24a (-) Claims on central banks excluded | (366.7) | (409.1) |
| UK-24b Total exposure measure excluding claims on central banks | 2,571.1 | 2,574.8 |
| **Leverage ratios** | | |
| 25 Leverage ratio excluding claims on central banks (%) | 5.6 | 5.6 |
| UK-25a Fully loaded ECL accounting model leverage ratio excluding claims on central banks (%) | 5.6 | 5.6 |
| UK-25b Leverage ratio excluding central bank reserves as if the temporary treatment of unrealised gains and losses measured at fair value through other comprehensive income had not been applied (%) | 5.6 | 5.6 |
| UK-25c Leverage ratio including claims on central banks (%) | 4.9 | 4.8 |
| 26 Regulatory minimum leverage ratio requirement (%) | 3.3 | 3.3 |
| **Additional leverage ratio disclosure requirements – leverage ratio buffers** | | |
| 27 Leverage ratio buffer (%) | 0.9 | 0.9 |
| UK-27a – of which: G-SII or O-SII additional leverage ratio buffer (%) | 0.7 | 0.7 |
| UK-27b – of which: countercyclical leverage ratio buffer (%) | 0.2 | 0.2 |
| **Additional leverage ratio disclosure requirements – disclosure of mean values** | | |
| 28 Mean of daily values of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivable | 297.2 | 292.2 |
| 29 Quarter-end value of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables | 296.1 | 313.1 |
| UK-31 Average total exposure measure including claims on central banks | 2,972.8 | 2,903.0 |
| UK-32 Average total exposure measure excluding claims on central banks | 2,608.4 | 2,498.6 |
| UK-33 Average leverage ratio including claims on central banks (%) | 4.9 | 4.9 |
| UK-34 Average leverage ratio excluding claims on central banks (%) | 5.5 | 5.7 |

Our leverage ratio was 5.6% at 31 December 2024, unchanged from 31 December 2023. Leverage exposures decreased primarily due to strategic disposals and adverse foreign currency translation differences, which exceeded the increase in the underlying balance sheet. This was offset by a fall in the tier 1 capital.

At 31 December 2024, our UK minimum leverage ratio requirement of 3.25% was supplemented by a leverage ratio buffer of 0.9%, which consists of an additional leverage ratio buffer of 0.7% and a countercyclical leverage ratio buffer of 0.2%.

These buffers translated into capital values of \$18.0bn and \$5.1bn respectively.

The average leverage ratio was 5.5% at 31 December 2024, down from 5.7% at 31 December 2023. The increase in the average leverage exposures led to a 0.1 percentage point fall in the leverage ratio, primarily due to growth in the average balance sheet. This was compounded by a 0.1 percentage point decrease due to a fall in average tier 1 capital.

The table below provides a reconciliation of the total assets in our published balance sheet under IFRS and the total leverage exposure.

Table 12: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1- LRSum)

| | At | |
|---|---|---|
| | 31 Dec 2024 \$bn | 31 Dec 2023 \$bn |
| 1 Total assets as per published financial statements | 3,017.0 | 3,038.7 |
| 2 Adjustment for entities which are consolidated for accounting purposes but are outside the scope of prudential consolidation | (108.2) | (104.1) |
| 3 (Adjustment for securitised exposures that meet the operational requirements for the recognition of risk transference) | (0.9) | (1.2) |
| 4 (Adjustment for exemption of exposures to central banks) | (366.7) | (409.1) |
| 6 Adjustment for regular-way purchases and sales of financial assets subject to trade date accounting | (12.5) | (22.8) |
| 7 Adjustment for eligible cash pooling transactions | (6.8) | (7.1) |
| 8 Adjustment for derivative financial instruments | (174.4) | (150.4) |
| 9 Adjustment for securities financing transactions (‘SFTs’) | 30.6 | 37.5 |
| 10 Adjustment for off-balance sheet items (i.e. conversion to credit equivalent amounts of off-balance sheet exposures) | 231.2 | 235.4 |
| 11 (Adjustment for prudent valuation adjustments and specific and general provisions which have reduced tier 1 capital (leverage)) | (40.4) | (40.1) |
| 12 Other adjustments | 2.2 | (2.0) |
| 13 Total leverage ratio exposure | 2,571.1 | 2,574.8 |

The table below provides a breakdown of on-balance sheet exposures excluding derivatives, SFTs and exempted exposures by asset class.

Table 13: Leverage ratio – split of on-balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3-LRSpl)

| | At 31 Dec 2024 \$bn | At 31 Dec 2023 \$bn |
|---|---|---|
| UK-1 Total on-balance sheet exposures (excluding derivatives, SFTs and exempted exposures), of which: | 1,921.9 | 1,922.3 |
| UK-2 Trading book exposures | 285.6 | 250.0 |
| UK-3 Banking book exposures, of which: | 1,636.3 | 1,672.3 |
| UK-4 – Covered bonds | 2.0 | 1.9 |
| UK-5 – Exposures treated as sovereigns | 429.2 | 381.8 |
| UK-6 – Exposures to regional governments, multilateral development banks, international organisations and public sector entities not treated as sovereigns | 2.6 | 3.4 |
| UK-7 – Institutions | 69.1 | 73.6 |
| UK-8 – Secured by mortgages of immovable properties | 362.9 | 408.8 |
| UK-9 – Retail exposures | 71.3 | 69.4 |
| UK-10 – Corporates | 492.8 | 532.1 |
| UK-11 – Exposures in default | 16.1 | 12.6 |
| UK-12 – Other exposures (e.g. equity, securitisations and other non-credit obligation assets) | 190.3 | 188.7 |

# Liquidity

## Management of liquidity and funding risk

We manage liquidity and funding risk at an operating entity level, in accordance with globally consistent policies, procedures and reporting standards.

### Liquidity coverage ratio

The LCR aims to ensure that a bank has sufficient unencumbered HQLA to meet its liquidity needs in a 30 calendar day liquidity stress scenario. For the disclosure of the LCR, we follow Article 451a of CRR II.

The average Group LCR for the 12 months to 31 December 2024 was 138% or \$179bn above the regulatory requirement. At 31 December 2024, all of the Group’s material operating entities exceeded their minimum required regulatory levels. The Group consolidation methodology includes a deduction to reflect the impact of limitations in the transferability of entity liquidity around the Group. The result was an adjustment of \$141bn to LCR HQLA and \$6bn to LCR inflows on an average basis.

During 2024, we enhanced our liquidity consolidation process by revising provisions that addressed historical limitations. As Group LCR is reported as a 12-month average, the benefit of these changes have been recognised incrementally over the year starting from 30 June 2024.

The average Group LCR HQLA of \$649bn (31 December 2023: \$648bn) was held in a range of asset classes and currencies.

The Group and its entities actively manage liquidity and funding drivers within the balance sheet, including derivatives and collateral management.

### Net stable funding ratio

We use the NSFR or other appropriate metrics as a basis for ensuring operating entities raise sufficient stable funding to support their business activities. The NSFR is defined as the ratio between the amount of stable funding available and the amount of stable funding required. The average Group NSFR over the previous four quarters was 143% at 31 December 2024 and 138% at 31 December 2023.

As highlighted in the LCR section, we enhanced our liquidity consolidation process by revising provisions that addressed historical limitations in 2024. As Group NSFR is reported on an average basis, the benefit of these changes have been recognised incrementally over the year starting from 30 June 2024.

### Currency mismatch in the LCR

The Group’s internal liquidity and funding risk management framework requires all operating entities to monitor the LCR for material currencies. Limits are set to ensure that outflows can be met, given assumptions on stressed capacity in the foreign exchange swap markets. This continuous monitoring helps with the overall management of currency exposures, in line with our internal framework.

### Sources of funding

Our primary sources of funding are customer current accounts and savings deposits payable on demand or at short notice. We issue secured and unsecured wholesale securities to supplement customer deposits, meet regulatory obligations and to change the currency mix, maturity profile or location of our liabilities.

For further details of our approach to managing Liquidity Risk, see Treasury Risk management section on page 16.

More details on the concentration of funding and liquidity sources may be found on page 209 of the Annual Report and Accounts 2024.

Table 14: Quantitative information of LCR (LIQ1)

| | Total unweighted value \$m | Total weighted value \$m | Total unweighted value \$m | Total weighted value \$m | Total unweighted value \$m | Total weighted value \$m | Total unweighted value \$m | Total weighted value \$m |
|---|---|---|---|---|---|---|---|---|
| **Quarter ended 31 Dec 2024** | | | **Quarter ended 30 Sep 2024** | | **Quarter ended 30 Jun 2024** | | **Quarter ended 31 Mar 2024** | |
| UK-1b Number of data points used in the calculation of averages | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| **High quality liquid assets** | | | | | | | | |
| 1 Total high quality liquid assets (‘HQLA’) | 649,210 | | 649,199 | | 646,052 | | 645,789 | |
| **Cash outflows** | | | | | | | | |
| 2 Retail deposits and small business funding | 838,008 | 91,064 | 840,445 | 91,106 | 844,777 | 90,817 | 857,463 | 91,303 |
| – of which: | | | | | | | | |
| 3 stable deposits | 348,397 | 17,420 | 344,131 | 17,207 | 348,761 | 17,438 | 356,599 | 17,830 |
| 4 less stable deposits | 489,611 | 73,644 | 496,314 | 73,899 | 496,016 | 73,379 | 500,864 | 73,473 |
| 5 Unsecured wholesale funding | 793,848 | 360,467 | 792,760 | 358,466 | 788,146 | 355,493 | 796,520 | 358,589 |
| 6 – operational deposits (all counterparties) and deposits in networks of cooperative banks | 250,089 | 61,088 | 250,731 | 61,277 | 249,673 | 61,012 | 251,419 | 61,449 |
| 7 – non-operational deposits (all counterparties) | 532,596 | 288,216 | 530,853 | 286,013 | 527,745 | 283,753 | 534,794 | 286,833 |
| 8 – unsecured debt | 11,163 | 11,163 | 11,176 | 11,176 | 10,728 | 10,728 | 10,307 | 10,307 |
| 9 Secured wholesale funding | 31,688 | 29,826 | 29,527 | 29,355 | | | | |
| 10 Additional requirements | 345,860 | 96,645 | 339,232 | 97,190 | 333,111 | 99,137 | 326,390 | 100,330 |
| 11 – outflows related to derivative exposures and other collateral requirements | 50,057 | 41,153 | 49,718 | 41,616 | 50,552 | 43,503 | 51,512 | 45,129 |
| 13 – credit and liquidity facilities | 295,803 | 55,492 | 289,514 | 55,574 | 282,559 | 55,634 | 274,878 | 55,201 |
| 14 Other contractual funding obligations¹ | 92,734 | 54,431 | 96,920 | 59,610 | 99,966 | 63,366 | 101,135 | 65,088 |
| 15 Other contingent funding obligations | 643,283 | 21,983 | 648,174 | 21,746 | 654,775 | 21,788 | 663,448 | 21,888 |
| **16 Total cash outflows** | | **656,278** | | **657,944** | | **660,128** | | **666,553** |
| **Cash inflows** | | | | | | | | |
| 17 Secured lending transactions (including reverse repos) | 376,767 | 48,548 | 361,134 | 47,043 | 347,607 | 46,365 | 343,819 | 47,931 |
| 18 Inflows from fully performing exposures | 104,474 | 79,173 | 107,274 | 81,171 | 108,691 | 82,418 | 109,992 | 83,145 |
| 19 Other cash inflows | 113,504 | 57,907 | 114,418 | 56,717 | 116,281 | 59,012 | 119,703 | 61,690 |
| **20 Total cash inflows** | | **185,628** | | **184,931** | | **187,795** | | **192,766** |
| UK-20c Inflows Subject to 75% Cap | 594,745 | 185,628 | 582,826 | 184,931 | 572,579 | 187,795 | 573,514 | 192,766 |
| **Liquidity coverage ratio (Adjusted value)** | | | | | | | | |
| UK-21 Liquidity Buffer | | 649,210 | | 649,199 | | 646,052 | | 645,789 |
| 22 Total net cash outflows | | 470,650 | | 473,013 | | 472,333 | | 473,787 |
| 23 Liquidity coverage ratio (%) | | 138 | | 137 | | 137 | | 136 |

1 We enhanced our liquidity consolidation process in 2Q24 by revising provisions that addressed historical limitations. As our Group LCR is reported on an average basis, the benefit of these changes incrementally increased our LCR by circa 3% during the year by reducing net outflows. This reduction was partly offset by an organic increase in outflows mostly in Asia, resulting in a net 2% increase of our LCR compared to year ended 31 December 2023.

Table 15: Net stable funding ratio² (LIQ2)

| | **31 Dec 2024** | | | | |
|---|---|---|---|---|---|
| | **Unweighted value by residual maturity** | | **Weighted Value** |
| | **No maturity \$m** | **< 6 months \$m** | **6 months to < 1yr \$m** | **≥ 1yr \$m** | **\$m** |
| **Available stable funding (‘ASF’) Items** | | | | | |
| 1 Capital items and instruments: | 183,355 | 40 | 234 | 29,219 | 212,569 |
| 2 – Own funds | 183,355 | 40 | 234 | 29,219 | 212,569 |
| 4 Retail deposits: | 845,389 | 351 | 990 | 779,605 |
| 5 – Stable deposits | 351,341 | 71 | 1 | 333,806 |
| 6 – Less stable deposits | 494,048 | 280 | 989 | 445,799 |
| 7 Wholesale funding: | 1,139,335 | 42,884 | 143,605 | 525,447 |
| 8 – Operational deposits | 236,022 | 4 | | 118,013 |
| 9 – Other wholesale funding | 903,313 | 42,880 | 143,605 | 407,434 |
| 10 Interdependent liabilities | 3,681 | — | — | — |
| 11 Other liabilities: | 2,775 | 241,996 | 317 | 5,789 | 5,786 |
| 12 – NSFR derivative liabilities | 2,775 | | | |
| 13 – All other liabilities and capital instruments not included in the above categories | | 241,996 | 317 | 5,789 | 5,786 |
| **14 Total available stable funding (‘ASF’)** | | | | | **1,523,407** |
| **Required stable funding (‘RSF’) Items** | | | | | |
| 15 Total high-quality liquid assets (‘HQLA’) | | | | | 67,798 |
| 16 Deposits held at other financial institutions for operational purposes | 591 | | | 296 |
| 17 Performing loans and securities: | 531,192 | 99,530 | 806,162 | 824,970 |
| 18 – Performing securities financing transactions with financial customers collateralised by Level 1 HQLA subject to 0% haircut | 168,066 | 7,406 | 3,338 | 13,947 |
| 19 – Performing securities financing transactions with financial customer collateralised by other assets and loans and advances to financial institutions | 88,863 | 6,147 | 7,223 | 19,402 |
| 20 – Performing loans to non-financial corporate clients, loans to retail and small business customers, and loans to sovereigns, and PSEs | 143,943 | 54,110 | 267,634 | 329,340 |
| 21 – of which: With a risk weight of less than or equal to 35% under the Basel II standardised approach for credit risk³ | 2,291 | 1,690 | 22,680 | 23,862 |
| 22 – Performing residential mortgages³ | 8,992 | 7,629 | 348,177 | 243,710 |
| 23 – of which: With a risk weight of less than or equal to 35% under the Basel II standardised approach for credit risk³ | 6,217 | 6,173 | 306,117 | 205,843 |
| 24 – Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products¹ | 121,328 | 24,238 | 179,790 | 218,571 |
| 25 Interdependent assets | — | | 4,347 | |
| 26 Other assets: | 193,348 | 41 | 89,880 | 132,550 |
| 27 – Physical traded commodities | | | 14,306 | 12,160 |
| 28 – Assets posted as initial margin for derivative contracts and contributions to default funds of CCPs | 35,032 | — | — | 29,777 |
| 30 – NSFR derivative liabilities before deduction of variation margin posted | 92,569 | — | — | 4,830 |
| 31 – All other assets not included in the above categories | 65,747 | 41 | 75,574 | 85,783 |
| 32 Off-balance sheet items | 182,151 | 90,206 | 656,639 | 38,877 |
| **33 Total RSF** | | | | | **1,064,491** |
| **34 Net stable funding ratio (%)** | **143** | | | | |

2 Reporting of residential mortgage average weighted balances have been enhanced from 31 December 2024 and comparatives have been restated for the year ended 31 December 2023.

Table 15: Net stable funding ratio² (LIQ2) (continued)

| | **31 Dec 2023** | | | | |
|---|---|---|---|---|---|
| | **Unweighted value by residual maturity** | | **Weighted Value** |
| | **No maturity \$m** | **< 6 months \$m** | **6 months to < 1yr \$m** | **≥ 1yr \$m** | **\$m** |
| **Available stable funding (‘ASF’) items** | | | | | |
| 1 Capital items and instruments: | 183,605 | 44 | 159 | 25,838 | 209,442 |
| 2 – Own funds | 183,605 | 44 | 159 | 25,838 | 209,442 |
| 4 Retail deposits: | 866,634 | 2,838 | 939 | 801,557 |
| 5 – Stable deposits | 363,232 | 707 | 181 | 345,888 |
| 6 – Less stable deposits | 503,402 | 2,131 | 758 | 455,669 |
| 7 Wholesale funding: | 1,128,068 | 39,491 | 166,065 | 546,468 |
| 8 – Operational deposits | 241,680 | 50 | 66 | 120,931 |
| 9 – Other wholesale funding | 886,388 | 39,441 | 165,999 | 425,537 |
| 10 Interdependent liabilities | 2,499 | — | — | — |
| 11 Other liabilities: | 2,512 | 258,120 | 341 | 44,298 | 44,468 |
| 12 – NSFR derivative liabilities | 2,512 | | | |
| 13 – All other liabilities and capital instruments not included in the above categories | | 258,120 | 341 | 44,298 | 44,468 |
| **14 Total available stable funding (‘ASF’)** | | | | | **1,601,935** |
| **Required stable funding (‘RSF’) Items** | | | | | |
| 15 Total high-quality liquid assets (‘HQLA’) | | | | | 52,025 |
| 16 Deposits held at other financial institutions for operational purposes | 419 | | | 209 |
| 17 Performing loans and securities: | 577,617 | 102,617 | 895,827 | 909,816 |
| 18 – Performing securities financing transactions with financial customers collateralised by Level 1 HQLA subject to 0% haircut | 204,888 | 8,349 | 2,097 | 11,585 |
| 19 – Performing securities financing transactions with financial customers collateralised by other assets and loans and advances to financial institutions | 97,576 | 5,064 | 5,256 | 17,059 |
| 20 – Performing loans to non-financial corporate clients, loans to retail and small business customers, and loans to sovereigns, and PSEs³ | 146,922 | 56,183 | 292,913 | 353,004 |
| 21 – of which: With a risk weight of less than or equal to 35% under the Basel II standardised approach for credit risk³ | 1,763 | 1,737 | 27,078 | 27,066 |
| 22 – Performing residential mortgages³ | 10,921 | 9,643 | 373,004 | 268,456 |
| 23 – of which: With a risk weight of less than or equal to 35% under the Basel II standardised approach for credit risk³ | 7,672 | 7,736 | 313,687 | 214,749 |
| 24 – Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products¹ | 117,310 | 23,378 | 222,557 | 259,712 |
| 25 Interdependent assets | 4,348 | — | 3,110 | |
| 26 Other assets: | 194,499 | 137 | 129,514 | 162,990 |
| 27 – Physical traded commodities | | | 14,306 | 12,160 |
| 28 – Assets posted as initial margin for derivative contracts and contributions to default funds of CCPs | 22,615 | — | — | 19,217 |
| 30 – NSFR derivative liabilities before deduction of variation margin posted | 107,198 | — | — | 5,564 |
| 31 – All other assets not included in the above categories | 64,686 | 137 | 116,773 | 127,379 |
| 32 Off-balance sheet items | 184,909 | 73,254 | 655,060 | 37,305 |
| **33 Total RSF** | | | | | **1,162,345** |
| **34 Net stable funding ratio (%)** | **138** | | | | |

1 We enhanced our liquidity consolidation process in 2Q24 by revising provisions that addressed historical limitations. As our Group NSFR is reported on an average basis, the benefit of these changes incrementally increased our NSFR by circa 11% during the year by reducing required stable funding. This reduction was partly offset by a rise in financial investments and derivatives activities, resulting in a net 5% increase of NSFR compared to year ended 31 December 2023.
2 We enhanced our calculation processes during 1Q24 and our NSFR comparatives have been restated.
3 Reporting of residential mortgage average weighted balances have been enhanced from 31 December 2024 and comparatives have been restated for the year ended 31 December 2023.

## Interest rate risk in the banking book

Interest rate risk in the banking book (‘IRRBB’) is the risk of an adverse impact to earnings or capital due to changes in market interest rates. It is generated by our non-traded assets and liabilities, specifically loans, deposits and financial instruments that are not held for trading intent.

### Risk management and governance

Our Global IRRBB risk management framework is designed to ensure that all material sources of IRRBB are identified, measured, managed, and monitored, with robust policies and frameworks in place.

Our IRRBB risks are measured and managed using a combination of economic value and earnings-based measures to ensure that the balance between stabilising earnings and generating value sensitivity is managed appropriately. These metrics measure IRRBB risks across the banking book, to support the overall monitoring against risk appetite, including:
– Banking Net Interest Income (‘BNII’) Sensitivity; and
– Economic Value of Equity (‘EVE’) Sensitivity.

Table 16: Quantitative information on IRRBB (UK IRRBB1)

| | $\Delta$EVE | | $\Delta$NII | | Tier 1 capital | |
|---|---|---|---|---|---|---|
| | 31 Dec 2024 \$m | 31 Dec 2023 \$m | 31 Dec 2024 \$m | 31 Dec 2023 \$m | 31 Dec 2024 \$m | 31 Dec 2023 \$m |
| 10 Parallel shock up | (8,369) | (7,303) | 4,696 | 5,334 | | |
| 20 Parallel shock down | 4,095 | 3,572 | (6,624) | (7,228) | | |
| 30 Steepener shock | (460) | (1,664) | | | | |
| 40 Flattener shock | (1,648) | (519) | | | | |
| 50 Short rates shock up | (4,371) | (2,700) | | | | |
| 60 Short rates shock down | 2,211 | 1,075 | | | | |
| 70 Maximum | (8,369) | (7,303) | (6,624) | (7,228) | | |
| 80 Tier 1 capital | | | | | 144,127 | 144,163 |

1 $\Delta$NII values have been updated, for both reporting periods, to show Banking NII sensitivities to align with other disclosures.

### Banking net interest income sensitivity and Economic value of equity sensitivity

BNII sensitivity captures the risk to earnings generated from the banking book from changes in market implied interest rates over a 12-month period using static rolling balance sheet assumptions. The static rolling balance sheet assumption is in place to ensure that IRRBB management actions are focused on risks which can be managed within Treasury. A particular exception to this is related to the price sensitivity of certain interest bearing non-maturity deposits (‘NMDs’), where we apply dynamic assumptions to ensure we capture any potential margin widening or compression over the corresponding shock horizon and rate scenario.

HSBC has a significant quantity of trading book assets that are funded by banking book liabilities, and the NII sensitivity measure does not include the sensitivity of the internal transfer income from this funding. The BNII sensitivity measure, which was first introduced in the Annual Report and Accounts 2023, includes an adjustment on top of the NII sensitivity to reflect this. To ensure alignment with other disclosures, we are now reporting the BNII sensitivity measure in Pillar 3 disclosure as this is our primary measure for monitoring and management of interest rate risk in the banking book. The currency split of BNII sensitivities includes the impact of vanilla foreign exchange swaps to optimize cash management across the Group. The BNII sensitivities are shown in $\Delta$NII column in the UK IRRBB1 table.

EVE measures the present value of the banking book assets and liabilities excluding equity, based on a run-off balance sheet. EVE sensitivity measures the impact to EVE from a movement in interest rates, including the assumed term profile of NMDs having adjusted for stability and price sensitivity. It is measured and reported as part of HSBC’s internal risk metrics, regulatory rules (including the Supervisory Outlier Test) and external Pillar 3 disclosures. The Group and operating entities monitor EVE sensitivities as a percentage of their capital resources.

The measurement frequency of BNII sensitivity and EVE sensitivity is quarterly, and for material entities we assess this monthly.

### Active management of IRRBB

Interest rate risk that can be economically hedged is transferred to Markets Treasury, with some exceptions. Any interest rate risk that Markets Treasury cannot economically hedge is not transferred and will remain within the global business from where the risks originate. Hedging is generally executed through interest rate derivatives or fixed-rate bonds.

Markets Treasury safeguards the entities by ensuring that risk remains within our risk appetite and seeks to generate sustainable returns through management of those risks within the risk appetite set by the Treasury Risk function (second line of defence). Markets Treasury manages a variety of risks including duration, spread, cross currency basis, inflation and convexity, utilising products including liquid fixed income securities, interest rate swaps, cross currency swaps, and money markets loans and deposits. The Treasury Risk function measures and monitors (against limits) the Markets Treasury exposures, using metrics including present value of one basis point, credit spread of one basis point and VaR on a daily basis.

The majority of Markets Treasury activity is capitalised on a banking book basis. The only Markets Treasury trading book activity is the use of FX swaps to manage cash. Markets Treasury operates in all of the banking entities within the Group and is managed at an entity level. All returns generated by Markets Treasury are transferred to the global businesses.

### Interest rate shock and stress scenarios applied

The BNII sensitivities are indicative and based on the shocks prescribed by the PRA instructions (Rule 9.7 of the PRA Rulebook: CRR II Firms: Internal Capital Adequacy Assessment) and in accordance with Article 448(1) of the Disclosure (CRR) part of PRA Rulebook).

The BNII sensitivity calculations are done under the following shocks:
– parallel up;
– parallel down;
– These shocks consider an immediate impact of +/-200 basis points for US dollars, euros, Hong Kong dollars and +/-250 basis points for pounds sterling to the current market-implied path of interest rates across all four currencies (effects over one year); and
– other currency shocks are as per the regulatory guidelines (effects over one year).

The EVE sensitivities are based on the six PRA standard outlier Test shocks:
– parallel up;
– parallel down;
– steepener;
– flattener;
– short rates shock up; and
– short rates shock down.

### Key modelling assumptions

For BNII sensitivities, we assume a constant balance sheet, and we include commercial margins. All forecasted market rates are based on implied forward rates from the reporting date. Customer pricing includes flooring where there are contractual obligations, and customer optionality including prepayment and early redemption risk is included where present.

We have made a prospective revision, from 30 June 2024 onwards, to the pass-on assumptions for major entities on certain interest bearing deposits to a simplified 50%, to align with other disclosures. We have not restated our comparatives, however our results would have reflected a reduction in the sensitivities irrespective of this change.

For EVE sensitivities, commercial margins and other spread components have been excluded from the interest cash flows calculation, and all balance sheet items are discounted at risk free rates back to the reporting date. As prescribed by the regulator, the interest rate floors start at -1.0% for overnight yield curve tenors and increase five basis points per year to 0.0% at 20-year tenors. All of the negative values are netted with 50% of the positive values by currency, as per the regulatory guidelines.

NMDs are deposits that have no explicit maturity and no explicit repricing date, thus behavioural assumptions are applied.

The Pillar 3 disclosure has different assumptions to Group IRRBB’s internal model assumptions. These different assumptions include, but are not limited to, treatment of NMDs, shocks and flooring.

### Quantitative information on IRRBB

The most adverse BNII sensitivity scenario over the next 12 months is the parallel down shock, resulting in a decrease in projected BNII of \$6,624m as at 31 December 2024, as compared with \$7,228m as at 31 December 2023.

At 31 December 2024, the maximum decline in EVE was in the parallel up shock at \$8,369m. This translates to 5.81% of tier 1 capital.

The changes in sensitivities have been driven by factors including balance sheet evolution, an increase in stabilisation activities in line with our strategy and modelling improvements.

The average repricing maturity for NMDs, as of 31 December 2024, was 16 months, which increased from 12 months as of 31 December 2023. The longest repricing maturity for NMDs, as of 31 December 2024, was 120 months.

For further details of our IRRBB and BNII, see page 212 of the Annual Report and Accounts 2024.

## Asset encumbrance

The below asset encumbrance tables are prepared on the regulatory scope of consolidation basis consistent with the regulatory scope of consolidation used to prepare other liquidity reporting. Each of the reported values in the below tables is based on the average of the previous four quarters.

Assets pledged that are subject to any restrictions in withdrawal, such as assets that require prior approval before withdrawal or replacement by other assets, are considered encumbered.

The carrying amount of unencumbered assets includes amounts that are not readily available for encumbrance in the normal course of business, such as debt and equity securities designated through profit and loss, prepayments, accrued income and Hong Kong Government certificates of indebtedness.

HSBC Group has \$274bn of encumbered assets, which represents 9.4% of the total assets. The carrying amount of encumbered other assets is \$98bn, which is predominantly cash collateral posted for derivative margin requirements of \$59bn and loans and advances of \$24bn.

HSBC Group has \$2.6tn of unencumbered assets, which represents 90.6% of the total assets. This balance predominantly includes loans and advances of \$1.3tn and derivatives financial assets of \$239bn.

The carrying amount of selected financial liabilities is \$320bn, which primarily relates to repurchase agreements of \$217bn and cash collateral posted for derivatives margin requirements of \$76bn.

HSBC has \$278bn of collateral encumbered, which represents 54.4% of the total collateral received.

The table below provides a split of on-balance sheet assets between encumbered and unencumbered.

Table 17: Encumbered and unencumbered assets (UK AE1)

| | Carrying amount of encumbered assets | Fair value of encumbered assets | Carrying amount of unencumbered assets | Fair value of unencumbered assets |
|---|---|---|---|---|
| | Total of which: notionally eligible EHQLA and HQLA | Total | of which: notionally eligible EHQLA and HQLA | Total | of which: EHQLA and HQLA | Total | of which: EHQLA and HQLA |
| 010 Assets of the reporting institution | 274,280 | 131,638 | — | — | 2,640,718 | 716,355 | — | — |
| 030 Equity instruments | 54,489 | 33,178 | 54,489 | 33,178 | 105,664 | 25,895 | 105,664 | 25,895 |
| 040 Debt securities | 121,663 | 98,431 | 121,259 | 98,431 | 489,074 | 412,201 | 486,102 | 409,694 |
| – of which: | | | | | | | | |
| 050 covered bonds | 151 | 140 | 151 | 140 | 9,841 | 9,082 | 9,841 | 9,082 |
| 060 securitisations | 280 | — | 280 | — | 8,304 | 4,311 | 8,292 | 4,311 |
| 070 issued by general governments | 112,087 | 94,686 | 111,701 | 94,686 | 373,564 | 326,413 | 371,020 | 324,190 |
| 080 issued by financial corporations | 5,641 | 2,730 | 5,641 | 2,730 | 64,923 | 49,887 | 64,413 | 49,887 |
| 090 issued by non-financial corporations | 3,524 | 944 | 3,524 | 944 | 13,208 | 3,638 | 13,181 | 3,631 |
| 120 Other assets | 98,128 | 29 | | | 2,045,980 | 278,259 | | |

The table below provides details for collateral received and own debt security issued.

Table 18: Collateral received and own debt securities issued (UK AE2)

| | Fair value of encumbered collateral received or own debt securities issued | Unencumbered | Fair value of collateral received or own debt securities issued available for encumbrance |
|---|---|---|---|
| | Total \$m | of which: notionally eligible EHQLA and HQLA \$m | Total \$m | of which: EHQLA and HQLA \$m |
| 130 Collateral received by the reporting institution | 277,656 | 197,490 | 232,740 | 147,516 |
| 150 Equity instruments | 30,799 | 15,179 | 26,387 | 8,018 |
| 160 Debt securities | 246,857 | 182,311 | 206,353 | 139,498 |
| 170 – of which: | | | | |
| covered bonds | 1,879 | 1,597 | 3,583 | 3,206 |
| securitisations | 449 | — | 3,289 | 703 |
| issued by general governments | 208,189 | 168,138 | 149,775 | 118,095 |
| issued by financial corporations | 26,996 | 8,009 | 30,370 | 7,696 |
| issued by non-financial corporations | 8,684 | 3,178 | 20,391 | 8,723 |
| 241 Own covered bonds and asset-backed securities issued and not yet pledged | 2,953 | — | | |
| 250 Total assets, collateral received and own debt securities issued | 551,936 | 329,128 | 2,953 | — |

The table below provides sources of encumbrance, values are the average of quarterly data points in the year.

Table 19: Sources of encumbrance (UK AE3)

| | Matching liabilities, contingent liabilities or securities lent \$m | Assets, collateral received and own debt securities issued other than covered bonds and securitisations encumbered \$m |
|---|---|---|
| 010 Carrying amount of selected financial liabilities | 320,102 | 416,082 |

### Importance of encumbrance

We are a deposit-led bank and hence the majority of our funding is from customer current accounts and customer savings deposits payable on demand or at short notice. Given this structural unsecured funding position, we have little requirement to fund ourselves in secured markets, and therefore our overall low level of encumbrance reflects this position. However, we do provide collateralised financing services to clients as part of our GBM business model, providing cash financing or specific securities.

The other sources that contribute to encumbrance are securities pledged in derivative transactions, mostly for hedging purposes, issuance of asset-backed securities, and covered bond programmes. HSBC Holdings ALCO reviews the asset encumbrance of the institution as a whole quarterly, and any events changing the asset encumbrance level are examined.

## Pillar 2 and ICAAP

### Pillar 2

We conduct an ICAAP to determine a forward-looking assessment of our capital requirements given our business strategy, risk profile, risk appetite and capital plan. The process incorporates the Group’s risk management processes and governance framework. Economic capital models, coupled with stress testing and other risk assessment techniques, are used to assess our internal capital adequacy requirements and inform our view of our internal capital planning buffer. The ICAAP is formally approved by the Board, which has the ultimate responsibility for the effective management of risk and approval of HSBC’s risk appetite.

The ICAAP is reviewed by the PRA as part of the joint risk assessment and decision process during the Supervisory Review and Evaluation Process. This process occurs periodically to enable the regulator to define the individual capital requirement (‘ICR’) or total minimum capital requirements for HSBC, including Pillar 2A.

Pillar 2A considers any supplementary requirements for those risks assessed under Pillar 1, and any requirements for risk categories not captured under Pillar 1. The risk categories covered under Pillar 2A depend on the specific circumstances of a firm and the nature and scale of its business.

Pillar 2B, also known as the PRA buffer, consists of guidance from the PRA on the capital buffer a firm would require in order to remain above its ICR in adverse circumstances that may be largely outside the firm’s normal and direct control; for example, during a period of severe but plausible downturn stress, when asset values and the firm’s capital surplus may become strained. The assessment is informed by stress tests and any other information that the PRA considers relevant in order to protect the safety and soundness of firms.

Where the PRA assesses that a firm’s risk management and governance are significantly weak, it may also increase the PRA buffer to cover the risks posed by those weaknesses until they are addressed.

The PRA buffer is not intended to duplicate the Capital Requirements Regulation and Directive (CRD IV) buffers, and is intended to be drawn upon in times of stress. Its use is not of itself a breach of capital requirements that would trigger automatic restrictions on distributions. In specific circumstances, the PRA should agree a plan with a firm for its restoration over an agreed timescale. The PRA buffer is not disclosed.

### Internal capital adequacy assessment

The Board manages the Group ICAAP and, together with the RMM and the GRC, it examines the Group’s risk profile from a regulatory and economic capital viewpoint. They aim to ensure that capital resources:
– remain sufficient to support our risk profile and outstanding commitments;
– meet current and future regulatory requirements;
– allow the Group to remain adequately capitalised in the event of a severe economic downturn stress scenario; and
– remain consistent with our strategic and operational goals, and our shareholder and investor expectations.

The minimum regulatory capital that we are required to hold is determined by the rules and guidance established by the PRA for the consolidated Group and by local regulators for individual Group companies. These capital requirements are a primary factor in influencing and shaping the business planning process, in which targets are established for our global businesses in accordance with the Group’s strategic direction and risk appetite.

Economic capital is the internally calculated capital requirement that we deem necessary to support the risks to which we are exposed. The economic capital assessment is a more risk-sensitive measure than the regulatory minimum, and takes account of the diversification of risk accruing from our operations. Both the regulatory and the economic capital assessments rely upon the use of models that are integrated into our risk management processes. Our economic capital models are calibrated to quantify the level of capital that is sufficient to absorb potential losses over a one-year time horizon to a 99.95% level of confidence for our banking and trading activities, to a 99.5% level of confidence for our insurance activities and pension risks, and to a 99.9% level of confidence for our operational risks.

Preserving our strong capital position remains a priority, and the level of integration of our risk and capital management helps to optimise our response to business demand for regulatory and economic capital. Risks that are explicitly assessed through economic capital are credit risk (including CCR), market risk, operational risk, IRRBB, insurance risk, pension risk and structural foreign exchange risk.

## Minimum requirement for own funds and eligible liabilities

### Overview and requirements

A minimum requirement for total loss-absorbing capacity (‘TLAC’) in line with the final standards adopted by the Financial Stability Board, came into effect in the UK in January 2019. This includes a minimum requirement for own funds and eligible liabilities (‘MREL’).

MREL includes own funds and liabilities that can be written down or converted into capital resources in order to absorb losses or recapitalise a bank in the event of its failure. The framework is complemented with disclosure requirements and these disclosures are based on the formats provided in the Basel Committee Standards for Pillar 3 disclosures requirements.

HSBC’s preferred resolution strategy is a multiple point of entry (‘MPE’) bail-in, as determined by the Bank of England (‘BoE’) in coordination with HSBC’s other regulators and members of HSBC’s Global Crisis Management Group. This strategy provides flexibility for a resolution in two ways:
– through a bail-in at the HSBC Holdings level, which facilitates recapitalisation of operating bank subsidiaries in the Group (as required) through the write-down or conversion to equity of TLAC/MREL issued on an intra-Group basis, while restructuring actions are undertaken, with the Group remaining together; and/or
– at a resolution group level pursuant to the application of statutory resolution powers by host resolution authorities locally.

HSBC is expected to maintain a sufficient amount of resources that can credibly and feasibly be used to absorb losses in resolution and recapitalise to a level that ensures compliance with the conditions for regulatory authorisation and sustains market confidence. Further details on HSBC’s resolvability can be found in our Resolvability Assessment Framework available on the hsbc.com website.

HSBC considers that the first option is the optimal strategy to deliver the most effective resolution outcome for its stakeholders, as it should help reduce the risk of disrupting the continuity of critical functions, including cross-border; wholesale services to clients between resolution groups and across the HSBC network; avoid the destruction of value associated with a disorderly and/or sudden break up of our global business lines; and minimise the risk to public funds.

HSBC issues loss-absorbing instruments to external investors from HSBC Holdings in order to ensure loss-absorbing capacity is available to support the objectives of a resolution, were such an event to occur. In the event of a resolution of the Group, it is anticipated that the BoE will apply statutory powers to write down or convert to equity the TLAC/MREL issued externally by HSBC Holdings. This would enable operating bank subsidiaries of the Group to be recapitalised, as needed, to support the resolution objectives and maintain the provision of critical functions globally. Recapitalisation of operating bank subsidiaries could be achieved through the write-down, or conversion to equity, of internally issued TLAC/MREL as required. This approach to recapitalising the Group’s operating bank subsidiaries would aim to allow the Group to stay together to help ensure an effective stabilisation of the Group as a whole and the continuity of critical functions, while also facilitating an orderly restructuring process, to address the cause of failure.

It is anticipated that any resolution of HSBC as a group would be coordinated by the BoE and the PRA as HSBC’s home resolution authority and prudential regulator, respectively. HSBC expects that the BoE would coordinate closely with the Group’s host resolution authorities outside the UK in the run-up to resolution and would seek to apply our resolution strategy pre-emptively to recapitalise operating bank subsidiaries as needed.

Given the Group’s corporate structure, HSBC is overseen by various regulators and resolution authorities. Host resolution authorities outside the UK could also use their statutory resolution powers in respect of the resolution groups for which they are responsible. This may occur, for example, in the event that host resolution authorities consider that holding the Group together may no longer achieve their resolution objectives. The application of these local statutory resolution powers may or may not result in such resolution groups ceasing to be part of the Group, depending on the resolution strategy adopted by the relevant host resolution authority. HSBC’s operating bank subsidiaries that are not part of the three resolution groups would be subject to relevant statutory proceedings independently of the rest of the Group, if the conditions to initiating such proceedings were met.

In line with its existing structure and business model, HSBC has three resolution groups, the European resolution group (‘ERG’), the Asian resolution group (‘ARG’) and the US resolution group (‘URG’). There are some smaller entities that fall outside of these resolution groups. The table below lists the resolution groups, the related resolution entities and their material subsidiaries subject to TLAC requirements.

Resolution structure

| Resolution group | Resolution entity | Material entity or subgroup with MREL requirements |
|---|---|---|
| European resolution group | HSBC Holdings plc | HSBC Bank plc, HSBC UK Bank plc, HSBC Continental Europe |
| Asian resolution group | HSBC Asia Holdings Limited | The Hongkong and Shanghai Banking Corporation Limited, Hang Seng Bank Limited |
| US resolution group | HSBC North America Holdings Inc. | N/A |

The current binding requirement for the Group is the sum-of-the-parts requirement which is made up of the sum of each resolution group’s local regulatory requirements and other group entities’ local regulatory requirements.

Including capital buffers this requirement is equivalent to 27.3% of RWAs as at 31 December 2024 for which we have a buffer of \$41bn. The chart below highlights the Group’s binding requirements.

The external MREL requirement applicable in 2024 was the highest of the following:
– the sum of all loss absorbing capital (‘LAC’) requirements and other capital requirements relating to other Group entities or sub-groups;
– 18% of the Group’s consolidated RWAs; or,
– 6.75% of the Group’s consolidated leverage exposure.

### MREL/TLAC position versus requirements of Group RWAs

```mermaid
pie title MREL/TLAC position versus requirements of Group RWAs (31 Dec 2024)
    "Sum-of-the-parts" : 32.1
    "18% of RWAs" : 27.3
    "6.75% of leverage exposures" : 23.2
    "CET1 buffers¹" : 7.9
    "Other*" : 10.4
```

```mermaid
pie title MREL/TLAC position versus requirements of Group RWAs (Non-binding requirements)
    "18% of RWAs" : 25.9
    "6.75% of leverage exposures" : 20.7
    "CET1 buffers¹" : 5.2
    "Other*" : 5.2
    "European Resolution Group" : 1.3
    "Asian Resolution Group" : 2.5
    "US Resolution Group" : 18.0
```

Key:
* CET1 buffers¹
* Other*
* US Resolution Group
* Asian Resolution Group
* European Resolution Group
* HSBC Group TLAC

1 Group CET1 buffers are shown in addition to the MREL requirements. The buffers shown in addition to the RWA, leverage and sum-of-the-parts TLAC/MREL requirement are calculated in accordance with the PRA Supervisory statement 16/16 updated in December 2020.
* Capital or TLAC requirements relating to other Group entities.

HSBC Holdings is the provider of own funds, MREL-eligible debt and other types of funding to its subsidiaries. These investments are funded by HSBC Holdings’ own equity capital and MREL-eligible debt. In line with the BoE MREL statement of policy, non CET1 own funds instruments issued to external holders are no longer eligible as external or internal MREL if issued by a non-resolution entity. Therefore, non-CET1 own funds issued by HSBC Bank plc, HSBC Bank USA NA and HSBC Continental Europe SA do not qualify as external or internal MREL. Their eligibility as own funds is not impacted.

For further details of our approach to capital management, see ‘Treasury risk management’ on page 200 of the Annual Report and Accounts 2024.

## Key metrics of the resolution groups

The following tables summarise key metrics for the total loss absorbing capacity of each of the Group’s three resolution groups. Fully loaded values and ratios are calculated without applying any regulatory transitional arrangements for expected credit losses (‘ECL’) that may be available to the resolution group.

The Group and the ERG report in accordance with CRR II, and the leverage exposure is calculated in line with the PRA’s UK leverage rules and excludes central bank claims. Reporting for the ARG follows the Hong Kong Monetary Authority regulatory rules and there are no IFRS 9 transitional arrangements. For the URG, leverage exposures and ratios are based on ‘total assets for the leverage ratio’ as reported in the regulatory capital calculations. The US accounting standard corresponding to IFRS 9 is in force with transitional adjustments.

Table 20.i: Key metrics of the European resolution group (KM2)

| | At | | | | |
|---|---|---|---|---|---|
| | 31 Dec 2024 \$bn | 30 Sep 2024 \$bn | 30 Jun 2024 \$bn | 31 Mar 2024 \$bn | 31 Dec 2023 \$bn |
| 1 Total loss absorbing capacity ('TLAC') available | 107.1 | 108.6 | 105.7 | 97.6 | 103.0 |
| 1a Fully loaded ECL accounting model TLAC available | 107.0 | 108.6 | 105.7 | 97.6 | 103.0 |
| 2 Total RWAs at the level of the resolution group | 290.9 | 293.9 | 280.9 | 278.4 | 275.0 |
| 3 TLAC as a percentage of RWA (row1/row2) (%) | 36.8 | 37.0 | 37.6 | 35.1 | 37.5 |
| 3a Fully loaded ECL accounting model TLAC as a percentage of fully loaded ECL accounting model RWA (%) | 36.8 | 37.0 | 37.6 | 35.1 | 37.4 |
| 4 Leverage exposure measure at the level of the resolution group¹ | 966.8 | 1,037.0 | 992.9 | 998.0 | 969.0 |
| 5 TLAC as a percentage of leverage exposure measure (row1/row4) (%)¹ | 11.1 | 10.5 | 10.6 | 9.8 | 10.6 |
| 5a Fully loaded ECL accounting model TLAC as a percentage of fully loaded ECL accounting model leverage exposure measure (%)¹ | 11.1 | 10.5 | 10.6 | 9.8 | 10.6 |
| 6a Does the subordination exemption in the antepenultimate paragraph of section 11 of the FSB TLAC term sheet apply? | No | No | No | No | No |
| 6b Does the subordination exemption in the penultimate paragraph of section 11 of the FSB TLAC term sheet apply? | No | No | No | No | No |
| 6c If the capped subordination exemption applies, the amount of funding issued that ranks pari passu with excluded liabilities and that is recognised as external TLAC, divided by funding issued that ranks pari passu with excluded liabilities and that would be recognised as external TLAC if no cap was applied (%) | N/A | N/A | N/A | N/A | N/A |

1 From 30 September 2024, we aligned our treatment of the leverage exposure measure to the calculation of total TLAC resources for the ERG, which excludes investments up to TLAC resources in group entities outside ERG. This approach helps to ensure that all items are treated consistently in both the numerator and denominators of these rows.

Table 20.ii: Key metrics of the Asian resolution group

| | At | | | | |
|---|---|---|---|---|---|
| | 31 Dec 2024 \$bn | 30 Sep 2024 \$bn | 30 Jun 2024 \$bn | 31 Mar 2024 \$bn | 31 Dec 2023 \$bn |
| 1 Total loss absorbing capacity ('TLAC') available | 111.3 | 118.7 | 110.9 | 110.8 | 110.7 |
| 1a Fully loaded ECL accounting model TLAC available | 111.3 | 118.7 | 110.9 | 110.8 | 110.7 |
| 2 Total RWAs at the level of the resolution group | 407.8 | 424.2 | 420.0 | 418.7 | 411.2 |
| 3 TLAC as a percentage of RWA (row1/row2) (%) | 27.3 | 28.0 | 26.4 | 26.5 | 26.9 |
| 3a Fully loaded ECL accounting model TLAC as a percentage of fully loaded ECL accounting model RWA (%) | 27.3 | 28.0 | 26.4 | 26.5 | 26.9 |
| 4 Leverage exposure measure at the level of the resolution group | 1,292.1 | 1,332.1 | 1,257.1 | 1,257.1 | 1,237.8 |
| 5 TLAC as a percentage of leverage exposure measure (row1/row4) (%) | 8.6 | 8.9 | 8.8 | 8.8 | 8.9 |
| 5a Fully loaded ECL accounting model TLAC as a percentage of fully loaded ECL accounting model Leverage exposure measure (%) | 8.6 | 8.9 | 8.8 | 8.8 | 8.9 |
| 6a Does the subordination exemption in the antepenultimate paragraph of Section 11 of the FSB TLAC Term Sheet apply? | No | No | No | No | No |
| 6b Does the subordination exemption in the penultimate paragraph of Section 11 of the FSB TLAC Term Sheet apply? | No | No | No | No | No |
| 6c If the capped subordination exemption applies, the amount of funding issued that ranks pari passu with excluded liabilities and that is recognised as external TLAC, divided by funding issued that ranks pari passu with excluded liabilities and that would be recognised as external TLAC if no cap was applied (%) | N/A | N/A | N/A | N/A | N/A |

Table 20.iii: Key metrics of the US resolution group

| | At | | | | |
|---|---|---|---|---|---|
| | 31 Dec 2024 \$bn | 30 Sep 2024 \$bn | 30 Jun 2024 \$bn | 31 Mar 2024 \$bn | 31 Dec 2023 \$bn |
| 1 Total loss absorbing capacity ('TLAC') available | 23.8 | 23.6 | 23.3 | 23.2 | 23.1 |
| 1a Fully loaded ECL accounting model TLAC available | 23.8 | 23.6 | 23.3 | 23.2 | 23.1 |
| 2 Total RWAs at the level of the resolution group | 106.4 | 109.4 | 109.9 | 107.3 | 105.1 |
| 3 TLAC as a percentage of RWA (row1/row2) (%) | 22.3 | 21.6 | 21.2 | 21.6 | 22.0 |
| 3a Fully loaded ECL accounting model TLAC as a percentage of fully loaded ECL accounting model RWA (%) | 22.3 | 21.6 | 21.2 | 21.6 | 22.0 |
| 4 Leverage exposure measure at the level of the resolution group | 233.4 | 230.4 | 231.8 | 229.4 | 222.4 |
| 5 TLAC as a percentage of leverage exposure measure (row1/row4) (%) | 10.2 | 10.2 | 10.1 | 10.1 | 10.4 |
| 5a Fully loaded ECL accounting model TLAC as a percentage of fully loaded ECL accounting model leverage exposure measure (%) | 10.2 | 10.2 | 10.1 | 10.1 | 10.4 |
| 6a Does the subordination exemption in the antepenultimate paragraph of section 11 of the FSB TLAC term sheet apply? | No | No | No | No | No |
| 6b Does the subordination exemption in the penultimate paragraph of section 11 of the FSB TLAC term sheet apply? | No | No | No | No | No |
| 6c If the capped subordination exemption applies, the amount of funding issued that ranks pari passu with excluded liabilities and that is recognised as external TLAC, divided by funding issued that ranks pari passu with excluded liabilities and that would be recognised as external TLAC if no cap was applied (%) | N/A | N/A | N/A | N/A | N/A |

Given the MPE resolution strategy, and the fact that the BoE framework includes requirements set on the basis of the HSBC Group consolidated position, the following table presents data for both the consolidated Group and the resolution groups.

The European resolution group must meet minimum eligible liabilities requirements and it has no capital or leverage requirements. Total TLAC resources are reduced to avoid duplication of own funds and TLAC eligible liabilities across resolution groups and non-resolution group entities. Since 3Q24 we have made the reduction on a corresponding basis, whereas prior to this, the investment in TLAC eligible liabilities issued by the Asian and US resolution groups was against own funds. To allow for this change we exclude these investments from the RWA calculation. The leverage exposure measure now excludes all items excluded from total TLAC resources rather than solely those from Total Tier 1, as the European Resolution Group is not subject to capital or leverage requirements. This approach helps to ensure that all items are treated consistently in both the numerator and denominators of both the TLAC/RWA and TLAC/leverage ratios.

The difference between Group CET1 and the aggregate of resolution groups’ CET1 is driven by entities that fall outside of the resolution groups and by differences in regulatory frameworks.

Table 21: TLAC composition (TLAC1)

| | **At 31 Dec 2024** | | **At 31 Dec 2023** | |
|---|---|---|---|---|---|
| | **Resolution group** | | **Resolution group** | |
| | **Group \$bn** | **European \$bn** | **Asian \$bn** | **US \$bn** | **Group \$bn** | **European \$bn** | **Asian \$bn** | **US \$bn** |
| **Regulatory capital elements of TLAC and adjustments (\$bn)** | | | | | | | | |
| 1 Common equity tier 1 capital ('CET1')¹ | 124.9 | 19.2 | 66.5 | 12.9 | 126.5 | 3.9 | 65.1 | 12.4 |
| 2 Additional tier 1 capital ('AT1') before TLAC adjustments | 19.2 | 19.0 | 8.4 | 1.6 | 17.7 | 17.6 | 6.9 | 1.6 |
| 4 Other adjustments¹ | — | (9.5) | — | — | — | (17.6) | — | — |
| 5 AT1 instruments eligible under the TLAC framework | 19.2 | 9.5 | 8.4 | 1.6 | 17.7 | — | 6.9 | 1.6 |
| 6 Tier 2 capital ('T2') before TLAC adjustments | 28.3 | 28.1 | 8.0 | 2.2 | 27.0 | 27.0 | 8.9 | 2.2 |
| 7 Amortised portion of T2 instruments where remaining maturity > 1 year | 1.4 | — | — | — | 3.2 | — | — | — |
| 8 T2 capital ineligible as TLAC as issued out of subsidiaries to third parties | (0.9) | (0.5) | — | — | (1.1) | (0.7) | — | — |
| 9 Other adjustments¹ | — | (9.4) | — | (2.2) | (0.1) | (27.1) | — | (2.2) |
| 10 T2 instruments eligible under the TLAC framework | 28.8 | 19.6 | 8.0 | — | 29.0 | 2.4 | 8.9 | — |
| 11 TLAC arising from regulatory capital | 172.9 | 48.3 | 82.9 | 14.5 | 173.2 | 6.3 | 80.9 | 14.1 |
| **Non-regulatory capital elements of TLAC** | | | | | | | | |
| 12 External TLAC instruments issued directly by the bank and subordinated to excluded liabilities | 96.5 | 96.5 | 28.4 | 9.3 | 96.7 | 96.7 | 29.8 | 9.0 |
| 17 TLAC arising from non-regulatory capital instruments before adjustments | 96.5 | 96.5 | 28.4 | 9.3 | 96.7 | 96.7 | 29.8 | 9.0 |
| **Non-regulatory capital elements of TLAC: adjustments** | | | | | | | | |
| 18 TLAC before deductions | 269.4 | 144.8 | 111.3 | 23.8 | 269.9 | 103.0 | 110.7 | 23.1 |
| 19 Deductions of exposures between MPE resolution groups that correspond to items eligible for TLAC¹ | — | (37.7) | — | — | — | — | — | — |
| 22 TLAC after deductions | 269.4 | 107.1 | 111.3 | 23.8 | 269.9 | 103.0 | 110.7 | 23.1 |
| **Risk-weighted assets and leverage exposure measure for TLAC purposes** | | | | | | | | |
| 23 Total risk-weighted assets | 838.3 | 290.9 | 407.8 | 106.4 | 854.1 | 275.0 | 411.2 | 105.1 |
| 24 Leverage exposure measure² | 2,571.1 | 966.8 | 1,292.1 | 233.4 | 2,574.8 | 969.0 | 1,237.8 | 222.4 |
| **TLAC ratios and buffers** | | | | | | | | |
| 25 TLAC (as a percentage of risk-weighted assets) | 32.1 | 36.8 | 27.3 | 22.3 | 31.6 | 37.5 | 26.9 | 22.0 |
| 26 TLAC (as a percentage of leverage exposure)² | 10.5 | 11.1 | 8.6 | 10.2 | 10.5 | 10.6 | 8.9 | 10.4 |
| 27 CET1 (as a percentage of risk-weighted assets) available after meeting the resolution group’s minimum capital and TLAC requirements | 8.9 | N/A | N/A | 4.3 | 8.9 | N/A | N/A | 4.0 |
| 28 Institution-specific buffer requirement expressed as a percentage of risk-weighted assets | 5.2 | N/A | N/A | 2.5 | 5.2 | N/A | N/A | 2.5 |
| 29 – of which: | | | | | | | | |
| capital conservation buffer requirement | 2.5 | N/A | N/A | 2.5 | 2.5 | N/A | N/A | 2.5 |
| 30 bank specific countercyclical buffer requirement | 0.7 | N/A | N/A | N/A | 0.7 | N/A | N/A | N/A |
| 31 higher loss absorbency (G-SIB) requirement | 2.0 | N/A | N/A | N/A | 2.0 | N/A | N/A | N/A |

1 From 30 September 2024, the investments in eligible liabilities issued by the Asian and US resolution groups are deducted on a corresponding basis, previously they were against own funds.
2 From 30 September 2024, we aligned our treatment of the leverage exposure measure to the calculation of total TLAC resources for the ERG, which excludes investments up to TLAC resources in group entities outside ERG. This approach ensures that all items are treated consistently in both the numerator and the denominator of these rows.

## Creditor ranking at legal entity level

The following tables present information regarding the ranking of creditors in the liability structure of HSBC legal entities at 31 December 2024. The main features of capital instruments disclosure for the Group, Asia and US resolution groups are published on our website, https://www.hsbc.com/investors/fixed-income-investors/regulatory-capital-securities.

### European resolution group

The ERG comprises HSBC Holdings plc, the designated resolution entity, together with its material operating entities – namely HSBC Bank plc and its subsidiaries including HSBC Continental Europe, and HSBC UK Bank plc and its subsidiaries.

The tables below present the ranking of creditors of HSBC Holdings plc and their material sub-group entities. Nominal values are disclosed.

Table 22: HSBC Holdings plc creditor ranking (TLAC3)

| | 1 (most junior) | 2 | 3 | 4 (most senior) | Sum of 1 to 4 |
|---|---|---|---|---|---|
| | Ordinary shares¹ \$m | Preference shares, AT1 instruments and certain Subordinated notes \$m | Subordinated notes \$m | Senior notes and other pari passu liabilities \$m | \$m |
| 1 Description of creditor ranking | | | | | |
| 2 Total capital and liabilities net of credit risk mitigation | 8,973 | 18,902 | 33,192 | 103,154 | 164,221 |
| 3 – of row 2 that are excluded liabilities² | — | — | — | 251 | 251 |
| 4 Total capital and liabilities less excluded liabilities (row 2 minus row 3)³ | 8,973 | 18,902 | 33,192 | 102,903 | 163,970 |
| 5 – of row 4 that are potentially eligible as TLAC³ | 8,973 | 18,902 | 33,192 | 100,019 | 161,086 |
| 6 – of row 5: | | | | | |
| with 1 year ≤ residual maturity < 2 years | — | — | 892 | 17,826 | 18,718 |
| with 2 years ≤ residual maturity < 5 years | — | — | 2,668 | 39,870 | 42,538 |
| with 5 years ≤ residual maturity < 10 years | — | — | 14,704 | 33,155 | 47,859 |
| with residual maturity ≥ 10 years, but excluding perpetual securities | — | — | 12,358 | 9,168 | 21,526 |
| 10 that are perpetual securities | 8,973 | 18,902 | — | — | 27,875 |

1 Excludes the value of share premium and reserves attributable to ordinary shareholders.
2 Excluded liabilities are defined in CRR II Article 72a (2). The current balance mainly relates to liabilities with a maturity of less than seven days and accruals for service company recharges.
3 The difference between rows 4 and 5 relates to pari passu liabilities of \$2.9bn.
4 The difference between row 5 and the sum of rows 6-10, \$2.6bn, is instruments maturing in less than one year, considered eligible for TLAC up to the value included in own funds.

Table 23: HSBC UK Bank plc creditor ranking (TLAC2)

| | 1 (most junior) | 2 | 3 | 4 (most senior) | Sum of 1 to 4 |
|---|---|---|---|---|---|
| | Ordinary shares² \$m | AT1 instruments \$m | Subordinated loans \$m | Senior subordinated loans \$m | \$m |
| 1 Is the resolution entity the creditor/investor?¹ | Yes | Yes | Yes | Yes | |
| 2 Description of creditor ranking | | | | | |
| 3 Total capital and liabilities net of credit risk mitigation | — | 2,754 | 4,013 | 16,074 | 22,841 |
| 5 Total capital and liabilities less excluded liabilities (row 3 minus row 4) | — | 2,754 | 4,013 | 16,074 | 22,841 |
| 6 – of row 5 that are eligible as TLAC | — | 2,754 | 4,013 | 16,074 | 22,841 |
| 7 – of row 6: | | | | | |
| with 1 year ≤ residual maturity < 2 years | — | — | — | 1,773 | 1,773 |
| 8 with 2 years ≤ residual maturity < 5 years | — | — | — | 8,165 | 8,165 |
| 9 with 5 years ≤ residual maturity < 10 years | — | 4,013 | 6,136 | 10,149 |
| 11 that are perpetual securities | — | 2,754 | — | — | 2,754 |

1 The entity’s capital and TLAC are owned by HSBC Holdings plc.
2 The nominal value of ordinary shares is £50,002. This excludes the value of reserves attributable to ordinary shareholders.

### HSBC Bank plc creditor ranking (TLAC2)

Table 24: HSBC Bank plc creditor ranking (TLAC2)

| | 1 (most junior) | 2 | 3 | 4 | 4 | Sum of 1 to 4 |
|---|---|---|---|---|---|---|
| | Ordinary shares² \$m | Third Dollar preference shares and AT1 instruments \$m | Deeply Subordina ted Notes \$m | Subordinated notes and subordinated loans \$m | Subordinated notes and subordinated loans \$m | \$m |
| 1 Is the resolution entity the creditor/investor?¹ | Yes | Yes | No | Yes | No | |
| 2 Description of creditor ranking | | | | | | |
| 3 Total capital and liabilities net of credit risk mitigation | 1,000 | 5,117 | 878 | 20,987 | 840 | 28,822 |
| 5 Total capital and liabilities less excluded liabilities (row 3 minus row 4)³ | 1,000 | 5,117 | 878 | 20,987 | 840 | 28,822 |
| 6 – of row 5 that are eligible as TLAC | 1,000 | 5,117 | — | 20,987 | — | 27,104 |
| – of row 6: | | | | | | |
| 7 – of row 6: with 1 year ≤ residual maturity < 2 years | — | — | — | — | — | — |
| 8 with 2 years ≤ residual maturity < 5 years | — | — | — | 5,437 | — | 5,437 |
| 9 with 5 years ≤ residual maturity < 10 years | — | — | — | 14,149 | — | 14,149 |
| 10 with residual maturity ≥ 10 years, but excluding perpetual securities | — | — | — | 1,401 | — | 1,401 |
| 11 that are perpetual securities | 1,000 | 5,117 | — | — | — | 6,117 |

1 The entity’s ordinary shares are owned by HSBC Holdings plc.
2 Excludes the value of share premium and reserves attributable to ordinary shareholders.
3 The difference between row 5 and 6 relates to externally issued non-CET1 own funds. In line with the Bank of England Statement of Policy on MREL (December 2021), non-CET1 own fund instruments issued externally by HSBC Bank plc and its subsidiaries do not count towards MREL for HSBC Bank plc.

### Asian resolution group

The ARG comprises HSBC Asia Holdings Limited, The Hongkong and Shanghai Banking Corporation Limited, Hang Seng Bank Limited and their subsidiaries. HSBC Asia Holdings Ltd is the designated resolution entity.

The following tables present information regarding the ranking of creditors of HSBC Asia Holdings Limited, The Hongkong and Shanghai Banking Corporation Limited, and Hang Seng Bank Limited.

Table 25: HSBC Asia Holdings Ltd creditor ranking¹ (TLAC3)

| | 1 (most junior) | 2 | 3 | 4 (most senior) | Sum of 1 to 4 |
|---|---|---|---|---|---|
| | Ordinary shares² \$m | AT1 instruments \$m | Tier 2 instruments \$m | LAC loans \$m | \$m |
| 1 Description of creditor ranking | | | | | |
| 2 Total capital and liabilities net of credit risk mitigation | 57,587 | 8,300 | 3,777 | 29,210 | 98,874 |
| 4 Total capital and liabilities less excluded liabilities (row 2 minus row 3) | 57,587 | 8,300 | 3,777 | 29,210 | 98,874 |
| 5 – of row 4 that are potentially eligible as TLAC | 57,587 | 8,300 | 3,777 | 29,210 | 98,874 |
| 6 – of row 5 with 1 year ≤ residual maturity < 2 years | — | — | — | 4,118 | 4,118 |
| 7 – of row 5 with 2 years ≤ residual maturity < 5 years | — | — | — | 14,588 | 14,588 |
| 8 – of row 5 with 5 years ≤ residual maturity < 10 years | — | 3,777 | 5,339 | 9,116 |
| 9 – of row 5 with residual maturity ≥ 10 years, but excluding perpetual securities | — | — | — | 5,165 | 5,165 |
| 10 – of row 5 that are perpetual securities | 57,587 | 8,300 | — | — | 65,887 |

1 The entity’s capital and LAC are held by HSBC Holdings plc.
2 Excludes the value of share premium and reserves attributable to ordinary shareholders.

Table 26: The Hongkong and Shanghai Banking Corporation Limited creditor ranking (TLAC2)

| | 1 (most junior) | 2 | 3 | 4 (most senior) | Sum of 1 to 4 |
|---|---|---|---|---|---|
| | Ordinary shares¹ \$m | AT1 instruments \$m | Tier 2 instruments \$m | LAC loans \$m | \$m |
| 1 Is the resolution entity the creditor/investor? | Yes | Yes | Yes | Yes | |
| 2 Description of creditor ranking | | | | | |
| 3 Total capital and liabilities net of credit risk mitigation | 23,201 | 8,300 | 3,777 | 29,210 | 64,488 |
| 5 Total capital and liabilities less excluded liabilities (row 3 minus row 4) | 23,201 | 8,300 | 3,777 | 29,210 | 64,488 |
| 6 – of row 5 that are eligible as TLAC | 23,201 | 8,300 | 3,777 | 29,210 | 64,488 |
| 7 – of row 6 with 1 year ≤ residual maturity < 2 years | — | — | — | 4,118 | 4,118 |
| 8 – of row 6 with 2 years ≤ residual maturity < 5 years | — | — | — | 14,588 | 14,588 |
| 9 – of row 6 with 5 years ≤ residual maturity < 10 years | — | 3,777 | 5,339 | 9,116 |
| 10 – of row 6 with residual maturity ≥ 10 years, but excluding perpetual securities | — | — | — | 5,165 | 5,165 |
| 11 – of row 6 that are perpetual securities | 23,201 | 8,300 | — | — | 31,501 |

1 Excludes the value of share premium and reserves attributable to ordinary shareholders.

### US resolution group

The URG comprises HSBC North America Holdings Inc. and its subsidiaries. HSBC North America Holdings Inc. is the designated resolution entity.

The following table presents information regarding the ranking of creditors of HSBC North America Holdings Inc.

Table 28: HSBC North America Holdings Inc. creditor ranking¹ (TLAC3)

| | 1 (most junior) | 2 | 3 | 4 (most senior) | Sum of 1 to 4 |
|---|---|---|---|---|---|
| | Common stock² \$m | Preferred stock \$m | Subordinated loans \$m | Senior unsecured loans and other pari passu liabilities \$m | \$m |
| 1 Description of creditor ranking | | | | | |
| 2 Total capital and liabilities net of credit risk mitigation | — | 1,640 | — | 12,594 | 14,234 |
| 3 – of row 2 that are excluded liabilities³ | — | — | — | 208 | 208 |
| 4 Total capital and liabilities less excluded liabilities (row 2 minus row 3)⁴ | — | 1,640 | — | 12,386 | 14,026 |
| 5 – of row 4 that are potentially eligible as TLAC | — | 1,640 | — | 9,250 | 10,890 |
| 6 – of row 5: | | | | | |
| with 1 year ≤ residual maturity < 2 years | — | — | — | — | — |
| 7 with 2 years ≤ residual maturity < 5 years | — | — | — | 7,000 | 7,000 |
| 8 with 5 years ≤ residual maturity < 10 years | — | — | — | 2,250 | 2,250 |
| 9 with residual maturity ≥ 10 years, but excluding perpetual securities | — | — | — | — | — |
| 10 that are perpetual securities | — | 1,640 | — | — | 1,640 |

1 The entity’s capital and TLAC are held by HSBC Overseas Holdings (UK) Limited.
2 The nominal value of common stock is \$2. This excludes the value of share premium and reserves attributable to ordinary shareholders.
3 Excluded liabilities consists of ‘unrelated liabilities’ as defined in the Final US TLAC rules. This mainly represents accrued employee benefit obligations.
4 Row 4 includes liabilities related to intercompany borrowings with URG subsidiaries that are not eligible as TLAC.

Table 27: Hang Seng Bank Ltd creditor ranking (TLAC2)

| | 1 (most junior) | 2 | 3 (most senior) | Sum of 1 to 3 |
|---|---|---|---|---|
| | Ordinary shares¹ \$m | AT1 instruments \$m | LAC loans \$m | \$m |
| 1 Is the resolution entity the creditor/investor? | No | No | No | |
| 2 Description of creditor ranking | | | | |
| 3 Total capital and liabilities net of credit risk mitigation | 1,244 | 1,500 | 3,539 | 6,283 |
| 5 Total capital and liabilities less excluded liabilities (row 3 minus row 4) | 1,244 | 1,500 | 3,539 | 6,283 |
| 6 – of row 5 that are eligible as TLAC | 1,244 | 1,500 | 3,539 | 6,283 |
| 7 – of row 6 with 1 year ≤ residual maturity < 2 years | — | — | 803 | 803 |
| 8 – of row 6 with 2 years ≤ residual maturity < 5 years | — | — | 2,336 | 2,336 |
| 9 – of row 6 with 5 years ≤ residual maturity < 10 years | — | — | 400 | 400 |
| 11 – of row 6 that are perpetual securities | 1,244 | 1,500 | — | 2,744 |

1 Excludes the value of reserves attributable to ordinary shareholders.

# Credit risk

## Overview and responsibilities

Credit risk represents our largest regulatory capital requirement.

The principal objectives of our credit risk management function are:
– to maintain across HSBC a strong culture of responsible lending and a robust credit risk policy and control framework;
– to both partner and challenge our businesses in defining, implementing and continually re-evaluating our credit risk appetite under actual and stress scenario conditions; and
– to ensure there is independent, expert scrutiny of credit risks, their costs and their mitigation.

The credit risk functions within Wholesale Credit Risk Management, and Wealth and Personal Banking (‘WPB’) are the constituent parts of Global Risk that support the GCRCO in overseeing credit risks. Their major duties comprise undertaking independent reviews of large and high-risk credit proposals, overseeing large exposure policy and reporting on our wholesale and retail credit risk management disciplines. They also own our credit policy and credit systems programmes, oversee portfolio management and report on risk matters to senior executive management and regulators.

These credit risk functions work closely with other parts of Global Risk, for example, with Operational Risk on the internal control framework and with Risk Strategy on the risk appetite process. In addition, they work jointly with Risk Strategy and Global Finance on stress testing.

For further details of the credit responsibilities of Global Risk, see page 129 of the Annual Report and Accounts 2024.

The credit risk functions form a network of credit risk management offices around the Group reporting within regional risk functions. They fulfil an essential role as independent risk control units distinct from business line management providing objective scrutiny of risk rating assessments, credit proposals for approval and other risk matters.

Our credit risk procedures operate through a hierarchy of personal credit limit approval authorities. Operating company chief executives, acting under authorities delegated by their boards and Group standards, are accountable for credit risk and other risks in their business. In turn, chief executives delegate authority to operating company chief risk officers and management teams on an individual basis. Each operating company is responsible for the quality and performance of its credit portfolios in accordance with Group standards. Above these thresholds of delegated personal credit limited approval authorities, approval must be sought from the regional and, as appropriate, the global credit risk function.

### Credit risk management

Credit risk

Our exposure to credit risk arises from a wide range of customer types and products, and the risk rating systems in place to measure and monitor these risks are correspondingly diverse. Senior management receives reports on our credit risk exposures, including expected credit losses, total exposures and RWAs, as well as updates on specific portfolios that are considered to have heightened credit risk.

Credit risk exposures are generally measured and managed in portfolios of either customer types or product categories. Risk rating systems are designed to assess the PD and LGD associated with distinct customers who are typically managed as individual relationships or, in the case of retail business exposures, on a product portfolio basis.

Risk rating systems for retail exposures are generally quantitative in nature, applying techniques such as behavioural analysis across product portfolios comprising large numbers of homogeneous transactions.

Rating systems for individually managed relationships typically use customer financial statements and market data analysis, but also qualitative elements and a final judgemental overlay to reflect any relevant risk drivers not captured in the rating system.

For further details of the application of the IRB approach, see page 59.

A fundamental principle of our policy and approach is that analytical risk rating systems and scorecards are valuable management tools that are fully embedded within the credit risk management framework, ensuring compliance with the regulatory use test requirements.

The credit process for wholesale lending requires a review of the PDs at least annually and for retail lending revolving facilities, an annual review is undertaken. Review may be more frequent as required by circumstances, such as the emergence of adverse risk factors.

We seek to continually improve the quality of our risk management. Group IT systems that process credit risk data continue to be enhanced to deliver both comprehensive management information in support of business strategy and solutions to evolving regulatory reporting requirements.

Like other facets of risk management, analytical risk rating systems are not static. They are subject to review and modification in light of the changing economic environment, changing regulatory requirements and any deficiencies identified through internal and external regulatory review. Structured processes and metrics are in place to capture relevant data and feed this into continuous model improvement.

Post Model Adjustments (‘PMAs’) are held to ensure that capital requirements are not understated due to non-compliance of risk rating systems or other IRB model limitations. PMAs will be held until new models are approved by the PRA or model limitations have been remediated. PMAs are reviewed at least quarterly and updated where required.

For further details of model performance, see page 86.

### Dilution risk

Dilution risk is the risk that an amount receivable is reduced through cash or non-cash credit to the obligor, and arises mainly from factoring and invoice discounting transactions.

Where there is recourse to the seller, we treat these transactions as loans secured by the collateral of the debts purchased and do not report dilution risk for them. For our non-recourse portfolio we obtain an indemnity from the seller that indemnifies us against this risk. Factoring transactions involve lending at a discount to the face-value of the receivables, which provides protection against dilution risk.

### Credit quality of assets

Our credit risk is diversified across a number of asset classes and geographies with a credit quality profile mainly concentrated in the higher quality bands.

The IFRS 9 stages have the following characteristics:
– Stage 1: These financial assets are unimpaired and without a significant increase in credit risk. A 12-month allowance for ECL is recognised.
– Stage 2: A significant increase in credit risk has been experienced on these financial assets since initial recognition. A lifetime ECL is recognised.
– Stage 3: There is objective evidence of impairment and the financial assets are therefore considered to be in default or otherwise credit impaired. A lifetime ECL is recognised.
– Purchased or originated credit-impaired (‘POCI’): Financial assets purchased or originated at a deep discount are seen to reflect incurred credit losses and a lifetime ECL is recognised. These exposures are included in stage 3 in the table below.

For further details of credit-impaired (stage 3) exposures, see pages 170 and 185 of the Annual Report and Accounts 2024.

The table below breaks down the gross carrying amount of the performing and non-performing exposures and related impairments, and details of the collateral and financial guarantees received within each of the FINREP categories and definitions. Gross carrying amount includes reverse repos and settlement accounts, and the on-balance sheet exposures exclude assets held for sale. The staging analysis is non-additive as totals contain instruments not eligible for staging, such as those held at fair value through profit and loss.

Table 29: Performing and non-performing exposures and related provisions (CR1)

| | Gross carrying amount/ nominal amount | Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions | Collateral and financial guarantees received |
|---|---|---|---|
| | Performing exposures \$bn | Non-performing exposures \$bn | Performing exposures \$bn | Non-performing exposures \$bn | On performing exposures \$m | On non performing exposures \$m |
| | Total | of which: stage 1 | of which: stage 2 | of which: stage 3 | of which: stage 1 | of which: stage 2 | of which: stage 3 | | |
| 005 Cash balances at central banks and other demand deposits | 314.7 | 314.6 | 0.1 | — | — | — | — | — | — | — | — | — |
| 010 Loans and advances | 1,278.0 | 1,174.0 | 96.4 | 23.3 | 23.3 | (3.9) | (1.2) | (2.7) | (6.3) | (6.4) | (3.2) | 886.8 | 13.4 |
| 020 Central banks | 23.1 | 23.1 | — | — | — | — | — | — | — | — | — | 3.6 | — |
| 030 General governments | 11.4 | 11.3 | 0.1 | 0.2 | 0.2 | — | — | — | — | — | — | 5.1 | 0.1 |
| 040 Credit institutions | 125.9 | 125.3 | 0.1 | — | — | — | — | — | — | — | — | 87.3 | — |
| 050 Other financial corporations | 258.3 | 250.8 | 2.3 | 0.7 | 0.7 | (0.1) | (0.1) | — | (0.3) | (0.4) | — | 187.9 | 0.3 |
| 060 Non-financial corporations | 410.1 | 354.4 | 53.8 | 18.8 | 18.8 | (2.0) | (0.5) | (1.5) | (5.2) | (5.2) | (3.0) | 204.3 | 10.7 |
| 070 – of which: SMEs | 21.7 | 18.1 | 3.7 | 1.2 | 1.2 | (0.2) | (0.1) | (0.1) | (0.2) | (0.2) | (0.1) | 16.2 | 0.9 |
| 080 Households | 449.2 | 409.1 | 40.1 | 3.6 | 3.6 | (1.8) | (0.6) | (1.2) | (0.8) | (0.8) | (0.2) | 398.6 | 2.3 |
| 090 Debt securities | 494.6 | 491.3 | 0.8 | — | — | (0.1) | (0.1) | — | — | — | — | 35.4 | — |
| 100 Central banks | 22.9 | 22.9 | — | — | — | — | — | — | — | — | — | — | — |
| 110 General governments | 416.3 | 414.7 | 0.8 | — | — | (0.1) | (0.1) | — | — | — | — | 31.6 | — |
| 120 Credit institutions | 38.4 | 38.2 | — | — | — | — | — | — | — | — | — | 3.5 | — |
| 130 Other financial corporations | 12.3 | 12.0 | — | — | — | — | — | — | — | — | — | 0.1 | — |
| 140 Non-financial corporations | 4.7 | 3.5 | — | — | — | — | — | — | — | — | — | 0.2 | — |
| 150 Off-balance-sheet exposures | 985.7 | 626.7 | 23.1 | 2.7 | 1.4 | (0.4) | (0.1) | (0.1) | (0.4) | (0.2) | | 106.2 | 0.2 |
| 160 Central banks | 0.7 | 0.7 | — | — | — | — | — | — | — | — | — | — | — |
| 170 General governments | 3.8 | 3.4 | — | — | — | — | — | — | — | — | — | — | — |
| 180 Credit institutions | 50.8 | 43.1 | 0.1 | — | — | — | — | — | — | — | — | 0.5 | — |
| 190 Other financial corporations | 104.0 | 78.1 | 2.1 | 0.1 | 0.1 | — | — | — | — | — | — | 13.5 | — |
| 200 Non-financial corporations | 571.3 | 248.4 | 19.2 | 2.5 | 1.2 | (0.4) | (0.1) | (0.1) | (0.4) | (0.2) | | 36.1 | 0.2 |
| 210 Households | 255.1 | 253.0 | 1.7 | 0.1 | 0.1 | — | — | — | — | — | — | 56.1 | — |
| 220 Total at 31 Dec 2024 | 3,072.9 | 2,606.6 | 120.4 | 26.0 | 24.7 | (4.4) | (1.4) | (2.8) | (6.7) | (6.6) | (3.2) | 1,028.4 | 13.6 |

Table 29: Performing and non-performing exposures and related provisions (CR1) (continued)

| | Gross carrying amount/ nominal amount | Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions | Collateral and financial guarantees received |
|---|---|---|---|
| | Performing exposures \$bn | Non-performing exposures \$bn | Performing exposures \$bn | Non-performing exposures \$bn | On performing exposures \$m | On non performing exposures \$m |
| | Total | of which: stage 1 | of which: stage 2 | of which: stage 3 | of which: stage 1 | of which: stage 2 | of which: stage 3 | | |
| 005 Cash balances at central banks and other demand deposits | 332.1 | 330.9 | 1.2 | — | — | — | — | — | — | — | — | — |
| 010 Loans and advances | 1,314.2 | 1,183.8 | 125.0 | 20.1 | 20.1 | (4.4) | (1.2) | (3.2) | (7.2) | (7.2) | (2.0) | 900.6 | 9.6 |
| 020 Central banks | 41.8 | 41.1 | 0.6 | — | — | — | — | — | — | — | — | 12.1 | — |
| 030 General governments | 8.5 | 8.3 | 0.2 | 0.2 | 0.2 | — | — | — | — | — | — | 3.2 | 0.1 |
| 040 Credit institutions | 138.4 | 138.2 | 0.1 | — | — | — | — | — | — | — | — | 93.0 | — |
| 050 Other financial corporations | 249.0 | 240.8 | 3.8 | 0.8 | 0.8 | (0.1) | (0.1) | — | (0.3) | (0.3) | — | 174.9 | 0.2 |
| 060 Non-financial corporations | 427.9 | 354.5 | 72.6 | 15.5 | 15.5 | (2.2) | (0.5) | (1.7) | (6.0) | (6.0) | (1.8) | 221.1 | 7.2 |
| 070 – of which: SMEs | 26.5 | 21.5 | 5.0 | 1.9 | 1.9 | (0.3) | (0.1) | (0.2) | (0.3) | (0.3) | — | 20.0 | 1.5 |
| 080 Households | 448.6 | 400.9 | 47.7 | 3.6 | 3.6 | (2.1) | (0.6) | (1.5) | (0.9) | (0.9) | (0.2) | 396.3 | 2.1 |
| 090 Debt securities | 433.3 | 430.6 | 1.2 | — | — | (0.1) | — | (0.1) | — | — | — | 32.7 | — |
| 100 Central banks | 26.2 | 26.1 | 0.1 | — | — | — | — | — | — | — | — | — | — |
| 110 General governments | 358.8 | 357.0 | 1.0 | — | — | (0.1) | — | (0.1) | — | — | — | 29.4 | — |
| 120 Credit institutions | 31.0 | 30.9 | 0.1 | — | — | — | — | — | — | — | — | 2.9 | — |
| 130 Other financial corporations | 13.9 | 13.6 | — | — | — | — | — | — | — | — | — | 0.2 | — |
| 140 Non-financial corporations | 3.4 | 3.0 | — | — | — | — | — | — | — | — | — | 0.2 | — |
| 150 Off-balance-sheet exposures | 1,017.6 | 656.0 | 31.6 | 3.0 | 1.7 | (0.3) | (0.2) | (0.1) | (0.3) | (0.2) | | 142.8 | 0.3 |
| 160 Central banks | 0.8 | 0.8 | — | — | — | — | — | — | — | — | — | — | — |
| 170 General governments | 4.4 | 3.4 | — | — | — | — | — | — | — | — | — | — | — |
| 180 Credit institutions | 57.5 | 50.7 | 0.2 | — | — | — | — | — | — | — | — | 0.8 | — |
| 190 Other financial corporations | 112.7 | 86.6 | 4.9 | 0.1 | 0.1 | — | — | — | — | — | — | 28.5 | — |
| 200 Non-financial corporations | 584.1 | 260.2 | 23.0 | 2.5 | 1.3 | (0.3) | (0.2) | (0.1) | (0.3) | (0.2) | | 56.1 | 0.1 |
| 210 Households | 258.1 | 254.3 | 3.5 | 0.4 | 0.3 | — | — | — | — | — | — | 57.4 | 0.2 |
| 220 Total at 31 Dec 2023 | 3,097.2 | 2,601.3 | 159.0 | 23.1 | 21.8 | (4.8) | (1.4) | (3.4) | (7.5) | (7.4) | (2.0) | 1,076.1 | 9.9 |

Table 33: Credit quality of performing and non-performing exposures by past due days (CQ3)

| | Gross carrying amount/nominal amount | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | Performing exposures \$bn | Non-performing exposures \$bn | | | | | | | | | | |
| | Total | Not past due or past due $\le$ 30 days \$bn | Past due > 30 days $\le$ 90 days \$bn | Total \$bn | Unlikely to pay that are not past due or are past due $\le$ 90 days \$bn | Past due > 90 days $\le$ 180 days \$bn | Past due > 180 days $\le$ 1 year \$bn | Past due > 1 year $\le$ 2 years \$bn | Past due > 2 years $\le$ 5 years \$bn | Past due > 5 years $\le$ 7 years \$bn | Past due > 7 years \$bn | of which: defaulted \$bn |
| 005 Cash balances at central banks and other demand deposits | 314.7 | 314.7 | — | — | — | — | — | — | — | — | — | — |
| 010 Loans and advances | 1,278.0 | 1,276.8 | 1.2 | 23.3 | 14.6 | 2.2 | 2.9 | 1.5 | 1.8 | 0.1 | 0.2 | 23.3 |
| 020 Central banks | 23.1 | 23.1 | — | — | — | — | — | — | — | — | — | — |
| 030 General governments | 11.4 | 11.4 | — | 0.2 | — | — | — | — | 0.1 | — | 0.1 | 0.2 |
| 040 Credit institutions | 125.9 | 125.9 | — | — | — | — | — | — | — | — | — | — |
| 050 Other financial corporations | 258.3 | 258.2 | 0.1 | 0.7 | 0.7 | — | — | — | — | — | — | 0.7 |
| 060 Non-financial corporations | 410.1 | 409.9 | 0.2 | 18.8 | 11.7 | 1.6 | 2.5 | 1.4 | 1.4 | 0.1 | 0.1 | 18.8 |
| 070 – of which SMEs | 21.7 | 21.6 | 0.1 | 1.2 | 0.6 | 0.1 | 0.5 | — | — | — | — | 1.2 |
| 080 Households | 449.2 | 448.3 | 0.9 | 3.6 | 2.2 | 0.6 | 0.4 | 0.1 | 0.3 | — | — | 3.6 |
| 090 Debt securities | 494.6 | 494.6 | — | — | — | — | — | — | — | — | — | — |
| 100 Central banks | 22.9 | 22.9 | — | — | — | — | — | — | — | — | — | — |
| 110 General governments | 416.3 | 416.3 | — | — | — | — | — | — | — | — | — | — |
| 120 Credit institutions | 38.4 | 38.4 | — | — | — | — | — | — | — | — | — | — |
| 130 Other financial corporations | 12.3 | 12.3 | — | — | — | — | — | — | — | — | — | — |
| 140 Non-financial corporations | 4.7 | 4.7 | — | — | — | — | — | — | — | — | — | — |
| 150 Off-balance-sheet exposures | 985.7 | 2.7 | 2.7 | — | — | — | — | — | — | — | — | — |
| 160 Central banks | 0.7 | 0.7 | — | — | — | — | — | — | — | — | — | — |
| 170 General governments | 3.8 | — | — | — | — | — | — | — | — | — | — | — |
| 180 Credit institutions | 50.8 | — | — | — | — | — | — | — | — | — | — | — |
| 190 Other financial corporations | 104.0 | 0.1 | 0.1 | — | — | — | — | — | — | — | — | — |
| 200 Non-financial corporations | 571.3 | 2.5 | 2.5 | — | — | — | — | — | — | — | — | — |
| 210 Households | 255.1 | 0.4 | 0.4 | — | — | — | — | — | — | — | — | — |
| 220 Total at 31 Dec 2024 | 3,072.9 | 2,086.1 | 1.2 | 26.0 | 14.6 | 2.2 | 2.9 | 1.5 | 1.8 | 0.1 | 0.2 | 26.0 |
| 005 Cash balances at central banks and other demand deposits | 332.1 | 332.1 | — | — | — | — | — | — | — | — | — | — |
| 010 Loans and advances | 1,314.2 | 1,312.2 | 2.0 | 20.1 | 13.3 | 1.8 | 1.9 | 1.2 | 1.3 | 0.2 | 0.3 | 20.1 |
| 020 Central banks | 41.8 | 41.8 | — | — | — | — | — | — | — | — | — | — |
| 030 General governments | 8.5 | 8.5 | — | 0.2 | 0.2 | — | — | — | — | — | — | 0.2 |
| 040 Credit institutions | 138.4 | 138.4 | — | — | — | — | — | — | — | — | — | — |
| 050 Other financial corporations | 249.0 | 248.7 | 0.3 | 0.8 | 0.4 | — | — | 0.4 | — | — | — | 0.8 |
| 060 Non-financial corporations | 427.9 | 427.3 | 0.6 | 15.5 | 10.7 | 1.2 | 1.5 | 0.6 | 1.0 | 0.2 | 0.2 | 15.5 |
| 070 – of which SMEs | 26.5 | 26.4 | 0.1 | 1.9 | 0.7 | 0.2 | 0.9 | 0.1 | — | — | — | 1.9 |
| 080 Households | 448.6 | 447.5 | 1.1 | 3.6 | 2.0 | 0.6 | 0.4 | 0.2 | 0.3 | 0.1 | 0.1 | 3.6 |
| 090 Debt securities | 433.3 | 433.3 | — | — | — | — | — | — | — | — | — | — |
| 100 Central banks | 26.2 | 26.2 | 0.1 | — | — | — | — | — | — | — | — | — |
| 110 General governments | 358.8 | 357.0 | 1.0 | — | — | (0.1) | — | (0.1) | — | — | — | — |
| 120 Credit institutions | 31.0 | 30.9 | 0.1 | — | — | — | — | — | — | — | — | — |
| 130 Other financial corporations | 13.9 | 13.6 | — | — | — | — | — | — | — | — | — | — |
| 140 Non-financial corporations | 3.4 | 3.0 | — | — | — | — | — | — | — | — | — | — |
| 150 Off-balance-sheet exposures | 1,017.6 | 3.0 | 3.0 | — | — | — | — | — | — | — | — | — |
| 160 Central banks | 0.8 | 0.8 | — | — | — | — | — | — | — | — | — | — |
| 170 General governments | 4.4 | 3.4 | — | — | — | — | — | — | — | — | — | — |
| 180 Credit institutions | 57.5 | 50.7 | 0.2 | — | — | — | — | — | — | — | — | — |
| 190 Other financial corporations | 112.7 | 86.6 | 4.9 | 0.1 | 0.1 | — | — | — | — | — | — | — |
| 200 Non-financial corporations | 584.1 | 260.2 | 23.0 | 2.5 | 1.3 | (0.3) | (0.2) | (0.1) | (0.3) | (0.2) | | 56.1 | 0.1 |
| 210 Households | 258.1 | 254.3 | 3.5 | 0.4 | 0.3 | — | — | — | — | — | — | 57.4 | 0.2 |
| 220 Total at 31 Dec 2023 | 3,097.2 | 2,601.3 | 159.0 | 23.1 | 21.8 | (4.8) | (1.4) | (3.4) | (7.5) | (7.4) | (2.0) | 1,076.1 | 9.9 |

Table 34: Collateral obtained by taking possession and execution processes (CQ7)

| | At 31 Dec 2024 | | At 31 Dec 2023 | |
|---|---|---|---|---|
| | Collateral obtained by taking possession \$m | | Collateral obtained by taking possession \$m | |
| | Value at initial recognition \$m | Accumulated negative changes \$m | Value at initial recognition \$m | Accumulated negative changes \$m |
| 020 Other than property, plant and equipment | 93.3 | (18.3) | 79.4 | (11.9) |
| 030 Residential immovable property | 67.5 | (6.2) | 65.3 | (9.2) |
| 040 Commercial immovable property | 25.1 | (12.1) | 13.9 | (2.7) |
| 050 Movable property (auto, shipping, etc.) | 0.6 | — | 0.1 | — |
| 070 Other | 0.1 | — | 0.1 | — |
| 080 Total | 93.3 | (18.3) | 79.4 | (11.9) |

### Concentration risk

Concentrations of credit risk arise when a number of counterparties or exposures have comparable economic characteristics, are engaged in similar activities or operate in the same geographical areas or industry sectors so that their collective ability to meet contractual obligations is uniformly affected by changes in economic, political or other conditions.

We have a number of global businesses with a broad range of products. We operate in a number of geographical markets with the majority of our exposures in Asia and Europe. We use a number of controls and measures to minimise undue concentration of exposure in our portfolios across industries, countries and global businesses. These include portfolio and counterparty limits, approval and review controls, and stress testing. The following tables present information on the concentration of exposures by geography and industry.

The table below shows the credit quality of on- and off- balance sheet exposures by geography. The geographical breakdown is based on the country or territory of residence of the immediate counterparty. The table presents the countries that are contributing 10% or more of the total on-balance sheet and off-balance sheet exposures separately, with the remaining exposures aggregated within ‘other countries’. The on-balance sheet exposures exclude cash and balances at central banks and assets held for sale.

Table 35: Quality of non-performing exposures by geography (CQ4)

| | Gross carrying/ Nominal amount \$m | Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions \$m | Provisions on off-balance sheet commitments and financial guarantee given \$m |
|---|---|---|---|
| | Total | of which: non performing | of which: defaulted | of which: subject to impairment | On performing exposures \$m | On non performing exposures \$m | Total \$m | of which: on balance sheet |
| 010 On-balance sheet exposures | 1,795,926 | 23,347 | 23,347 | 1,785,814 | (10,329) | |
| 020 United Kingdom | 375,331 | 4,694 | 4,694 | 373,007 | (2,242) | |
| 030 Hong Kong | 341,109 | 9,693 | 9,693 | 339,321 | (2,945) | |
| 040 United States | 318,818 | 904 | 904 | 317,371 | (352) | |
| 070 Other countries/territories | 760,668 | 8,056 | 8,056 | 756,115 | (4,790) | |
| 080 Off-balance sheet exposures | 988,355 | 2,682 | 2,682 | | | (769) |
| 090 Hong Kong | 218,528 | 224 | 224 | | | (30) |
| 100 United Kingdom | 127,378 | 614 | 614 | | | (164) |
| 110 United States | 122,885 | 366 | 366 | | | (56) |
| 140 Other countries/territories | 519,564 | 1,478 | 1,478 | | | (519) |
| 150 Total at 31 Dec 2024 | 2,784,281 | 26,029 | 26,029 | 1,785,814 | (10,329) | (769) |
| 010 On-balance sheet exposures | 1,767,522 | 20,051 | 20,051 | 1,760,605 | (11,712) | |
| 020 United Kingdom | 365,954 | 5,121 | 5,121 | 364,832 | (2,326) | |
| 030 Hong Kong | 350,671 | 4,358 | 4,358 | 348,939 | (2,382) | |
| 040 United States | 287,408 | 994 | 994 | 285,567 | (376) | |
| 070 Other countries/territories | 763,489 | 9,578 | 9,578 | 761,267 | (6,628) | |
| 080 Off-balance sheet exposures | 1,020,552 | 3,007 | 3,007 | | | (611) |
| 090 Hong Kong | 219,193 | 192 | 192 | | | (39) |
| 100 United Kingdom | 126,789 | 514 | 514 | | | (164) |
| 110 United States | 131,931 | 463 | 463 | | | (45) |
| 140 Other countries/territories | 542,639 | 1,838 | 1,838 | | | (363) |
| 150 Total at 31 Dec 2023 | 2,788,074 | 23,058 | 23,058 | 1,760,605 | (11,712) | (611) |

Table 36: Credit quality of loans and advances to non-financial corporations by industry (CQ5)

| | Gross carrying amount | Accumulated impairment |
|---|---|---|
| | Total | Non-performing | of which: defaulted | of which: subject to impairment \$m | Accumulated impairment \$m |
| 010 Agriculture, forestry and fishing | 7,101 | 282 | 282 | 7,101 | (96) |
| 020 Mining and quarrying | 8,419 | 318 | 318 | 8,419 | (46) |
| 030 Manufacturing | 89,832 | 1,602 | 1,602 | 88,921 | (943) |
| 040 Electricity, gas, steam and air conditioning supply | 18,407 | 239 | 239 | 18,339 | (133) |
| 050 Water supply | 2,963 | 43 | 43 | 2,963 | (23) |
| 060 Construction | 30,184 | 3,279 | 3,279 | 29,993 | (1,768) |
| 070 Wholesale and retail trade | 87,428 | 2,989 | 2,989 | 87,203 | (1,595) |
| 080 Transport and storage | 24,003 | 418 | 418 | 23,956 | (322) |
| 090 Accommodation and food service activities | 14,795 | 1,611 | 1,611 | 14,715 | (298) |
| 100 Information and communication | 19,883 | 229 | 229 | 19,850 | (160) |
| 110 Financial and insurance activities | 270 | — | — | 270 | (1) |
| 120 Real estate activities | 61,175 | 5,700 | 5,700 | 61,129 | (964) |
| 130 Professional, scientific and technical activities | 26,158 | 648 | 648 | 25,878 | (266) |
| 140 Administrative and support service activities | 20,272 | 739 | 739 | 20,269 | (320) |
| 150 Public administration and defence, compulsory social security | 87 | — | — | 87 | — |
| 160 Education | 2,637 | 81 | 81 | 2,637 | (58) |
| 170 Human health services and social work activities | 4,031 | 184 | 184 | 4,031 | (51) |
| 180 Arts, entertainment and recreation | 2,065 | 78 | 78 | 2,065 | (35) |
| 190 Other services | 9,212 | 338 | 338 | 9,194 | (116) |
| 200 Total at 31 Dec 2024 | 428,922 | 18,778 | 18,778 | 427,020 | (7,195) |
| 010 Agriculture, forestry and fishing | 7,236 | 307 | 307 | 7,236 | (131) |
| 020 Mining and quarrying | 7,718 | 326 | 326 | 7,718 | (102) |
| 030 Manufacturing | 92,296 | 1,999 | 1,999 | 91,741 | (1,197) |
| 040 Electricity, gas, steam and air conditioning supply | 16,083 | 287 | 287 | 15,882 | (128) |
| 050 Water supply | 3,264 | 103 | 103 | 3,264 | (62) |
| 060 Construction | 35,477 | 3,956 | 3,956 | 35,477 | (2,690) |
| 070 Wholesale and retail trade | 87,552 | 2,564 | 2,564 | 87,462 | (1,551) |
| 080 Transport and storage | 22,620 | 543 | 543 | 22,620 | (231) |
| 090 Accommodation and food service activities | 15,894 | 970 | 970 | 15,886 | (257) |
| 100 Information and communication | 19,478 | 299 | 299 | 19,478 | (173) |
| 110 Financial and insurance activities | 291 | 9 | 9 | 291 | (2) |
| 120 Real estate activities | 66,290 | 2,085 | 2,085 | 66,290 | (735) |
| 130 Professional, scientific and technical activities | 26,523 | 740 | 740 | 26,513 | (400) |
| 140 Administrative and support service activities | 22,396 | 597 | 597 | 22,396 | (269) |
| 150 Public administration and defence, compulsory social security | 1,042 | — | — | 1,042 | (1) |
| 160 Education | 2,416 | 77 | 77 | 2,416 | (40) |
| 170 Human health services and social work activities | 4,326 | 183 | 183 | 4,326 | (56) |
| 180 Arts, entertainment and recreation | 1,993 | 99 | 99 | 1,993 | (42) |
| 190 Other services | 10,465 | 328 | 328 | 10,442 | (158) |
| 200 Total at 31 Dec 2023 | 443,360 | 15,472 | 15,472 | 442,473 | (8,225) |

# Risk mitigation

## Our approach to granting credit facilities is on the basis of capacity to repay, rather than placing primary reliance on credit risk mitigants. Depending on a customer’s standing and the type of product, facilities may be provided unsecured.

Mitigation of credit risk is a key aspect of effective risk management and takes many forms. Our general policy is to promote the use of credit risk mitigation, justified by commercial prudence and capital efficiency. Detailed policies cover the acceptability, structuring and terms relating to the availability of credit risk mitigation such as in the form of collateral security. These policies, together with the setting of suitable valuation parameters, are subject to regular review to ensure that they are supported by empirical evidence and continue to fulfil their intended purpose.

### Collateral

The most common method of mitigating credit risk is to take a charge over collateral. In our retail residential and commercial real estate (‘CRE’) businesses, a mortgage over the property is usually taken to help secure claims. Physical collateral is also taken in various forms of specialised lending and leasing transactions where income from the physical assets that are financed is also the principal source of facility repayment. In the commercial and industrial sectors, charges are created over business assets such as premises, stock and debtors. Loans to private banking clients may be made against a pledge of eligible marketable securities, cash or real estate. Facilities to SMEs are commonly granted against guarantees given by their owners and/or directors.

For credit risk mitigants in the form of immovable property, the key determinant of concentration at Group level is geography. Use of immovable property mitigants for risk management purposes is predominantly in Asia and Europe.

For further details of collateral held over CRE and residential property, see pages 180 and 194 of the Annual Report and Accounts 2024.

### Financial collateral

In the institutional sector, trading facilities are supported by charges over financial instruments, such as cash, debt securities and equities. Financial collateral in the form of marketable securities is used in much of the Group’s derivatives activities and in securities financing transactions, such as repos, reverse repos, securities lending and borrowing. Netting is used extensively and is a prominent feature of market standards documentation.

For further details of collateral held for trading exposures, see page 184 of the Annual Report and Accounts 2024.

In the banking book, we provide customers with working capital management products. In some cases, these products combine loans and advances to customers, whose accounts we have the right of offset, which complies with the regulatory requirements for on balance sheet netting. Where this applies, the customer accounts are treated as cash collateral and are reflected in our LGD estimates.

Under on-balance sheet netting agreements, the customer accounts are treated as though they are covered by cash collateral and the effects of this collateral are incorporated in our LGD estimates. For risk management purposes, the net amounts of such exposures are subject to limits and the relevant customer agreements are subject to review to ensure the legal right of offset remains appropriate.

### Other forms of credit risk mitigation

Our GBM business uses credit risk mitigation to manage the credit risk of its portfolios, with the goal of reducing concentrations in individual names, sectors or portfolios. The techniques in use include credit default swap (‘CDS’) purchases, structured credit notes and securitisation structures. Buying credit protection creates credit exposure against the protection provider, which is monitored as part of the overall credit exposure to them. Where applicable, the transaction is entered into directly with a central clearing house counterparty; otherwise our exposure to CDS protection providers is diversified among mainly banking counterparties with strong credit ratings.

In our corporate lending, we also take guarantees from banks, corporates and export credit agencies. Corporates would normally provide guarantees as part of a parent and subsidiary or common parent relationship and would span a number of credit grades. The ECAs will normally be investment grade.

### Policy and procedures

Policies and procedures cover the end-to-end credit lending process including the governance of the protection of our position from the outset of a customer relationship; for instance, in requiring standard terms and conditions or specifically agreed documentation permitting the offset of credit balances against debt obligations, and through controls over the integrity, current valuation and, if necessary, realisation of collateral security.

### Valuing collateral

Valuation strategies are established to monitor collateral mitigants to ensure that they will continue to provide the anticipated secure secondary repayment source. The frequency of valuation increases with the volatility of the collateral. For market trading activities such as collateralised over-the-counter (‘OTC’) derivatives and SFTs, we typically carry out daily valuations. For residential mortgages, Group policy prescribes a revaluation of the portfolio at a minimum of every three years, or every 6 months for material portfolios. More frequent revaluations are required where market conditions are subject to significant change, and for non performing loans are subject to monitoring at a minimum annually. Residential property collateral values are determined through a combination of professional appraisals, desktop valuations, automated valuation models (‘AVMs’), house price indices or statistical analysis.

For CRE, where the facility exceeds regulatory threshold requirements, Group policy requires an independent review of the valuation at least every three years, or more frequently as the need arises. Revaluations are sought where, for example, material concerns arise in relation to the performance of the collateral. CRE revaluation also occurs commonly in circumstances where an obligor’s credit quality has declined sufficiently to cause concern that the principal payment source may not fully meet the obligation.

### Recognition of risk mitigation under the IRB approach

Within an IRB approach, risk mitigants are considered in two broad categories:
– those which reduce the intrinsic PD of an obligor and therefore operate as determinants of PD; and
– those which affect the estimated recoverability of obligations and require adjustment of LGD or, in certain limited circumstances, EAD.

The first category typically includes full parental guarantees where one obligor within a group guarantees another. In these circumstances, the PD of the parent guarantor is used to adjust or substitute the PD of the guaranteed obligor. PD estimates may be subject to a ‘sovereign ceiling’, constraining the risk ratings assigned to obligors in countries of higher risk, and where only partial parental support exists. In certain jurisdictions, certain types of third-party guarantee are recognised by substituting the obligor’s PD with that of the guarantor.

In the second category, LGD estimates are affected by a wider range of collateral, including cash, charges over real estate property, fixed assets, trade goods, receivables and floating charges such as mortgage debentures. Unfunded mitigants, such as third-party guarantees, are also considered in LGD estimates where there is evidence that they reduce loss expectation.

Table